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Stereoselective 5-exo radical and Heck cyclizations of axially chiral o-iodoanilides to 
enantioenriched oxindoles and dihydroindolones are described.  Mechanisms for the transfer of 
chirality from the atropisomeric anilides to the newly formed stereocenters in the cyclic products 
are proposed and supported with physical data.  Additionally, the N-aryl bond rotation barriers 
for eight o-iodoanilides are reported. 
 
 A series of axially chiral N-allyl-o-iodoanilides were cyclized under room temperature radical 
conditions to dihydroindolones with good to excellent chirality transfer (74–97 %).  Cyclization 
rate constant data is presented to rationalize the regioselective preference for N-allyl over N-
acryloyl cyclization when an o-methyl group is present.  X-ray crystallography was used to 
assign absolute configurations to a cyclization precursor/product pair.  Radical 5-exo cyclizations 
of axially chiral o-iodoanilides bearing branched, bulky N-substituents are covered.  The 
bulkiness of N-substituents permitted the resolution of a series of novel o-iodoanilides lacking a 
second ortho substituent.  Radical cyclizations of these o-iodoanilides transferred this transient 
axial chirality into a new stereocenter in the oxindole products with high fidelity (78–92 %).  The 
first Heck cyclizations of axially chiral o-iodoanilides with chirality transfer (84–89 %) are 
described.  X-ray crystallographic data is presented for one anilide cyclization precursor with   
studies to elucidate the mechanism of chiral transfer. 
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1. AXIALLY CHIRAL ANILIDES 
 
1.1. Axial Chirality 
A molecule is chiral when the geometrical placement of its atoms in three-dimensional space is 
such that it cannot be superimposed on its mirror image.  Chiral molecules with one stereogenic 
center meet this requirement by having four differing groups attached to a shared or common 
atom.  In the case of axially chiral molecules, the element of asymmetry is an axis within the 
molecule.
1
 A classic example of axial chirality is an allene that has differing pairs of substituents 
at each end (Figure 1.1).  
Me
H Me
H
H
Me Me
H
Me
HMe
H
enantiomerization
by Me/H exchange
M P
ent-1
ent-11
 
Figure 1.1 - Enantiomers of 2,3-Pentadiene 
 
In 2,3-pentadiene 1, each methyl group is oriented 90˚ from the plane formed by the other methyl 
group and the carbons of the allene.  Conceptually, enantiomerization of 1 to ent-1 is possible by 
exchanging the methyl group and the hydrogen atom at one end of the molecule.  However, the 
energy barrier to this exchange is prohibitively high.   
 
 2 
1.2. Stereochemical Designations of Axially Chiral Groups 
Designations of M and P are often used to describe configurations of molecules with chiral axes.
1
  
For this designation, only the ligands of highest priority at either end of the axis are considered.  
When the molecule is viewed down the length of the chiral axis (the choice of end is arbitrary), if 
the turn from priority ligand in front to the priority ligand in the rear is clockwise, then the 
designation is P (Figure 1.2).   Correspondingly, counterclockwise represents M.   
Me
H Me
H
1'
2'
2
1
1
H Me
Me
H
2 1
1'
2'
M  
Figure 1.2 - Assigning Stereochemical Designations to Axially Chiral Molecules 
 
1.3. Atropisomerism 
Atropisomers (from the Greek a and tropos, meaning “not” and “turn”) are a sub-category of 
axially chiral molecules whose chirality exists by virtue of restricted rotations around a formal 
single bond.  Eliel has suggested that atropisomers are “stereoisomers resulting from restricted 
rotation about single bonds where the rotational barrier is high enough to permit isolation.”
2
 The 
pioneering example of atropisomerism dates back to 1922, when George Christie and James 
Kenner resolved the two enantiomers of 2,2'-dinitro-6,6'-diphenic acid 2 by an asymmetric 
recrystallization (Figure 1.3).
3
 Similar to the methyl-bearing termini of 2,3-butadiene, each 
phenyl ring in 2,2'-dinitro-6,6'-diphenic acid is oriented roughly perpendicular to the plane 
formed by the other phenyl ring.  By virtue of the placement of the two rings and their 
differential substitution with respect to the axis along the C-C bond connecting the two phenyl 
 3 
rings, the molecule is chiral. Conversion of (M)-2 to (P)-2 is achieved by rotating 180˚ about the 
C-C bond connecting the phenyl rings.  
NO2
CO2H
O2N
HO2C
O2N
HO2C
NO2
CO2H
(P)-2(M)-2  
Figure 1.3 - Atropisomeric Pair of 2,2'-Dinitro-6,6'-diphenic Acid Enantiomers  
Oki put forth the arbitrary definition that a rotational isomer must have a half-life of at least 1000 
s for the molecule to be considered to exhibit atropisomerism.
4
  The temperature dependence of 
this definition is a weak point. For example, an atropisomer with a 1000 s lifetime at –100 ˚C 
would only have a fleeting existence at ambient temperature.  A more apt criterion for 
atropisomerism is to consider the energetic barrier to rotation.  For example, a rotation barrier of 
approximately 21.8 kcal/mol (90.9 kJ/mol) translates to a half-life of about 1000 s (just under 17 
min) at ambient temperature.  Thus, to conveniently handle atropisomers at room temperature, 
rotation barriers above ~22 kcal/mol (~92 kJ/mol) are needed. 
 
1.4. Tertiary Anilide Conformers 
1.4.1. Restricted N-CO Bond Rotation 
Tertiary amides exhibit restricted rotation about their N–CO bonds.  The N–CO bond of anilides, 
as in most amides, has significant ? character as a result of nitrogen lone pair delocalization 
 4 
towards the electronegative oxygen (Figure 1.4).  The additional contributions of the resonance 
forms with ? bonding 3A, 3B increase the barrier to N–CO rotation significantly.   
O
NR
R1
R2
O
NR
R2
R1
O
NR
R1
R2
O
NR
R2
R1
3A 3A' 3B' 3B
3B' favored where R2 is larger than R1 or R1 is an aryl group.    
Figure 1.4 – Rotational Isomers and Resonance Structures of Tertiary Amides 
 
1.4.2. Tertiary Anilides E/Z Preferences 
If R
1
 and R
2
 (Figure 1.4) differ in size, then the energy levels of the two conformers, 3A' and 
3B', will not be equally populated.  The conformation 3B' in which the larger group is syn to 
oxygen is more favored for steric reasons.  Tertiary anilides are an exception to this 
generalization because of the possibility of N-aryl bond rotation, which places the aromatic ring 
perpendicular to the plane of the amide and relieves steric interactions. For example, amide 4 in 
pyridine exhibits a 99.5/0.5 preference for the E isomer (Figure 1.5).
5
 This conformational 
preference has been supported by crystallographic data and theoretical calculations.
6
 
 
N
O
NO99.5/0.5
(E)-4 (Z)-4
pyridine
  
Figure 1.5 - Conformers of N-Methylacetanilide 
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1.5. Restricted N-Aryl Bond Rotation 
It has been long known that tertiary anilides exhibit restricted rotation about the N-aryl bond.  
Following the discovery of biaryl atropisomerism in 1922, researchers sought out other classes of 
optically active compounds that exhibit restricted rotation.
7
  If the N-aryl bond rotation barrier is 
sufficiently high, then the separation and laboratory manipulations of anilide enantiomers at 
ambient temperatures would be possible.  In 1928, Mills published the first example of an axially 
chiral anilide 5 (Figure 1.6).
8
   
N
O
SO3Na ?Grot = 23.4 kcal/mol (98.0 J/mol)
?1/2 = 5.25 h at T = 292 K
(P)-5
N
O
SO3Na
(M)-5  
 
Figure 1.6 – The First Axially Chiral Anilide Reported 
 
In the years ensuing Mill’s discovery, a number of axially chiral anilides have been synthesized 
by our group
9
 and others.
10–17
  By late 2005, the N-aryl bond rotation barrier has been quantified 
for numerous substrates.  A gallery of 32 representative anilides and related compounds sorted 
by ascending rotation barriers is diagrammed in the Appendix (page 246).  
 
Substitution at positions flanking the chiral axis affect the magnitude of the rotation barrier.  If 
an ortho substituent is sufficiently large or if two different, medium-sized ortho substituents are 
present, then an anilide can have a rotational barrier high enough to allow separation and 
laboratory manipulations of enantiomers at ambient temperatures. For example, the chiral o-
iodoacrylamide 8 has a rotation barrier of 30.8 kcal/mol (129.0 kJ/moL), which translates to a 
 6 
half-life of over 175 years at 20 ºC (Figure 1.7).  The ortho methyl group alone does not result in 
a large rotational barrier; anilide 6 racemizes in seconds under typical laboratory conditions.
11
  In 
the case of anilide 7, a single ortho tert-butyl group is sufficiently bulky enough to enable a 
barrier of 29.1 kcal/mol (121.8 kJ/mol). 
N Ph
O
6 
19.3 kcal/mol
(80.8 kJ/mol)
I
N
O
7
29.1 kcal/mol
(121.8 kJ/mol)
8
30.8 kcal/mol
(129.0 kJ/mol)
N
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Figure 1.7 - Rotational barrier of Selected Axially Chiral Anilides 
 
1.6. Synthetic Approaches to Enantioenriched Axially Chiral Anilides (Stoichiometric) 
To date, only a few synthetic approaches exist for the preparation of enantioenriched samples of 
axially chiral anilides.  The earliest known methodology was put forth by Taguchi and coworkers 
in 1998.
12
 In it, the chiral pool reagent lactic acid 9 was coupled with N-allyl aniline 10 to 
generate a separable mixture of diastereomers 11a, 11b (Scheme 1.1). The acetoxy group was 
subsequently removed by a four-step process to yield corresponding acrylamide enantiomers 
12a, 12b with ees as high as 97 %.  A modification of this method by Simpkins used SmI2 to 
reductively deoxygenate the acetate (not shown).
13
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Scheme 1.1 - Taguchi’s Chiral Pool Approach to Axially Chiral o-t-Butylanilides  
 
A conceptually different approach developed by Ates and Curran relies on the crystallization-
induced asymmetric transketalization of amide ketals (Scheme 1.2).
9e
  Beginning with rac-13, 
the dimethyl ketal 15 was formed in two steps; ketal 15 was subjected to trans-ketalization with 
dimethyl L-tartrate to give a 52/48 mixture of atropisomers 16a, 16b.  When the mixture was 
slowly crystallized, the ratio of 16a/16b was increased to 95/5 in what is likely a crystallization-
induced asymmetric transformation.  Hydrolysis of the amide ketals regenerates anilide (M)-13 
with 96.5/3.5 er.  That the er of 13 is roughly equivalent to the dr of the starting mixture of 
16a/16b indicates that hydrolysis of the ketal occurs faster than the N-aryl bond rotation. 
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NaOMe
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Scheme 1.2 - Enantioenriched Anilides via Asymmetric Crystallization 
 
An elegant protocol by Uemura includes the enantiotopic lithiation of prochiral methyl groups in 
tricarbonylchromium complexes of N-benzoyl-N-methyl-2,6-dimethylaniline rac-17 by a chiral 
lithium amide from amine 18, followed by quenching of the benzylic anion with methyl iodide to 
generate 19 with ees as high as 99 % (Scheme 1.3).  Subsequent exposure of the chromium 
complex 19 to light and air allowed the isolation of the axially chiral anilide (M)-20 with no loss 
of enantiopurity.
14
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Me
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Scheme 1.3 - Uemura’s Method: Enantiotopic Lithiation of Chromium Complexes 
 
1.7. Synthetic Approaches to Enantioenriched Axially Chiral Anilides (Catalytic)  
A common feature of the methodologies thus far is that they all rely on a stoichiometric amount 
of a chiral species.  Dr. Jun Terauchi developed the first catalytic enantioselective methodology 
in our labs in 2000.
9f
  Deprotonation of a prochiral, secondary anilide 21 generates an anionic 
intermediate that reacts preferentially with one enantiotopic face of a chiral Pd ?-allyl complex 
(Scheme 1.4).  In the best example, a 76 % yield of 22 was obtained in 53 % ee.  Soon after, the 
Taguchi group published a nearly identical approach, albeit with lower ees obtained.
15
  Taken 
together, these examples represent the first examples of catalytic asymmetric syntheses of axially 
chiral anilides. 
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N
O
Ph
t-BuH
Pd2(allyl)2Cl2
6 % (S)-BINAP
n-BuLi
-40 ºC, PhMe
N
O
Ph
t-Bu
OAc
21 (P)-22
76 % yield
53 % ee  
Scheme 1.4 - Pd-catalyzed Enantioselective Allylation of Secondary Anilides 
 
Earlier in 2005, Taguchi reported an extension to the N-allylation approach.  When secondary 
anilide 23 and 1-iodo-4-nitrobenzene 24 were treated with base and in the presence of catalytic 
Pd coordinated with the (R)-TBDM-SEGPHOS chiral ligand, anilide 25 was produced in high 
yield and 93 % ee.
16
  Surprisingly, despite the high temperatures required for the reaction to 
occur over 2 to 6 h, products were isolated without racemization. 
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H
t-Bu
O
t-Bu
NO2OPd(OAc)2, 0.033 equiv
(R)-TBDM-SEGPHOS, 0.05 equiv
t-BuOK, PhMe, 80 °C
23 P-25
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93 % ee
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Scheme 1.5 - Taguchi's  Catalytic Asymmetric N-Arylation Methodology 
 
1.8. Chromatographic Access to Enantioenriched Axially Chiral Anilides 
Although a wide variety of methodologies for the synthesis of axially chiral anilides have been 
published, a common feature that they lack is substrate generality.  When an appropriate 
 11 
asymmetric synthesis is not available for a substrate, the best option is often to prepare the 
compound in racemic form and then separate small quantities (10–100 mg) into enantiomers 
using commercial chiral HPLC columns.
17
  Regis Technologies’s (S,S)-Whelk-O 1 product in 
particular, is a workhorse column in our research.  This column has a covalently bound chiral 
stationary phase 26 that presents “a semi-rigid framework holding a ?-acidic 3,5-
dintirobenzamide group perpendicular to a ?-basic polynuclear aromatic group.”18  The amide N-
H group acts as a hydrogen bond donor and is situated in the cleft formed by the two aromatic 
systems.  The Whelk-O 1 column is capable of resolving enantiomers of a wide variety of chiral 
compounds, but is particularly suited for those possessing 1) Lewis basic functionality and 2) 
aromatic ring(s).  While a chromatographic approach is more general, it can be labor intensive 
when the separation between enantiomers is poor. 
O
Si
Me Me
SiO2
NH
O
NO2
NO2
26  
Scheme 1.6 – Chiral Stationary Phase of (S,S)-Whelk O 1 HPLC Columns
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2. MEMORY OF CHIRALITY 
 
2.1. Background 
In 1913, Leuch reported a curious result.  When he treated an optically active ketone 27, by 
virtue of an ? chiral center, with chlorine to effect an ? chlorination, the resulting product 28 
retained optical activity.
19
  This result was counterintuitive to thinking at the time because the 
enol intermediate was believed to be achiral and therefore, unable to influence stereoselection in 
subsequent steps.  Apparently, despite the loss of a chiral center a mechanism existed to translate 
chiral information to the product.  Half a century later, Marquet repeated Leuch’s experiment and 
confirmed that the ? chlorinated product 28 did indeed possess non-zero, albeit diminished, ee 
(Scheme 2.1).
20
 
O
H
CO2H
O
Cl
CO2H
Cl2
CHCl3
28, 
~55/45 er
27 
100/0 er  
Scheme 2.1 - Marquet's Confirmation of Leuchs' Observation 
 
Fifteen years later, Seebach and co-workers reported a related result.  While attempting the ? 
methylation of aspartate derivative 29 by a double lithiation procedure, they observed the 
expected ? methylated product 32 along with 15 % of the ? methylated side product 33.21  
Contrary to expectations, the er side product was not 50/50 but 80/20 (Scheme 2.2).   Like 
Leuch’s result, a seemingly achiral intermediate, in this case an enolate, produced non-racemic 
product.  Clearly, the intermediate must be chiral.  Seebach postulated that double deprotonation 
 13 
of 29 could result in an enolate 31 with transient axial chirality, about the bond highlighted with 
an arrow, that could influence the facial approach of the electrophile to the reactive site and 
result in a moderate transfer of chirality to the product 33.   
t-BuO2C
CO2t-Bu
NHCHOH
t-BuO2C
CO2t-Bu
NHCHOH
t-BuO2C
CO2t-Bu
NHCH2OH
Me
LiNEt2
Me
CO2t-Bu
N
OLi
OLi
t-BuO
N
OLi
t-BuO2C
Ot-Bu
OLi
MeI
MeI
33
15 % yield
60 % ee
29
30
31
32
55 % yield
 
Scheme 2.2 - Seebach's Original Observation 
 
A decade later, Fuji described the first substrate designed to exhibit and exploit the dynamic 
behavior that Seebach observed (Scheme 2.3).  When enolate 35, formed by the deprotonation of 
chiral naphthyl ketone 34 (100/0 er) at –78 ˚C, was quenched with methyl iodide, the resulting ? 
methyl product 36 was isolated with an 83/17 er.
22
  Despite the loss of the sole stereocenter, 
chirality is relayed to the product 36.  The key insight was the use of a naphthyl group to act as a 
surrogate for the original chiral information.  Upon deprotonation of 34, the chiral information is 
‘stored’ in the axially chiral enolate 35 that directs the stereoselection during the alkylation step.   
To eliminate the possibility that aggregates between the achiral enolate and chiral precursor were 
responsible for the stereoselection observed, a control experiment was conducted.  When phenyl 
ketone 37 was submitted to identical methylation conditions the resulting product was racemic, 
presumably because the intervening axially chiral intermediate (not shown) did not have a 
sufficiently long enough lifetime to delay racemization prior to alkylation. 
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Scheme 2.3 - Fuji's Substrate Designed to Relay Chiral Information 
 
Three years later, Fuji demonstrated a stereoselective ? alkylation of phenylalanine derivatives 
based on the same idea.  Whereas, in the previous example (Scheme 2.3), the naphthyl group 
served as a source of asymmetry in the axially chiral intermediate, the latter work exploited size 
differences between nitrogen protecting groups to influence the stereoselection on the reaction.
23
  
Fuji coined the name “memory of chirality” to describe this “principle.”
24
  The term memory 
evokes the ‘capacity of a substance to return to a previous state or condition after having been 
altered.’
25
  Initially Fuji narrowly defined as a reaction where “central chirality at a carbon ? to a 
carbonyl group is preserved as transient axial chirality of the intermediate enolate and is then 
regenerated as central chirality in the reaction product.” Two recent reviews document 
subsequent work over the past decade that demonstrates that this phenomenon is not restricted to 
enolate chemistry
26 
or axially chiral intermediates.
27
 
 
2.2. Memory of Chirality in Radical Chemistry 
In the years following Fuji’s initial report
22
 other examples of memory of chirality in enolates 
appeared in the literature.
26
  Yet, there are no reasons why memory of chirality phenomenon 
should be solely the domain of anion chemistry.  One of the earliest examples of a radical 
 15 
reaction that demonstrates memory of chirality behavior came from the labs of Giese.  In 1999, 
Giese and co-workers described the photoinduced Norrish-Yang cyclization of a protected 
alanine derivative 38 to proline derivatives 39 and 40.
28
  The initially formed diradical 41 
undergoes a 1,6-H abstraction to generate another diradical 42 (Scheme 2.5).  This event happens 
concomitantly with loss of chirality at the ? center due to the tiny barrier to inversion of acyclic 
radicals.
29
  Radical-radical recombination generates diastereomeric cyclic products, 39 and 40. 
When additive benzophenone was used as a triplet sensitizer the products were isolated with low 
ee (see Scheme 2.4, entry 1).  In contrast, when triplet quencher naphthalene was used as an 
additive 39 and 40 were produced with significant retention of chiralty.   
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benzophenone 58/42 58/42
naphthalene 96/4 94/6
+
38
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44/56
85/15
 
Scheme 2.4 - Photoinduced Norrish-Yang Cyclization Demonstrates Memory of Chirality 
 
Key intermediate 42 possesses transient axial chirality, a necessary outcome of the conformation 
required for the hydrogen transfer.  The rotation barrier about the C–C bond highlighted in 42 
(Scheme 2.5) is estimated to be 5 kcal/mol (21 kJ/mol). But, radical-radical recombination has an 
even lower activation barrier, approximately 2 kcal/mol (8 kJ/mol), and ring closure outpaces 
other conformational events that would lead to scrambled stereochemistry in the products. An 
explanation for the effect of the additive is tied to the relative reaction rates of the spinisomers.  
 16 
A triplet radical is slower to recombine because of the additional requirement of spin relaxation 
prior to ring closure (Scheme 2.5).  The singlet radical is correspondingly more reactive and ring 
closure is significantly faster than conformation changes within the intermediate (42). 
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Scheme 2.5 - Proposed Mechanism for Giese's Norrish-Yang Cyclization 
 
A year prior, Rychnovsky and co-workers reported the successful trapping of a cyclic radical 
with retention of configuration (Scheme 2.6).
30
  Photoinduced decarboxylation of optically active 
N-hydroxypyridine-2-thione esters 43 produces tetrahydropyran radical 44 which can racemize 
through ring inversion.  If the intermediate 44 can be trapped by an electrophile before ring 
inversion (estimated barrier of 10 kcal/mol or 42 kJ/mol) occurs, then an optically active product 
45 will be formed.  Like previous examples, an intermediate with fleeting chirality is 
transformed into a more stable chirality.  What distinguishes this example from ones previously 
discussed, is that the molecule retains its type of asymmetry throughout the reaction, which is in 
conflict with the guiding idea put forth by Fuji.
22
  Is this not also an example of memory of 
chirality, or is the defintion too exclusive?   A more encompassing definition was recently put 
forth by Zhao can Carlier:
26b
 “a ‘memory of chirality’ reaction can be defined as a formal 
substitution at an sp
3
 stereogenic center that proceeds stereospecifically, even though the reaction 
 17 
proceeds by trigonalization of that center, and despite the fact that no other permanently chiral 
elements are present in the system.”  Yet, Rychnovsky’s work also does not meet this criterion 
because of the presence of the benzyl stereocenter throughout the process.  We offer an even 
broader definition that covers Rychnovsky’s observations: a ‘memory of chirality’ reaction can 
be defined as the stereospecific formation of an sp
3
 stereogenic center, despite the reaction 
proceeding through a metastable chiral intermediate formed during the destruction of the initial 
chirality at the reactive site. 
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OMe
Bn
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Bn
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Scheme 2.6 – Trapping of a Cyclic Radical with Retention of Configuration 
 
2.3. Chirality Transfer in Radical Cyclizations of Axially Chiral Acrylanilides 
Past research from our group has revealed reactions that share some of the attributes of those in 
Rychnovsky’s report.  For over a decade, our group has studied axially chiral anilides and 
benzamides and their use in stereochemical transformations.
9,17
  In 1999, our group reported on 
the radical cyclization of enantioenriched o-iodoacrylanildes 8.  Acrylanilide 8 is a stable 
atropisomer with a N-aryl bond rotation barrier of 30.8 kcal/mol (129.0 kJ/mol).
9c
  Iodine 
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abstraction of (M)-8 (98/2 er) by a tin radical produces 46, which might be expected to racemize 
(46 ? ent-46) under the reaction conditions because of the drastic loss of the bulk in the ortho 
position. In fact, the 5-exo oxindole product (R)-47 was isolated significantly enantioenriched 
(92/8 er).  The chirality transfer for the radical cyclization of (M)-8 to (R)-47 is 94 %. The 
cyclization of 8 was found to proceed with high levels of chirality transfer, because the rate of 
the cyclization, about 8 x 10
7
 s
-1 
based on a comparable substrate,
9g
 surpasses that of any 
competing bond rotations.  Like the Rychnovsky example (Scheme 2.6) the transition from the 
stable chiraliy of the starting material to the transient chirality of the intermediate occurs without 
a change in the source of chiral information (stereocenter ? stereocenter, chiral axis ? chiral 
axis).  What sets the latter work apart is that the axial chirality of 8 is ultimately transferred to a 
new stereocenter in 47; the chirality is not ‘remembered.’ Although the above cyclization does 
not constitute a ‘memory of chirality’ process, like the other transformations in this chapter, it 
proceeds with a metastable chiral intermediate under non-equilibrium conditions. 
 
We use the term chirality transfer to describe the fidelity of the transfer of stereochemical 
information for memory/transfer of chirality reactions.  Chirality transfer is calculated by 
dividing the amount of the major enantiomer in the product by the amount of the major 
enantiomer in the starting material (in the above example, 92/98 = 94 %).  Thought of in another 
way, chirality transfer is the yield, not excess, of the major enantiomer one would expect to 
isolate from the reaction of an enantiopure sample.  Qualitatively, it is a measure of the 
partitioning of enantiomeric intermediates between two diastereomeric transition states. 
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Scheme 2.7 - Transfer of Chirality in Axially Chiral o-Iodoacrylanilides 
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3. RADICAL CYCLIZATIONS OF AXIALLY CHIRAL N-ALLYL-O-
IODOANILIDES 
 
3.1. Introduction 
The radical cyclization of N-acryloyl anilide 8 to provide 47 (Scheme 2.7) is an example of an 
intramolecular reaction that occurs with excellent chirality transfer (> 90 %).
9c
  In this reaction, 
the intermediate aryl radical 46 must have a much lower barrier of rotation than its precursor 8, 
but its barrier to cyclization is even lower yet, so racemization of the intermediate radical is not a 
significant reaction.  In the course of this investigation, Christine H.-T. Chen submitted 
iodoanilide 48 to the standard radical cyclization conditions.  Instead of the expected oxindole 
product 49, phenanthroline 50 was produced in 12 % yield along with the reduced product 51 
(Scheme 3.1).
31
  
N Ph
O
I
Bu3SnH
Et3B/O2
23 °C, PhH
N
O
50
12 % yield
N Ph
O
Et
49
not observed
N Ph
O
51
10 % yield
+ +
48
 
Scheme 3.1 - An Unexpected Cyclization Result 
 
A possible mechanism for the formation of 50 is suggested in Scheme 3.2.  Although, the yield 
of 50 is low, this striking result implies that aryl radical attack on the pendant benzyl group is 
faster than the expected 5-exo radical cyclization onto the crotonoyl group, itself known to be a 
rapid process.
32
  In the same study
9c
 the rate of cyclization (kcyc) of the N-ethyl analogue of 48 
 21 
was measured to be 7.8 x 10
7 
sec
-1
. If the 1,6 cyclization is occuring, then the newly formed 
stereocenter (*) in 55 is ultimately destroyed along with any possible data on chirality transfer. 
(The 1,5 pathway can only lead to achiral products.)  The observation that cyclization onto the 
N-benzyl group occurs faster than cyclization onto the crotonyl group hints that suitable axially 
chiral iodoanilides with a pendant N-allyl group instead of a benzyl one will cyclize with 
chirality transfer.  Based on this hint, we set out to study this class of radical cyclizations, shown 
generally in Figure 3.1.   
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Scheme 3.2 - A Possible Mechanism for the Formation of 50 
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Axial chirality (*) in 56 transferred
to new stereocenter (**) in 57.  
Figure 3.1 - Possible Radical Cyclizations of Axially Chiral N-Allyl-o-Iodoanilides 
 
3.2. Precursor and Product Preparation  
There are no available asymmetric methods to prepare axially chiral anilides such as 56.  As 
such, cyclizations precursors 56a-i were synthesized in racemic form (Table 3-1) and chiral 
preparative HPLC was used to resolve each enantiomeric pair of atropisomers.  The synthesis of 
cyclization precursors 56a-i began with the ortho iodination of 2,4-dimethylaniline (58 ? 59).  
A two-step sequence of N-acylation of 59 followed by N-allylation generated the nine anilides 
56a-i employed in this study. Aniline 59 was submitted to modified Schotten-Baumann 
conditions with a series of acyl chlorides to produce secondary anilides (not shown) in yields 
ranging from 47–100 %.  Addition of a secondary anilide to a slurry of sodium hydride in THF, 
followed by the appropriate allylating agent generated 56a-i in 35–100 % yield.  Racemic 
samples of 56a-g were cyclized using standard tin hydride mediated conditions to prepare rac-
57a-g, used as racemic standards for chiral HPLC analysis. 
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NH2
1) RCOCl
2) NaH
58
N RER
I
O RZ
rac-56
RE
RZ
X
59
87 % yield
RZ, RE=H, X = I
otherwise, X = Br
56a Ph H H
56b p-BrC6H4 Me Me
56c PhCH2 H H
56d PhCH2 H Ph
56e PhCH2 H Me
56f PhCH2 Me Me
56g PhCH2CH2 H H
56h CH3CH=CH H H
56i Me Me Me
RZ RE % yielda
a Overall yield of final two steps.
35
54
50
47
20
37
74
20
69
R
NH2
I
BTMA•ICl2
CaCO3
MeOH
CH2Cl2
 
Table 3-1 - Preparation of Cyclization Substrates 
 
3.3. Resolution and Rotation Barriers of Precursors  
To access enantioenriched samples of 56a-g, racemic samples were resolved on a semi-
preparative (S,S)-Whelk-O 1 column (25 cm x 10.0 mm I.D.), eluting with 10–40 % iPrOH in 
hexanes (8–10 mL/min). Typical injections amounts were between 40 to 80 mg and about one 
hundred milligrams of both enantiomers of each precursor were regularly isolated.  The ees of 
the enantioenriched samples 56a-g were measured by analytical chiral HPLC and fell reliably in 
the range of 96–99 %.  The racemic products 57a-g were injected into an analytical (S,S)-Whelk-
O 1 column and each pair of enantiomers was well resolved, allowing a quantitative analysis of 
chirality transfer experiments by chiral HPLC. 
 
The N-aryl bond rotation barriers for four representative precursors 56a-c,g were measured in a 
thermal equilibration experiment.  A solution of an enantioenriched sample of 56b in 9/1 
hexanes/iPrOH was placed in a sealable tube and heated at 114 ˚C (387 K).  Periodically, 
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aliquots were removed and their ee measured by chiral HPLC analysis.  A plot of the logarithmic 
decrease in ee versus time (e.g. 56b: plot Figure 3.2, data Table 3-2) showed the expected first 
order rate of racemization.   The value of the slope corresponds to the rate of racemization (krac); 
this value is divided in half to correct for the fact that only one of every two rotation events result 
in an observable racemization event.  Using the Arrhenius kinetics, krac was translated into a free 
energy barrier to rotation for p-bromobenzamide 56b, 30.7 kcal/mol or 128.3 kJ/mol (Equation 
3-1).   
 
Figure 3.2 - Thermal Equilibration Plot for 56b 
 
 
 
 
 
 
 
 
 
Table 3-2 - Thermal Equilibration Data for 56b 
 
(M)-56b T = 387 K 
Time (min) % ee 
0 96 
36 92 
68 70 
104 61 
131 55 
161 49 
196 41 
267 32 
N
I
O
N
I
O
(M)-56b(P)-56b
114 °CBr Br
 25 
ln
1 + [P-56b]/[M-56b]
1 - [P-56b]/[M-56b]
= kract + c
(slope = krac or 2krot)
krot =  slope/2 = (7.29 x 10
-5 s-1)/2 = 3.65 x10-5 s-1
Krot = krach / kT  =
(3.65 x 10-5 s-1) (6.626 x 10-34 Js)
(1.381 x 10-23 J/K) (387 K)
Krot    = 4.52x10
-18
?Grot    = 128.314 kJ/mol or 30.7 kcal/mol
2krac = 7.29 x 10
-5 s-1
substitute into ?G   = -RTlnK
 
Equation 3-1 - Calculation of the N-Aryl Bond Rotation Barrier of 56b 
 
Not surprisingly, the barrier of related benzamide 56a was comparable, 29.7 kcal/mol or 124.3 
kJ/mol (Figure 3.3).  Phenacetyl 56c and phenethyl 56g amides exhibited slightly higher rotation 
barriers of 32.6 (136.5 kJ/mol) and 32.7 kcal/mol (136.9 kJ/mol), respectively.  All of these 
barriers are sufficiently high enough to allow handling of these compounds under typical 
laboratory conditions. 
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?Grot
(M)-56 (P)-56
56b, 30.7 kcal/mol (128.5 kJ/mol) 56a, n = 0, 29.7 kcal/mol (124.3 kJ/mol)
56c, n = 1, 32.6 kcal/mol (136.5 kJ/mol)
56g, n = 2, 32.7 kcal/mol (136.9 kJ/mol)
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I
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Figure 3.3 - Rotation Barriers of Four Axially Chiral Anilides 56a-c,g 
 
3.4. Chirality Transfer in Radical Cyclizations of N-Allyl-o-Iodoanilides 
To measure the chirality transfer of the cyclization, enantioenriched samples of precursors 56a-g 
were submitted to room temperature tin hydride mediated radical cyclization conditions.  For 
example, a sample of anilide (M)-56c (98.5/1.5 er, Figure 3.4) was dissolved in benzene that had 
been aerated beforehand by exposure to the atmosphere for at least 10 min.  Bu3SnH (1.5 equiv, 
0.01 M) was added to the solution, followed by triethylborane (1.0 equiv) to initiate the 
reaction.
33
 After the reaction was judged to be complete by TLC (<5 min), the reaction was 
worked up and the crude material was purified by silica gel flash chromatography to give 
dihydroindolone (R)-57c in 53 % yield.   The er of (R)-57c was measured by chiral HPLC and 
found to be 93.5/6.5.  The opposite enantiomer, (P)-56c (99.5/0.5 er), produced dihydroindolone 
(S)-57c in 54 % yield and 96.5/3.5 er.  The levels of chirality transfer exhibited were 95 % and 
97 % respectively.  That chirality transfers occurs in these reaction demonstrates that the 
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intermediate radicals 60 and ent-60 do not interconvert by N–aryl bond rotation under the 
reactions conditions.  Instead, rapid radical 5-exo cyclization traps the axial chirality of 56 in a 
new stereocenter in 57. 
N
O
Ph
N
O
Ph
Bu3SnH
Et3B/O2
23 ˚C, C6H6
N
O
Ph
N
O
Ph
N
O
Ph
N
O
Ph
(M)-56c
98.5/1.5 er
SEE
(P)-56c
99.5/0.5 er
FEE
(R)-57c
93.5/6.5
FEE
(S)-57c
96.5/3.5 er
SEE
Bu3SnH
Et3B/O2
23 ˚C, C6H6
60
ent-60
Chirality transfer = 97 %
Chirality transfer = 95 %
I
I
 
Figure 3.4 - Transfer of Chirality in Axially Chiral N-Allyl-o-Iodoanilides 
 
Table 3-3 summarizes the cyclization data for all precursors 56a-g.  Yields of 57 were good to 
excellent (67–95 %), although substrates 56c,d were exceptions (40–54 %, entries 5/6 and 7/8).  
Substitution about the alkene radical acceptor impacted the level of chirality transfer observed.  
Substrates with no substitution or with a single E-substituent in the terminal alkene position 
cyclized with high levels of chirality transfer (87–97 %, Entries 1/2, 5/6, 7/8, 9/10 and 13/14).  
Marginally lower levels of chirality transfer (74–80 %) were observed for substrates bearing 
terminal Z-substitutients (Entries 3/4 and 11/12). 
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I
N
O
Ar
n
RE Bu3SnH
Et3B/O2
25 •C, C6H6
N
O
RZ
Ar
n
Entry Precursor n RE Product  %Yieldb
% Chirality 
Transfer
1 (+)-56a
Ar
Ph 0 H (+)-57a 93
2 (–)-56a Ph 0 H (–)-57a
56a-g 57a-g
94
3 (+)-(P)-56ba 4-BrC6H4 0 Me (+)-(S)-57ba 72 74
4 (–)-(M)-56ba 4-BrC6H4 0 Me (–)-(R)-57ba 95 74
5 (–)-56c Ph 1 H (–)-57c 54
6 (+)-56c Ph 1 H (+)-57c 53
7 (–)-56d Ph 1 Ph (–)-57d 40 87
8 (+)-56d Ph 1 Ph (+)-57d 50 89
9
RZ
RE
RZ
Me
Me
H
H
H
H
Ph 1 H Me (–)-57e 90
10 (+)-56e
(–)-56e
Ph 1 H Me (+)-57e 92
77
71
11 (–)-56f Ph 1 MeMe (–)-57f 79 80
12 (+)-56f Ph 1 Me Me (+)-57f 7981
13 (–)-56g Ph 2 (–)-57g 94
14 (+)-56g Ph 2 (+)-57g 95
67
74
97
95
a Absolute configuration assigned by X-ray crystallography.
b Isolated yield after chromatography.
92
95
HH
HH
H
H
erSM erP
99.5/0.5 93/7
99.5/0.5 93.5/6.5
99.5/0.5 74/26
99/1 73.5/26.5
99.5/0.5 96.5/3.5
98.5/1.5 93.5/6.5
99.5/0.5 87/13
88/1299/1
99.5/0.5 89.5/10.5
99.5/0.5 91.5/8.5
99.5/0.5 80/20
99.5/0.5 79/21
98/2 92.5/7.5
99.5/0.5 95/5
Elution
OrderSM
FEE
Elution
OrderP
SEE
FEE
SEE
SEE
FEE
FEE
SEE
FEE SEE
FEE
SEE
FEE
SEE
FEE
SEE
FEE
SEE
FEE
SEE
FEE
SEE
FEE
SEE
FEE
SEE
FEE
SEE
 
Table 3-3 - Summary of Radical Cyclizations of Anilides 56a-g 
 
3.5. Determination of Absolute Configuration 
The absolute configuration of precursor (–)-56b (second eluting enantiomer) was determined by 
X-ray crystallography using the anomalous dispersion method by Dr. Steve Geib.  The crystal 
structure of (–)-56b in Figure 3.5 shows it to possess the M configuration.  The plane of the 
amide bond in precursor 56b is nearly perpendicular to the plane of the aryl ring (84˚), a 
common feature of tertiary anilides.
6
  As predicted,
5
 the aryl ring is trans to the amide oxygen.   
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Figure 3.5 – ORTEP Diagrams of (M)-56b 
 
The X-ray crystal structure of (–)-(R)-57b (first eluting enantiomer) differs in that the N-Ar 
group is now nearly cis to the carbonyl oxygen (angle 10˚) while the N–CH2 group is nearly 
trans (angle 150˚).  The unusual amide bond geometry is likely the outcome of the severe strain 
that is imposed by the o-methyl group in the standard amide geometry. 
 
   
N
O
Br
H
I
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Figure 3.6 – ORTEP Diagrams of (R)-57b 
 
Having established the absolute configurations of anilide (M)-56b and dihydroindolone (R)-57b 
we examined the possibility of assignment of the absolute configurations of the remaining 
compounds, relying on optical rotation and chiral HPLC data.  A couple of trends were noted, 
e.g. for all seven enantiomeric pairs, the dextrorotatory enantiomer of the precursor yielded the 
dextrorotatory enantiomer of the product, and vice versa.  Secondly, the first eluting enantiomer 
of the precursor on a (S,S)-Whelk O 1 chiral HPLC column gave the second eluting enantiomer 
of the product, and vice versa.  The exception to the latter trend was benzamide 56a/57a (FEE ? 
FEE, SEE ? SEE).  Unfortunately, based on the above information it is not possible to make 
strong conclusions about the configurations of the remaining precursors/products.   
 
3.6. Preliminary Model of Chirality Transfer 
Having confirmed that (M)-56b cyclizes faithfully to (R)-57b, a preliminary model of chirality 
transfer in N-allyl cyclizations was proposed (Figure 3.7, upper).  When aryl radical 61 is 
formed, the aniline ring is in a perpendicular orientation with respect to the plane of the amide 
bond.  N-aryl bond rotation in 61 positions the radical for attack on the allyl group.  Also, a C–C 
Br
O
N
H
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bond rotation away from the radical (61 ? 62) exposes the reactive alkene face.  This model for 
cyclization stands in stark contrast to our current model for cyclization of N-acryloyl anilides
9e,h,i
 
(Figure 3.7, lower).  In it, a cyclization of radicals like 64 that proceeds with twisting of the 
acryloyl group towards the aryl radical (64 ? 65), accounts for the configurations of the final 
products.
 
  
N-Allyl cyclizations
N-Acryloyl cyclizations
N
O
Ar N
O
Ar
H
N
O
Ar
61 62 63
N N
64 65 66
O
O
Ar = 4-BrPh
N
O
H
 
Figure 3.7 - Rationalization of Observed Stereochemistry for N-Allyl and N-Acryloyl 
Anilides 
 
Apparently, the disparate cyclization models are the result of the differing conformational 
properties of the two systems.  In the N-acryloyl systems, ?-conjugation between the carbonyl 
group and the alkene in 64 rigidifies the conformation about the OC–C bond.  In contrast, C–C 
bonds in N-allyl groups possess greater conformational flexibility that can accommodate a 
different mode of twisting of the alkene group.  To date, the configurations of the N-acryloyl 
precursors and the products from their cyclizations have been established by a combination of 
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X-ray crystallography and optical rotation calculations and measurements for multiple 
substrates.
9c,h,i
  In contrast, stereochemical data for N-allyl cyclizations rests on a single pair of 
crystal structures (Figure 3.5, Figure 3.6).  Further confirmations of configurations of other 
precursors/products pairs in the N-allyl series would allow a more authoritative comparison of 
the two modes of cyclization. 
 
3.7. Regioselectivity, Competitive Cyclizations  
Radical cyclizations of racemic o-bromoanilides lacking a second ortho substituent have been 
studied previously (Figure 3.8).
34-37
  In a 1988 methodology study, Bowman and co-workers 
generated aryl radicals under standard tin hydride conditions that cyclized onto the N-acryloyl 
group to yield oxindoles 68.
34
  Earlier that same year, Dittami and Ramanathan published a study 
of the analogous N-allyl cyclizations.  In it, they observed that cyclization of anilides 69 
provided dihydroindolones 70.
35
  When Jones and Storey submitted anilides 71,
36
 a substrate 
possessing both types of alkene radical acceptors, under the same radical conditions, only 
cyclization to the crotonoyl group to give oxindole 72 was observed.
38
   Jones attributed this 
exclusivity to conformational preferences of starting material that biased 71 towards N-acryloyl 
cyclization.  In particular, local minima that placed the aryl ring at 60˚ to the amide plane (Br 
proximal to the N-acryloyl side) were proposed and supported by MM2 caluclations.   When the 
system was modeled again using improved parameters by us,
39
 a minimum was predicted with 
the aryl ring aligned nearly perpendicular.  Furthermore, this conformational preference was 
supported by crystallographic data of related anilides.
6
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Figure 3.8 - Radical Cyclizations of o-Bromoanilides Lacking ortho Substituents 
 
The unexpected regioselectivity in the cyclization of 48 (Scheme 3.1) appeared prima facie in 
conflict with Jones’ results (71 ? 72, Figure 3.8).  As a direct comparison to the Jones internal 
competition experiment, we studied the cyclization of analogous anilide rac-56h (Scheme 3.3). 
Like Jones’ compound 73, anilide 56h has identical N-crotonoyl and N-allyl groups in place as 
radical acceptors.  Unlike 73, the aryl ring of 56h has an ortho methyl group in lieu of a 
hydrogen atom.  There is also an additional para methyl group, but it is likely too far removed 
from the reactive center to influence reactivity.  Similarly, the use of an iodide as radical 
precursor over a bromide is also considered inconsequential.  When 56h was cyclized, it 
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produced dihydroindolone 57h in 65 % isolated yield, resulting from cyclization to the N-allyl 
group.  The 
1
H NMR spectrum of the crude product matched an authentic sample of 57h 
prepared by an alternative route (Scheme 3.4).  Furthermore, the 
1
H NMR spectrum of the crude 
product did not reveal any signals corresponding to the expected product 74, the outcome of 
cyclization to the N-crotonoyl group.  To verify Jones’ structural assignment, the o-iodoanilide 
analog of 71b was prepared and cyclized, which provided exclusively oxindole 72b in 93 % 
yield; dihydroindolone 73 was not detected (Scheme 3.3).  Clearly, the identity of the ortho 
substituent greatly impacts the regioselectivity of the cyclization. 
N
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N
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71b-I 73, not detected 72b, 93 % yield
+
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Scheme 3.3 - Regioselectivity Reversal Affected by ortho Substitution 
 
HN
I N
O
1) LDA, 0 °C
    THF 
2)
AIBN, Bu3SnH
    PhH, 80 °C
59
75
83 % yield
57h
72 % yield
O
Cl
TEA, CH2Cl2I
HN
76
72 % yield  
Scheme 3.4 - Synthesis of Authentic Sample of 57h 
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3.8. Cyclization Rate Constant Measurements 
To better understand the change in regioselectivity, we measured the cyclization rate constants of 
56h (N-allyl) and 78 (N-acryloyl) by standard competition kinetics.
40
  Samples of 56i and 78 
were cyclized at 80 ˚C at varying concentrations of tin hydride.  The molar ratios of cyclized to 
reduced product (57i/77, 79/80) were measured by GC against an internal standard.  Data for 
these experiments are shown in Figure 3.9 and the calculated rate constants are summarized in 
Figure 3.10.
†
 The rate constant for cyclization of 83 was found to be 3.0 x 10
9
 s
–1
, almost 40 
times larger than that for cyclization of 85 (7.8 x 10
7
 s
–1
).  We also attempted to measure the rate 
constant for cyclization of radical 81.  When anilide 71b-I was cyclized at 80 ˚C only trace 
amounts of the reduced product were detectable by GC, even when the reaction was conducted at 
the highest tin hydride concentrations.  Based on these observations, we estimate a lower limit 
for the cyclization rate constant of radical 81 at about 10
10
 s
–1
. 
 
[Bu3SnH] 57i/77
[Bu3SnH] 79/80
0.01 M 29/1
0.02 M 5.2/1
0.37 M 6.6/1
0.03 M 3.5/1
1.0 M 2.7/1
0.05 M 2.2/1
3.6 M 0.8/1
0.1 M 1.1/1
N
O
I
Bu3SnH
PhH
N
O
N
O
+
56i 57i 77
N
O
I +
N
O
N
O
78 79 80  
Figure 3.9 - Cyclization Rate Constant Measurements for 56i and 78 
 
                                                
† A fuller treatment of this data can be found in Section 6.8 (page 118). 
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A comparison of the two N-acryloyl examples reveals the dampening effect of ortho substitution 
on the speed of cyclizations.  The presence of the o-methyl group slowed the rate of cyclization 
by approximately two orders of magnitude (85 ? 86) versus the unsubstituted process (81 ? 
82).  In contrast, in the case of N-allyl cyclization (83 ? 84), the slowdown was less dramatic, 
allowing that process to overtake competing N-acryloyl cyclization in 56h (Scheme 3.3). 
N
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N
O
N
O
N
O
kcyc
3.0 x 109 s-1
kcyc
> 1010 s-1
N
O
N
O
kcyc
7.8 x 107 s-1
81 82
83 84
85 86  
Figure 3.10 - Cyclization Rate Constants 
 
A proposal for the role of o-methyl group in the slowdown of the N-acryloyl cyclization is 
diagrammed in Figure 3.11.  Cyclization to the N-acryloyl group probably requires significant 
co-planarity between the aniline ring and the amide group (87 ? 88a), forcing a steric 
interaction between the o-methyl group and methylene of the N-allyl group that increases the 
energetic barrier to the process.  In contrast, the N-allyl group, not being strained by resonance, 
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is more flexible and can extend out towards the attacking radical (87 ? 88b).  The net outcome 
is less twisting of the aryl group is necessary and steric interactions between the o-methyl group 
and the N-acryloyl group are avoided. 
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Figure 3.11 - Transition State Analysis 
 
3.9. Conclusions 
In summary, intrigued by the results a ‘failed’ reaction, a study axially chiral N-allyl-o-
iodoanilides revealed that they can be cyclized under radical conditions to the product 
dihydroindolones with high levels of chirality transfer (74–97 %).  Based on a pair of X-ray 
crystal structures a preliminary model has been proposed to predict the mechanism of chirality 
transfer.  A series of rate constants measurements were used to elucidate the role of ortho 
substitution in the unanticipated reversal from N-acryloyl cyclization to N-allyl cyclization.   As 
well, the N-aryl bond rotation barriers of four anilides were quantified (29.7–30.7 kcal/mol or 
124.3–136.9 kJ/mol). 
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4. RELAYING ASYMMETRY OF TRANSIENT ATROPISOMERS OF O-
IODOANILIDES  
 
4.1. Background 
Radicals were initially viewed by the synthetic community as unsuitable for enantioselective 
reactions because of their highly reactive nature.  This misconception has since subsided under 
growing evidence of enantioselective radical processes.
41
  In the 1980s, researchers in the radical 
community began to apply techniques of stereoselection brought over from the domains of ionic 
and pericyclic chemistry to radical reactions.
42
  In 1989, Porter and co-workers reported the 
successful 15-endo radical cyclization of 89.
43
  All four possible diastereomers of 90 were 
observed; the endo/exo ratio was found to be 8/1.  While the exo products (not shown) exhibited 
no stereoselection, the endo products were isolated in an 18/1 diastereomeric ratio, with 90 being 
the major component.  The key to the stereoselection is the C2-symmetric amide auxiliary, a 
strategy that had been used before successfully in enolate and cycloaddition chemistry.
44
  The 
auxiliary influences the face of attack of the intermediate radical at the ? alkene position.  That 
no stereoselection is observed at the ? position is likely because the auxiliary is too distant from 
the reaction site to have any influence.   
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Figure 4.1 –Radical Cyclization with Stereoselection Controlled by Chiral Auxiliary 
 
Not all uses of chiral auxiliaries resulted in high stereoselection.  Also in 1989, Jones and co-
workers reported on the radical cyclizations of o-haloacrylanilides bearing chiral N-substituents 
91 as part of their program towards the synthesis of oxindole and indole-derived natural products 
(Figure 4.2).
45
  Jones and McCarthy reasoned that the chiral substituents should induce 
stereoselectivity during their radical cyclization to form oxindoles 92.  In fact, only low levels of 
asymmetric induction were observed in the cyclization products 92.
46
  For example, cyclization 
of N-2-phenylethyl acrylanilide 91a with Bu3SnH in toluene at 105 ˚C provided dihydroindolone 
92a as a 51/49 mixture of stereoisomers. When vicinal methyl groups were introduced to the 
alkene (91b), the dr of the product (92b) rose to 69/31.  Jones reasoned that the additional steric 
bulk interacted with the chiral auxiliary in the transition state, thereby helping to differentiate the 
diastereotopic faces of the alkene. The failure to observe useful levels of stereoselection though, 
suggests that the chiral center is unable to influence the attack of the aryl radical and the two 
diastereomeric transitions states are near in energy. 
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Figure 4.2 – Radical Cyclization of Anilide 91 with Low Stereoselection 
 
Jones noted broadening of signals in the 
1
H NMR of 91, a feature he attributed to restricted 
rotation about the N-aryl bond.  If 91a could be resolved into its diastereomeric atropisomers, we 
believed it would be possible to cyclize them separately to the corresponding oxindole e.g. 
(M,S)-91a ? 93 ? 92a (Scheme 4.1) in a process analogous to the cyclization of enantiomeric 
(M)-8.
9c
  We began a research project to prepare and resolve diastereomeric anilides like 91 and 
to evalute whether they too can be cyclized under radical conditions to the corresponding 
oxindole with tranfer of axial chirality to the newly formed stereocenter. 
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Scheme 4.1 – Comparison of Cyclization of Anilides 8 (Curran) and 91a (Hypothetical) 
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Another reason for studying the stereoselective cyclizations of anilides like 91 is that the 
products lack an ortho substituent.  In comparison, the cyclization 8 ? 47 yields an product with 
a methyl group in the 7-position, an unseen substitution pattern in the oxindole class of natural 
alkaloids.  This feature may make this class of anilides better suited for the synthesis of natural 
oxindole alkaloids such as (–)-horsfiline
45
 and spirotryprostatin B (Figure 4.3).
47
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Figure 4.3 - Oxindole Natural Products 
 
4.2. Resolution of Chiral Auxiliary-based Atropisomers 
To address this question, co-worker Dr. Marc Petit prepared iodoacrylanilide 95 from 1,2-
diiodobenzene 94 in a two-step procedure (Scheme 4.2).  A Buchwald-Hartwig coupling 
between (S)-phenethylamine 93 and 1,2-diiodobenzene formed aniline 95 in 62 % yield.   
Acylation of 95 produced a mixture of atropisomers (M,S)-96/(P,S)-96 in a 68/32 ratio, as 
determined by NMR spectroscopic studies at room temperature.  Although the atropisomers of 
95 were not separable by silica gel flash chromatography, resolution of the diastereomers was 
possible using preparative chiral HPLC ((S,S)-Whelk-O 1).  At the time of this work, this was the 
first known example of resolution of mono-ortho-substituted anilides, except when the ortho-
substituent is tert-butyl.
9a,b 
 Dr. Petit was able to resolve 96 into its atropisomeric components 
(M,S)-96 and (P,S)-96 by preparative HPLC experiments.  The isolated major diastereomer 
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(M,S)-96 equilibrates to a 68/32 (M,S)-96/(P,S)-96 mixture, the N-aryl bond rotation barrier was 
found to be 23.0 kcal/mol or 96.3 kJ/mol (?1/2 = 156 min at 25 ˚C).  Because the barrier to 
equilibration is exceedingly low, care must be taken to minimize the exposure of enriched 
samples of (M,S) or (P,S)-96 to sources of heat during handling.   
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Scheme 4.2 - Synthesis of (S)-phenethylamine-derived o-Iodoacrylanilide 96 
 
Mixtures of 96 were cyclized at a number of different temperatures, as summarized in Table 4-1.  
When an equilibrium mixture of 96 was submitted to standard radical cyclization at 110 ˚C 
(entry 1), a 50/50 ratio of products (R,S)-97 and (S,S)-97 was obtained.  Anilide 96 differs in 
halide (Br ? I) and ortho substitution (OMe ? H) from 89a, but because the cyclization result 
is consistent with Jones’ observation, we believe that these changes to be immaterial to the 
stereoselectivity.  When the reaction temperature was lowered, the diastereomeric ratio of 97 
increased until plateauing at 84/16 (–25 ˚C) (entries 2–5). Diastereomerically enriched samples 
of 96 were obtained by preparative chiral HPLC.  When a mixture in a 91/9 ratio of (M,S)-
96/(P,S)-96 was cyclized at –78 ˚C, (R,S)-97 and (S,S)-97 were obtained in a 95/5 ratio, while a 
mixture in a 2/98 ratio gave (R,S)-97/(S,S)-97 in 16/84 ratio (entries 6–7).  In comparison, each 
atropisomer of 96 cyclizes to a different stereoisomer of oxindole 97, but the cyclization of the 
major atropisomer (M,S)-96 is more selective than that of the minor (P,S)-96.  
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97
(R,S)/(S,S)
68/32 78/22
68/32 110 50/50
68/32  0 81/19
20
68/32 –25 84/16
N Me
Ph
HO
N Me
Ph
HO
N
O
Me
H
Ph
N
O
Me
H
Ph
(M,S)-96 (P,S)-96 (R,S)-97 (S,S)-97
96
(M,S)/(P,S)
+
+
% Yield
82
79
76
82
91/9 95/5–78
2/98 16/84–78
68/32 –78 84/16 73
84
76
Bu3SnH 
Et3B/O2
CH2Cl2
Temp. (°C)
I I
 
Table 4-1 - Diastereoselective Cyclizations of o-Iodoacrylanilide 96 
 
A mechanistic proposal to rationalize the results in Table 4-1 is offered in Figure 4.4.  Tributyltin 
radical abstracts an iodine atom from 96 to form a mixture of diastereomeric radicals 98? , 98? , 
initially in a ratio comparable to the diastereomeric ratio of 96.  There are two relevant pathways 
for radicals 98, cyclization or N-aryl bond rotation.  Because of the loss of a bulky iodine atom, 
radicals 98? , 98?  are now more susceptible to interconversion by rotation and subsequent loss 
of stereochemical sense.  Radical cyclization of 98 produces 99, which leads to oxindole 97 after 
hydrogen abstraction from tributyltin hydride.  We hypothesize that the varying stereoselection 
with temperature can be explained by how the rates of rotation compare with those of 
cyclization.  At higher temperatures, the rates of interconversion between the diastereomeric 
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radical intermediates (kr and kr') compete with the rates of cylication (kc? and  kc?).
‡
 The net result 
is poor stereoselection because the sense of stereochemistry in axis is scrambled prior to 
cyclization. In contrast, at temperatures equal to or below 20 ˚C, the level of stereoselectivity 
actually exceeds that of the initial rotamer ratio (68/32) (entries 2–5). At lower temperatures the 
interconversion of radicals 98? ,?  is suppressed and each radical cyclizes with its own selectivity 
in favor of opposite stereoisomers of 99.  Radical 98?  cyclizes to (R,S)-99 with high fidelity, 
while 98? cyclizes predominately to (S,S)-99 but with approximately 20 % leakage to (R,S)-99.  
This leakage accounts for the observation that the product ratios differ from the starting 
atropisomer ratios when 98?  is present in significant amounts. 
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Figure 4.4 - Mechanistic Proposal 
 
                                                
‡ Based on control experiments, we do not believe that diastereoselective iodine abstration is a 
possibility.  A series of cyclization experiments at varying substoichiometric amounts of Bu3SnH 
showed that (M,S)-96 and (P,S)-96 were consumed at about equal rates. 
 45 
Dr. Petit next prepared iodoanilide 103 from L-valine 100.  Initial attempts to couple L-valine 
with diiodobenzene 94 under Pd-catalyzed conditions were unsuccessful (not shown), 
presumably for steric reasons, so a three step synthesis of 103 was employed (Scheme 4.3).  
First, L-valine 100 and p-bromotoluene 101 were coupled in a Cu-catalyzed reaction
48
 to produce 
aniline 102 in 50 % yield.  The iodinating agent benzyltrimethylammonium dichloroiodide was 
used to install an ortho iodine atom.  Subsequent acylation with acryloyl chloride yielded anilide 
103.  At ambient temperature, anilide 103 exists as a 58/42 equilibrium mixture of (M,S) and 
(P,S) rotamers, which were separable by preparative HPLC.  More conveniently, slow 
crystallization of the equilibrium mixture from hexanes deposited exclusively (M,S)-103 in a 
crystallization-induced asymmetric transformation.  The barrier to rotation from the major (M,S) 
to minor diastereomer (P,S) of 103 was measured to be 24.3 kcal/mol (101.7 kJ/mol).   The 
absolute configuration of the (M,S)-103 was established by X-ray crystallography. 
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Scheme 4.3 - Synthesis of L-Valine-derived o-Iodoacrylanilide 103 
 
Cyclization of a 99/1 mixture of rotamers (M,S)-103/(P,S)-103 faithfully provided (R,S)-104 
(94/6–97/3), while cyclization of a 97/3 mixture enriched in (P,S)-103 faithfully provided (S,S)-
104 (91/9).  A sample of (R,S)-104 was recrystallized; X-ray analysis of the resulting single 
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crystal allowed an unambiguous assignment of the absolute configuration of 104 to be assigned.  
The transfer of chirality observed for 103 ? 104 is consistent with the stereochemical model 
proposed for previous results in an enantiomeric series (Scheme 2.7).
9c,h
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Table 4-2 - Diastereoselective Cyclizations of o-Iodoacrylanilide 103 
 
4.3. Enantiomeric Series 
The successful resolution and selective cyclization of diastereomeric atropisomers such as 93 and 
103 suggested that analogous enantioselective transformations were possible.  We postulated that 
a key feature that enabled the resolution of anilides 96 and 103 was the use of branched N-alkyl 
groups to increase the N-aryl bond rotation barrier.  Based on the success of 96 and 103, we 
attempted to prepare and resolve a series of racemic o-iodoanilides with branched N-alkyl groups 
(Figure 4.5).  Each N-alkyl group was chosen for its bulkiness and synthetic accessibility.  
Anilide 105c is particularly promising because, unlike 105a,b, the N-diphenylmethyl group is 
potentially removable at a later stage by a reductive hydrogentation procedure. 
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Figure 4.5 - Proposed Series Enantiomeric o-Iodoanilides 
 
Our initial synthetic approach to this class of anilides relied on a modified Ullman reaction
49
 
between the amines 106 and 1,2-diiodobenzene 94 (Scheme 4.4).  Unfortunately, the reactions 
with cyclohexylamine 106a and isopropylamine 106b proceeded with little or no yield.  We 
attributed this failure to steric congestion at the reaction site by the neighboring iodine atom. 
HN R
R
I K2CO3, CuI
L-proline
DMSO, 100 °C
I
I
94 107a, 0 % yield
107b, 2 % yield
H2N R
R
106a, R = -(CH2)5-
106b, R = Me
+
 
Scheme 4.4 – Initial Unsuccesful Attempts at N-Arylation of 106 
 
Changing plans, for the cyclohexyl substrate we opted for the approach used for the synthesis of 
anilide 103 (Scheme 4.3).  Coupling of cyclohexyl amine to p-bromotoluene generated aniline 
108 in 55 % yield (Scheme 4.5).  Iodonation with dipyridine iodonium tetrafluoroborate
50
 
cleanly installed the requisite iodine atom.  Acylation of 108 with crotonoyl chloride under the 
standard acylation procedure was unsuccessful, possibly due to the bulky nature of the 
cyclohexyl group on the nitrogen.  Ultimately, acylation of 108 in the presence of excess DMAP 
(2 equiv), pyridine (3 equiv), and crotonoyl chloride (3 equiv) produced rac-109 in 74 % yield.  
To prepare isopropyl substrate 112, we opted for a reductive amination between 2-iodoaniline 
110 and acetone, which cleanly produced aniline 111 in 78 % yield (Scheme 4.5).  Acylation of 
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2-iodoaniline 110 with acryloyl chloride yielded the desired anilide rac-112 in racemic form.  
Attempted synthesis of the diphenylmethyl precursor 114a began with the alkylation of 
2-ioodoaniline 110 with diphenylmethyl bromide to give 113 (Scheme 4.5).   Unfortunately, the 
attempted acylation of 113 gave only decomposition products.  Similarly, recently published 
attempts by Clayden and co-workers to acetylate the same substrate, during a study of related 
axially chiral anilides, met with failure.
51
  Lacking a viable method to construct the amide bond, 
efforts to prepare anilide 114a were abandoned. 
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Scheme 4.5 - Synthesis of Branched N-Alkyl-o-Iodoanilides 
 
The enantiomers 109 and 112 were separated by using a (S,S)-Whelk O 1 chiral preparative 
HPLC column (25 cm x 10.0 mm I.D.) eluting with 9/1 hexanes/iPrOH.
17
  Typical injections 
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sizes were 25–100 mg and recovery averaged over 90 %.  The peaks of 109 were partially 
overlapped (Tr = 13.9 and 15.2 min), while the peaks of 112 exhibited baseline separation (Tr = 
11.3 and 13.2 min).  To minimize racemization, fractions were cooled to 0 ˚C prior to rapid 
concentration in vacuo.  The % ee of the recovered samples of 109 and 112 were typically 
greater than 80 %. 
 
We suspected that crystalline samples of 109 and 112 would not be susceptible to racemization 
at room temperature.  This suspicion was confirmed by keeping an 83 % ee crystalline sample of 
(P)-109 at room temperature.  After 1 week, the ee was measured at 81 %, unchanged within 
experimental error.  In contrast, enantioenriched samples of (P)-109 in solution were observed to 
racemize in minutes at room temperature.  We attribute the disparity in these results to 
conformational stability derived from packing forces in the crystal lattice.  The N-aryl bond 
rotation barriers of 109 and 112 were measured by dissolving their respective samples at room 
temperature and perioidically analyzing an aliquot by chiral HPLC to measure the decaying % 
ee.  Standard plots of the data showed the expected first order rate of racemization and provided 
rotation barriers of 23.1 (96.7) and 22.8 kcal/mol (95.5 kJ/mol) for 109 and 112, respectively. 
 
With the enantioenriched radical precursors 109 and 112 prepared, tin hydride mediated 
cyclizations were conducted to measure the level of chirality transfer. Triethylborane (1.0 equiv) 
was added to an aerated benzene solution of the o-iodoanilide and Bu3SnH (1.1 equiv, 0.01 M) to 
initiate the reaction.
33
  In all cases, the reactions were complete before any progress could be 
monitored by TLC.  Radical cyclization of (M)-109 (91/9 er) yielded (R)-114 in a 71/29 er (% 78 
chirality transfer) (Table 4-3, entry 1). The chirality transfer of the opposite enantiomer 
cyclization was slightly higher (69 %, entry 2).  Enantiomers of the isopropyl analogue 112 also 
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were observed to cyclize with faithful transfer of chirality to its oxindole product (115, entries 
3/4).  The levels of chirality transfer observed for 112 are comparable to those for related 
acrylanilide substrates in previous studies.
9c,h
  The crotonoyl substrate 109 exhibited slightly 
lower levels of chirality transfer than 112, consistent with observations that substitution about the 
alkene lowers the fidelity of the cyclization.
9
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Table 4-3 - Summary of Radical Cyclizations of 109 and 112 
 
4.4. Determination of Absolute Configuration of Cyclization Precursors and Products 
The second eluting enantiomer of 109 was recrystallized by quickly dissolving an 
enantionenriched sample in hexanes at room temperature before cooling the solution to 
approximately –15 ˚C.  Similarly, a sample of the first eluting enantiomer of 112 was 
recrystallized by this procedure, but 1-heptene was used as the solvent instead.  In both cases, 
single crystals of 109 and 112 were obtained. The absolute configuration of 109 and 112 were 
secured by X-ray crystallography using the anomalous dispersion method by Dr. Steve Geib.  In 
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both cases, the M enantiomer was observed.  The crystal structures of (M)-109 and (M)-112 are 
shown in Figure 4.6 and 4.7 respectively.   The aniline ring in 112 is nearly perpendicular to the 
plane of the amide bond (89.5˚).  As expected, the amide is trans and the acryloyl group is in an 
s-cis conformation.  The isopropyl group in 112 is twisted away from the iodine atom (Figure 
4.6).  The crystal structure of 109 closely matches that of 112.  Unlike 112, the aniline ring in 
109 is slightly more tilted (80˚) towards the plane of the amide bond (Figure 4.7).  
 
Figure 4.6 - ORTEP Diagram of (M)-112 
 
Figure 4.7 - ORTEP Diagram of (M)-109 
N
H
Me
MeO
I
N
HO
I
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When the respective M enantiomers of 109 and 112 were cyclized, in each case the dextrorotary 
enantiomers of the resulting cyclized products, 115 and 116 respectively, were obtained.  
Additionally, the oxindoles 115/116 isolated from the cyclization of (M)-109 and (M)-112 were 
both found to be the first eluting enantiomer (FEE) by chiral HPLC ((S,S)-Whelk-O 1).  
Unfortunately, we lacked direct information about the absolute configuration of 115/116.  
Because 115/116 lack heavy atoms, they are unsuitable for assignment of absolute configurations 
by X-ray analysis.  In order to assign an absolute configuration to the cyclized products, we 
compared optical rotation and elution order data with related oxindoles 117 and 118 of known 
absolute configuration (Figure 4.8).  In earlier work,
9h
 the second eluting enantiomer of oxindole 
117 was found to have an R configuration at the ? stereocenter by X-ray analysis.  Optical 
rotation measurements of (R)-117 showed it to be dextrorotatory.  Likewise, the second eluting 
enantiomer of substrate 118 is dextrorotatory. This was the predicted sign of optical rotation by 
calculation for (R)-118.
9d
  By analogy, we conclude that the cyclization of (M)-109 and (M)-112 
gave (R)-115 and (R)-116, respectively.  Furthermore, this model for cyclization is consistent 
with the stereochemical model previously discussed in the diastereomeric series (Figure 4.4). 
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Figure 4.8 - Assignment of Absolute Configurations of 115 and 116 
 
4.5. Conclusion 
The results show the enantiomeric and diastereomeric o-iodoanilides atropisomers bearing only a 
hydrogen atom at the other ortho-position can be resolved and handled under ambient laboratory 
conditions.  The asymmetry present in these transient atropisomers can then be locked into a 
stereocenter by a subsequent radical cyclization, which occurs with good to excellent levels of 
chirality transfer (78–92 %).  Because the precursors lack a second ortho substituent, the 
potential exists to use these compounds in the stereoselective syntheses of natural oxindole 
alkaloids. 
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5. ASYMMETRIC HECK-MIZOROKI CYCLIZATIONS OF O-IODOANILIDE 
ATROPISOMERS 
5.1. Introduction 
Work in our labs has demonstrated that axially chiral o-iodoacrylanilides can be reliably cyclized 
under radical conditions with transfer of chirality to a newly formed stereocenter (Scheme 2.7).  
This transformation (120 ? 121) is possible because rapid radical cyclization occurs before N-
aryl bond rotation can erode the sense of axial chirality. An analogous organometallic 5-exo 
cyclization process (123 ? 126) is a Heck-Mizoroki reaction.  In addition to acting as a 
precursor to a radical, an aromatic iodide 123 could also undergo C–I bond insertion by a Pd 
species to generate hypothetical organometallic intermediate 124.  Could a Heck-Mizoroki 
cyclization of a suitably substituted axially chiral o-iodoanilide also occur with transfer of 
chirality?   
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Figure 5.1 – Aryl Iodide as a Precursor to Radical or Heck-Mizoroki Cyclizations 
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5.2. Heck-Mizoroki Reaction 
The Mizoroki–Heck reaction was discovered independently by Mizoroki
52
 and Heck
53
 in the 
early 1970s.  The Heck-Mizoroki reaction is more commonly known as the Heck reaction 
because of his fundamental work that developed the reaction into a general method of 
chemistry.
54
 The classic Heck reaction is a Pd-catalyzed arylation of alkenes.  Key steps of the 
reaction cycle include oxidative addition (129 ? 130) of the Pd into an Ar-X bond (e.g. X = Br, 
I, or OTf) and addition of the formed ArPdX intermediate to unsaturated bonds (132 ? 133)  
(Figure 5.2). 
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Figure 5.2 - Heck Reaction Catalytic Cycle  
 
In 1989, Shibasaki and co-workers reported pioneering examples of enantioselective Heck 
reactions for the synthesis of fused ring systems such as decalins,
55,56
 hydrindans,
57
 indolizines,
58
 
diquinanes,
59
 and related natural products.  The Overman group has done important work,
60
 
including the first Heck reactions to generate asymmetric quarternary centers, on 
enantioselective intramolecular Heck reactions of o-iodoanilides that use chiral phosphine 
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ligands as the source of asymmetry (Scheme 5.1).
61
  In a typical experiment,
62
 o-iodoanilide rac-
139 was exposed to catalyst 143, preformed from Pd2(dba)3 and (R)-(+)-BINAP, in 
dimethylacetamide at 80 °C and produced (R)-140 with 66 % ee.  Interestingly, replacement of 
the amine base with Ag salts gave (S)-140 in 70 % ee, a reversal in the stereoselection of the 
process.  When the scope of this reaction was tested with anilide 141a and phenolic ether 141b 
little or no enantioselectivity was observed in the spirocyclic products (S)-142a,b.  The latter 
results suggest that the conformational features of the substrate 139 play a role in the 
stereoselection of the process. 
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Scheme 5.1 – Stereoselective Heck Cyclizations with (R)-(+)-BINAP 
 
Based on the above results and other mechanistic observations
§
 Overman outlined the following 
'neutral' and 'cationic' pathways (Figure 5.3) to begin to rationalize the observed changes in 
                                                
§ a) Reactions conducted with a BINAP analog synthetically modified to be monoligating 
occurred with poor stereoselection. Therefore, the stereodifferentiating step must involve a 
catalytic complex with a bidentate Pd-BINAP complex. b) Enantioselectivity is insensitive to 
solvent. c) The product ee correlates with the ee of BINAP used; therefore, a monomeric Pd-
BINAP complex is responsible for stereoselection. 
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stereoselection.  He proposed that the reactions where tertiary amines are used as the HI 
scavenger proceed through a neutral reaction pathway.  After oxidative insertion into an aryl 
halide (143a) to form 144a, the tethered alkene coordinates to Pd in the apical position and 
produces square pyramid complex 145.  Displacement of the halide anion (145 ? 146) followed 
by migratory insertion (146 ? 147) irreversibly locks in the new stereocenter (*).  The cationic 
pathway can be accessed by oxidative insertion in the analogous aryl triflate (143b ? 144b).  
Because the triflate anion is fully dissociated
63
 square planar complex 148 is formed that leads to 
the opposite configuration of intermediate 149. 
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Figure 5.3 - Proposed Cationic and Neutral Heck Pathways 
 
Two steps may be responsible for the stereoselectivity of the reaction: halide displacement by the 
alkene  (145 ? 146) or oxidative addition (143 ? 144).  Overman wrote62b that the latter “could 
be the enantioselective step if the intermediates undergoing oxidation addition were the 
diastereomeric Pd-BINAP alkene complex.”  The strongest evidence against the oxidative step is 
the observation that cyclizations of aryl triflates in the presence of added halide salts gave 
configurations of the product consistent with those from neutral reactions.  From this it was 
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concluded that halide salts shunt intermediate from the cationic to the neutral pathway and the 
stereoselective step is further downstream. 
 
5.3. Precursor Preparation, Resolution 
With the aim of better understanding the mechanism of chirality transfer during Heck 
cyclizations of o-iodoanilides, we wanted to evaluate whether the reactions could occur 
enantioselectively without an external source of asymmetry.  Suitable substrates to test this 
premise would be axially chiral o-iodoanilides with enantiomers that are resolvable and 
possessing a sufficiently high barrier to rotation to permit handling at room temperature.  
Furthermore, an ? substituent is necessary to avoid ?-hydride elimination in presumed 
intermediate 150 to form the more stable ?,? trisubstituted alkene (151) instead of the terminal 
alkene (152).  Formation of 151 would result in the destruction of the newly formed ? 
stereocenter and loss of stereochemical information (Figure 5.4). 
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Figure 5.4 - ?-Hydride Elimination Leading to Loss (R = H) or Retention (R ?  H) of 
Chirality 
 
We prepared a series of four possible anilide substrates to investigate this cyclization reaction 
(Scheme 5.2).  Iodoaniline 59 was first acylated with tigloyl chloride in the presence of 
 59 
pyridine
**
 to form 153a in 81 % yield.  Deprotonation of 153a with sodium hydride, followed by 
quenching with methyl iodide gave rac-154a in 62 % yield.  The bromo homolog rac-154b was 
prepared in a similar fashion (69 % yield) from a sample of 153b previously prepared by Dr. 
Weidong Liu. Treatment of aniline 155, graciously donated by Dr. Marc Petit,
9i
 with tigloyl 
chloride produced o-trimethylsilylanilide rac-156a cleanly in 97 % yield (Scheme 5.3).   The p-
bromo homolog of 156a was synthesized in four steps from aniline 157.  Double electrophilic 
iodination of the ortho positions yielded 4-bromo-2,6-diidoaniline (not shown).  Double 
treatment of the latter with LDA at –78 °C followed by TMSCl, achieved N,N-bissilylation to 
give aniline 158 in 66 % yield over two steps.  Exposure of 158 to sec-butyllithium triggers 
lithium halogen exchange with concomitant transfer of one of the silyl groups to the ortho 
position.  Quenching the resulting anion with methyl iodide gives the N-methyl-N-trimethylsilyl 
derivative (not shown).  Reaction of the latter aniline with tigloyl chloride generates rac-156b in 
26 % yield over two steps. 
I
NH2
N
O
Xpyridine
CH2Cl2
59
O
Cl
N
H
O
X
NaH, MeI
THF
153a, X =  I, 81 % yield
153b, X = Br
rac-154a, X =  I, 77 % yield
rac-154b, X = Br, 69 % yield  
Scheme 5.2 - Preparation of Anilides rac-154a,b 
                                                
** When triethylamine, diisopropylethylamine, or 4-dimethylaminopyridine were used as bases, 
the ?-? migrated alkene product was observed.  Presumably, the migration of the alkene is 
indicative of ketene formation.  
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Scheme 5.3 - Preparation of Anilides rac-156a,b 
The enantiomers of rac-154a were resolvable by injection onto a chiral HPLC column ((S,S)-
Whelk O 1).  Unfortunately, the enantiomers of rac-154b and rac-156a,b were not resolvable by 
using available chiral HPLC columns ((S,S)-Whelk O 1, Chiracel OD) and their further use in 
this study was discontinued.  The enantiomers of 154a were separated by using a (S,S)-Whelk O 
1 chiral preparative HPLC column (25 cm x 10.0 mm I.D.) eluting with 8/2 hexanes/iPrOH.
17
  
Typical injections amounts were 50 mg and combined recovery of enantioenriched atropisomers 
averaged over 80 %.  The rotation barrier of the anilide 154a was measured by racemizing a 
sample at 90 ˚C in 9/1 hexanes/iPrOH, and the decrease in ee was measured as a function of time 
by chiral HPLC analysis.  A standard plot of this data showed the expected first order rate of 
racemization, and provided a rotation barrier of 27.5 kcal/mol (115.1 kJ/mol).  The value for N-
aryl bond rotation barrier of 154a is about 3 kcal/mol lower that observed for acrylanilide 46 
(Figure 5.5).  Presumably, steric interactions in 154a between the ? methyl group and the aniline 
ring causes the alkene to twist out of plane with respect to the amide carbonyl group and thereby 
 61 
present a smaller substituent for the iodine or methyl group of the anilide to rotate past in the 
transition state (Figure 5.5, right). 
?GrotN
O
I
(M)-46, R = H
(M)-154a, R = Me
R
R N
O
IR
R
(P)-46, R = H
?Grot = 30.8 kcal/mol (129.0 J/mol)
(P)-154a, R = Me
?Grot = 27.5 kcal/mol (115.1 J/mol)
N
O
I
(M)-154a
?
 
Figure 5.5 - Comparison of Rotation Barriers of 46 and 154a 
 
5.4. Chirality Transfer in Heck Cyclizations 
When a sample of rac-154a was treated with (PPh3)4Pd, prepared in situ, in the presence of an 
amine base in refluxing MeCN, the expected racemic oxindole product rac-159 was obtained in 
87 % yield (Scheme 5.4).  When product rac-159 was injected into an analytical (S,S)-Whelk-O 
1 chiral column, each enantiomers was well resolved, thereby permitting a convenient 
quantitative analysis of a chirality transfer experiments by HPLC.   
 
However, at 80 ˚C, an enantiopure sample of 154a has a half-life of just over an hour.  
Consequently, any attempt to conduct a Heck cyclization of 154a at elevated temperatures would 
occur with the ee of 154a diminishing during the course of the reaction.  One way to avoid this 
fate would be to perform the reaction at temperature low enough to suppress the racemization 
pathway but permitting the cyclization.   Unfortunately, this also has the effect of slowing an 
already sluggish Heck reaction.
61b
  Taking a cue from work by Hartwig on room temperature 
 62 
Heck reactions,
64
 we used conditions employing bulky alkyl phosphine ligands.  Bulky 
phosphine ligands demonstrated greater catalytic activity in Heck reactions, perhaps because 
their electron-rich nature increases the electron density on the Pd center, promoting the oxidative 
addition step.  Additionally, bulky phosphines have a greater tendency to dissociate from the Pd 
complex, which can promote one or more steps of the catalytic cycle (Figure 5.2).  The use of 
tert-butyl phosphine along with large amounts of catalyst (40 mol % in Pd) achieved complete 
conversion to rac-159 at room temperature over a 48 h period.   
N
O
N
O
I
conditions
Conditions
a) (PPh3)4Pd (0.05 equiv), Et3N, 
    MeCN, 82 °C
b) Pd2(dba)3 (0.1 equiv), Et3N, 
    (t-Bu)3PH•BF4 (0.2 equiv)
    PhMe, RT
rac-154a rac-159
a) 87 % yield
b) 80 % yield
 
Scheme 5.4 - Heck Cyclizations of rac-154a 
 
When an enantioenriched sample of anilide (M)-154a was submitted to the room temperature 
Heck-Mizoroki conditions the product oxindole was obtained in 85 % yield and chirality transfer 
(Table 5-1, entry 1). The opposite enantiomer, (P)-154a, was cyclized with a similar level of 
chirality transfer (89 %, entry 2).  Because anilide 154a has a half-life of over four months at 
ambient temperature any in situ racemization during the reaction would be insignificant.  The 
chirality transfer observed for 154a ? 159 is slightly lower than previous radical cyclizations 
(160 ? 161) with the same alkene substitution pattern (Scheme 5.5).65 
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N
O
Pd2(dba)3 20 mol%, Et3N, 
(t-Bu)3PH•BF4 40 mol %
    
PhMe, RT, 48 h
(M)-154a
N
I
O
159
96/4 85/15
93/7 79/21
% YieldPrecursor
(P)-(+)-154a
Product
(+)-159
(–)-159
erSM erP
% Chirality 
Transfer
85
89
85
88
Note: Absolute configurations of the products are unassigned.
(M)-(–)-154a
*
Elution 
Order
Elution 
Order
FEE SEE
SEE FEE
 
Table 5-1 - Summary of Heck Cyclizations of Anilides Enantioenriched 154 
N
O
I
N
O
Bu3SnH, Et3B
CH2Cl2, RT
160
69/31 dr
161
85 %yield
70/30 dr
H
Me
Ph
H
Me
Ph
*
Note: Absolute configuration of product is unknown.  
Scheme 5.5 - Radical Cyclizations of Related Anilide 160 
 
The absolute configuration of 154a is tentatively assigned based on its structural similarity to 8.
††
  
It was observed that the levorotatory enantiomers of 8 and 154a both elute first by chiral HPLC 
((S,S)-Whelk O 1).  Unfortunately, we failed to obtain single-crystal samples of 154a, a waxy 
solid, via slow recrystallization in a number of solvents.  This prevented us from securing 
definitively the absolute configuration of 154a by X-ray crystallography.  Oxindole 159, lacking 
a heavy atom, is not suitable for assignment of absolute configuration by X-ray analysis.  
                                                
†† The absolute configuration of a synthetic precursor to 8 was definitively established by X-ray 
crystallography.9c 
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Attempts to derivatize 159 to an X-ray suitable compound were unsuccessful.  Without 
knowledge of the absolute configuration of both the precursor and cyclized product, we cannot 
propose a transition state to rationalize the observed stereoselection. 
 
5.5. Synthesis of Second Generation Precursor 
A novel cyclization substrate 164 was proposed with the idea that it be elaborated into the 
eseroline class of natural products
66
 with well-established absolute configurations (Figure 5.6).  
Using this approach, the absolute configuration of the stereocenter formed during cyclization 
could be assigned by comparing the sign of optical rotation.  Consistent with the previous 
cyclization substrate, o-iodoanilide 164 should be resolvable into its enantiomers.  Substrate 164 
differs from 154a in that the 3-siloxy group offers a functional group handle for further synthetic 
elaboration following the procedures of Fuji (Figure 5.6).
67
  Substitution of the bromide with a 
methoxy group and reductive removal of o-chloride would yield natural product esermethole 
162.  Secondly, replacing the 6-iodo-2,4-dimethyl aniline core with a trihalogenated core may 
increase crystallinity and potentially improve the chances of growing a single crystal for X-ray 
analysis. 
N
O
N
O
Br
Cl
Me
O
N
Me
N H
TBDPSO I Cl
Br
OMe
162
*
* *
163 164  
Figure 5.6 – Proposed Retrosynthesis of Esermethole 162 
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Synthesis of 164 (Scheme 5.6) began with the preparation of aniline 167.  Electrophilic 
bromination of 2-chloroaniline 165, followed by iodination generated aniline 167 in 60 % yield 
(2 steps).  Preparation of the acyl fragment began with known hydroxy ester 168.
68
  Silylation of 
168 with TBDPSCl protects the hydroxy group during subsequent steps.  Reaction of silyloxy 
ester (not shown) with aniline 167, pre-treated with AlMe3, under refluxing conditions produced 
secondary anilide 169.
69
  Deprotonation of anilide 169 with sodium hydride and quenching with 
methyl iodide produces the desired cyclization precursor rac-164 in 74 % yield (three steps). 
OMe
O
HO
1) TBDPSCl
    DCM
2) AlMe3, 167 
    PhH, 80 °C
O
N
H
I
Cl
Br
RO
N
Br
Cl I
O
RO
NaH, MeI
    THF
rac-164
74 % yield, 3 steps
I
Br
Cl
NH2
167
79 % yield
168 169
Br
Cl
NH2
166
76 % yield
Cl
NH2
165
KBr, NaBO3
(NH3)6Mo7O24
AcOH
I2, Ag2SO4
EtOH
R = TBDPS
 
Scheme 5.6 - Synthesis of Anilide rac-164 
 
5.6. Racemic Synthesis of Esermethole 
The synthesis of esermethole 162 was first executed in a racemic manner.  Heck cyclization of 
rac-164 gave a 1.2/1 mixture of the alkene E/Z isomers of 170.  The crude product of this 
reaction was redissolved in THF and treated with TBAF to remove the silyl group and reveal the 
aldehyde functionality of rac-163; yields of the aldehyde ranged from 36–51 %.  Aldehyde rac-
163 was reacted with methyl amine for in situ imine formation.  Adding lithium aluminum 
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hydride and refluxing the reaction mixture gave rac-171 in poor yields (18–23 %).  A side-
product of the reaction was the debrominated homolog 172.  Coupling of sodium methoxide with 
rac-171 under Cu-catalyzed conditions, installed the desired methoxy group in the para position, 
producing 7-chloroesermethole (not shown).  A reductive hydrodechlorination on a small scale 
(< 2 mg), catalyzed by Pd/C and using sodium formate as the hydride source, gave rac-
esermethole (rac-162).  Comparison of the crude 
1
H NMR spectrum of rac-162 to literature 
reports
62b
 confirmed the formation of the desired product.         
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Scheme 5.7 - Racemic Synthesis of rac-Esermethole 
 
5.7. Resolution and Recrystallization of Second Generation Precursor 
The enantiomers 164 were separated by using a (S,S)-Whelk O 1 chiral preparative HPLC 
column (25 cm x 10.0 mm I.D.) eluting with 98/2 hexanes/iPrOH.
17
  Typical injections sizes 
were 35 mg and recovery averaged only 25 % due to aggressive peak shaving. The N-aryl bond 
rotation barrier of 164 was measured by racemizing an enantioenriched sample.  An 
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enantioenriched sample of anilide 164 (92 % ee) was heated at 80 ˚C in 9/1 hexane/iPrOH, and 
the decrease in ee was measured as a function of time by chiral HPLC analysis.  A standard plot 
of this data showed the expected first order rate of racemization, and provided a rotation barrier 
of 26.7 kcal/mol (111.8 kJ/mol). 
N
Br
I Cl
O
(M)-164
TBDPSO
N
Br
Cl I
O
TBDPSO
(P)-164
?Grot
26.7 kcal/mol
(111.8 J/mol)
 
Figure 5.7 – N-Aryl Bond Rotation Barrier of 164 
 
In order to assign the absolute configuration, we attempted to prepare enantiomerically pure 
single crystals of 164 for X-ray analysis.  Attempts to recrystallize enriched samples by 
dissolution and slow evaporation of the solvent were unsuccessful or resulted in racemic crystals.  
Additionally, a highly enantioenriched (>98 % ee) sample of the second eluting enantiomer of 
164 formed X-ray suitable crystals upon cooling at approximately -15 ˚C. Unfortunately, these 
crystals were also found to be racemic.  Attempts to crystallize the desilylated derivative (not 
shown) were also unsuccessful. 
 
Despite failing to assign the absolute configuration of 164, the crystal structure of rac-164 
contains information about the alkene conformation (Figure 5.8).  The ?,? unsaturated carbonyl 
group is in an approximate s-trans conformation with the alkene twisted 38˚ from the plane of 
carbonyl group (C=C–C=O).  The s-trans conformation is consistent with observations made of 
similar tigloyl derivatives in the crystal state.
70
  The torsion angle between the plane of the amide 
 68 
bond and that of aniline ring (OC–N-C-CI) in 164 is more acute (67˚) than is typically observed 
for tertiary anilides, with the iodine edge tilted towards the alkene group.  Unusually, a small 
torsion angle (13˚) exists between the carbonyl group and the N-aryl bond (O=C–N-C).  The 
phenyl rings of the TBDPS group are slightly distorted, presumably as a result of the low quality 
of the crystal.   
 
Figure 5.8 - ORTEP Diagram of Anilide rac-164 
 
When the second eluting enantiomer of anilide 164 (99/1 er) was submitted to room temperature 
Heck conditions, oxindole 170 was obtained as a 1.2/1 mixture of alkene isomers (Scheme 5.8).  
By chiral HPLC, both geometrical isomers of 170 were found to be first eluting and with 83/17 
er (Figure 5.9).  The level of chirality transfer (84 %) in the cyclization is comparable to that of 
154a (Table 5-1).  Treatment of the mixture with HF-pyridine gave aldehyde (+)-163 in 70 % 
yield from 164.   A reductive amination cyclization with methylamine generated the heterocycle 
tricyclic core.  Crude 
1
H NMR and GC analysis revealed a mixture of the desired product and the 
debrominated by-product
71
 (~1/1).  Treatment of the crude mixture of products with NBS in 
acetonitrile gave pure (–)-171. Faced with limited amounts of (–)-171 (<5 mg) a double 
Br
N
O
I
ClO
Si
 69 
hydrodehalogenation was attempted in hopes of preparing related alkaloid desoxyeseroline 
(172).  Unfortunately, the reaction was unsuccessful and the desired product 172 was not 
obtained. 
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Scheme 5.8 - Heck Cyclization of Anilide (+)-164 and Attempted Elaboration to 
Desoxyeseroline  
 
  
Figure 5.9 - Chromatogram of (E)-170/(Z)-170 
N
O
Br
Cl
TBDPSO
(E)-170/(Z)-170 1.2/1
83/17 er
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5.8. Stereochemistry 
Although the desired synthetic target was not obtained, we can draw tentative conclusions about 
the stereochemistry obtained in the Heck cyclization.  The optical rotation of 171 was found to 
be levorotatory.  When compared with the optical activity of numerous related eseroline 
derivatives
72
 we can tentatively assign the absolute configuration of the stereocenter generated in 
170 as S. 
 
Lacking an absolute configuration assignment for the Heck cyclization precursor (+)-164 we are 
left to speculate on how the stereochemical information is transferred to the new stereocenter in 
the product 170.  Based on the available information we propose the following two possible 
mechanisms to account for the stereochemistry observed in the cyclization of 164.  If the 
configuration of 164 is M, then the cyclization must proceed through the s-trans rotamer (Figure 
5.10, top), the rotamer observed in the crystal state (Figure 5.8).  Subsequent Pd-insertion into 
the C-I bond ((M)-164 ? (M)-173) forms the penultimate cyclization intermediate.  Unlike in 
earlier radical cyclizations of o-iodoanilides,
9c,g,h
 formation of the key intermediate (173) may 
actually occur with an increase in the N-aryl bond rotation barrier because of the bulkiness of the 
Pd atom and bound ligands.  As such, we believe in situ racemization (M ? P) is unlikely to 
occur under the reaction conditions.  Insertion of the Pd-C bond across the alkene ((M)-173 ? 
174) transfers the chirality of the axis to the new ? stereocenter.  Subsequent ?-hydride 
elimination produces the (R)-170 as a mixture of E/Z isomers, depending on the C-C rotamer at 
the time.  If the starting configuration is P, the analogous cyclization process ((P)-164 ? 
(P)-173) must proceed via the s-cis rotamer, leading to common intermediate 174. 
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Figure 5.10 - Transition State Proposals 
 
5.9. Conclusion 
The results demonstrate, for the first time, that axially chiral o-iodoanilides can be cyclized under 
Pd-catalyzed conditions with transfer of chirality to the newly formed stereocenter without an 
external chiral source.  Like their radical counterparts, Heck cyclizations of enantioenriched o-
iodoanilides proceeded with significant (84–89 %) levels of chirality transfer.  This interesting 
observation supports the idea that oxidative addition may be the stereodifferentiating step in 
Pd-catalyzed enantioselective cyclizations of racemic anilides. 
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6. EXPERIMENTAL  
 
6.1. General Information 
Unless otherwise noted, all reactions were run under an argon atmosphere.  All reactions were 
performed in oven-dried glassware that was cooled under argon.  Benzoyl chloride, phenyl acetyl 
chloride, dihydrocinnamoyl chloride, 4-bromobenzoyl chloride, trans-crotonyl chloride, 2,4-
dimethyl aniline, benzyltrimethylammonium dichloroiodate, tributyl tin hydride, triethyl borane 
(1.0 M in hexanes), sodium hydride (95 % dispersion in oil), allyl iodide, crotonyl bromide, 4-
bromo-2-methyl-2-butene, cinnamyl bromide, 2-iodoaniline, pyridine, 4-dimethylaminopyridine, 
Cu(I) iodide, p-bromotoluene, L-proline, cyclohexylamine, diisopropylethylamine, sodium 
triacetyoxyborohydride, methyl iodide, trimethylaluminum (2.0 M in hexanes), 
(NH3)6Mo7O24•(H2O)4, potassium bromide NaBO3•(H2O)4, Ag2SO4, tert-
butyldiphenylchlorosilane, sodium formate, tris(dibenzylideneacetone)-dipalladium(0)-
chloroform adduct, and 10 % Pd/C  were purchased from Aldrich and used without modification, 
save for the following exceptions.  Phenylacetyl chloride and distilled prior to use.  2,4-Dimethyl 
aniline was dissolved in diethyl ether, filtered through a pad of silica gel to remove colored 
baseline impurities, and concentrated in vacuo.  Triethyl amine was purchased from Fisher 
Scientific and used without modification.  Pd(OAc)2, tert-butylphosphonium tetrafluoroborate 
were purchased from Strem Chemicals and used without modification.  Acryloyl chloride and 
methylamine (2.0 M in THF) were purchased from Acros and used without further modification.  
Lithium aluminum hydride was purchased from Alfa Aesar and used without further 
modification.   2-Iodo-4,6-dimethylaniline 59 was prepared according to Kajigaesi’s procedure.
73
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Methyl 4-hydroxy-2-methylbut-2E-enoate 168,
68
 N-allyl-2-Iodo-4,6-dimethylaniline 77,
74
 and N-
allyl-2-iodoaniline
75
 were prepared according to previous reported procedures. Air and moisture 
sensitive chemicals were handled using standard syringe techniques. THF, toluene, benzene, and 
diethyl ether were distilled from sodium/benzophenone under argon. Dichloromethane was 
distilled from calcium hydride under argon. Alternatively, each solvent, except benzene, was 
dried by passing them through columns of activated alumina. 
 
1
H and 
13
C NMR spectra were recorded on Bruker Avance DPX 300 (300 MHz), Avance 300 
(300 MHz), and Avance DRX 500 (500 MHz) NMR spectrometers.  Chemical shifts (?) are 
reported in ppm relative to TMS using the residual solvent proton resonance of CDCl3 (7.27 
ppm) or the CDCl3 carbon peak (77.0 ppm).  In reporting data, the following abbreviations were 
employed: s = singlet, d = doublet, m = multiplet, p = pentet, sex = sextet, o = octet, bs = broad 
singlet, dd = doublet of a doublet, ddd = doublet of a doublet of a doublet, dddd = doublet of a 
doublet of a doublet of a doublet, dq = doublet of a quartet, dt = doublet of a triplet, qq = quartet 
of a quartet, and tt = triplet of a triplet.  All quoted optical rotation values are corrected for 100 % 
ee samples.  IR spectra were recorded as thin films or neat on NaCl plates on an ATI Mattson 
Genesis Series FT-IR spectrometer.  Low and high resolution mass spectra were obtained on a 
Micromass Inc., Autospec with an E-B-E geometry.  Analytical chiral HPLC analysis was 
conducted using a S,S-Whelk-O 1 column (Pirkle) and a Waters model 440 UV detector at 
wavelength 254 nm.   Gas chromatograms (GC) were run on an Agilent 19091Z-413E gas 
chromatograph equipped with an enhanced HPCHEM integrator.  An HP-1 capillary methyl 
siloxane column of 30 m in length and 0.32 mm in diameter was used for all runs.  The initial 
temperature of the program was 50 ˚C with a temperature ramp of 10 ˚C/min up to 315 ˚C, where 
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after the same temperature is maintained for 10 min further.  Thin layer chromatography (TLC) 
was performed on silica gel 60 F254 glass-backed plates with a layer thickness of 0.25 mm 
manufactured by E. Merck.  TLC visualization was achieved by illumination with a 254 nm UV 
lamp or by staining with iodine impregnated silica gel.  Flash chromatography was performed on 
silica gel (230–400 mesh ASTM) purchased from Bodman or Sorbtech. Optical rotations were 
measured on a Perkin-Elmer 241 polarimeter at the Na D-line (? = 589 nm) using a 1 dm cell. 
 
6.2. General Procedures 
6.2.1. General procedure for acylation of anilines (I)  
To a CH2Cl2 solution of aniline (1.0 equiv) was added triethyl amine (1.1 equiv). The reaction 
mixture was cooled to 0 ˚C and the respective acid chloride (1.1 equiv) was added dropwise. The 
solution was warmed to room temperature. The reaction mixture was monitored by TLC and 
quenched accordingly with water upon completion. After separation of the layers, the aqueous 
layer was extracted with CH2Cl2 (3 x). The combined organic layers were washed with brine (1x) 
and dried with MgSO4.  Filtration and solvent evaporation in vacuo followed by purification by 
using flash chromatography on silica gel eluting with hexanes/ethyl acetate or recrystallization 
provided the corresponding o-iodoanilide.  
 
6.2.2. General procedure for N-allylation of anilides (II) 
To a THF slurry of NaH (1.1 equiv) at 0 ˚C was added the respective o-iodoanilide 60 (1.0 
equiv) dissolved in THF (2 mL/mmol iodoanilide). The reaction mixture was stirred until the 
solution became clear and then the appropriate allyl bromide or iodide (1.3 equiv) was added 
dropwise. The solution was warmed to room temperature. The reaction mixture was monitored 
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by TLC and quenched accordingly with water upon completion. The resulting mixture was 
extracted with diethyl ether (3 x 25 mL/mmol of anilide). The combined organic layers were 
washed with brine (1 x) and dried with MgSO4.  Filtration and solvent evaporation in vacuo 
followed by purification by flash chromatography on silica gel eluting with hexanes/ethyl acetate 
provided the respective racemic anilide. 
 
6.2.3. General procedure for thermally initiated radical cyclization of anilides (III) 
To a benzene solution of the respective o-iodoanilide  (1.0 equiv) was added Bu3SnH (1.5 equiv) 
and AIBN (0.2 equiv).  The reaction mixture was refluxed until the starting material was deemed 
consumed by TLC.  The solvents were removed in vacuo and the crude was submitted to the 
DBU workup.
76
  Purification of the remaining crude by flash column chromatography on silica 
gel eluting with hexanes/diethyl ether (9/1) provided the respective dihydroindole. 
 
6.2.4. General procedure for Et3B initiated radical cyclization of N-allyl anilides (IV) 
To an aerated benzene solution of the respective o-iodoanilide (1.0 equiv) and Bu3SnH (1.5 
equiv, 0.01 M) was added a hexane solution of Et3B (1.0 M, 1.0 equiv).  The reaction mixture 
was sealed and stirred at room temperature (23 ˚C) until the starting material was deemed 
consumed by TLC (typically less than 5 min).  The solvents were removed in vacuo and the 
crude was submitted the DBU workup.
76
  Purification of the remaining crude by flash column 
chromatography on silica gel eluting with hexanes/diethyl ether provided the respective 
dihydroindole. 
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6.2.5. General procedure for Et3B initiated radical cyclizations of acrylanilides (V)  
To an aerated benzene solution of the respective o-iodoanilide (1.0 equiv) and Bu3SnH (1.5 
equiv, 0.01 M) was added a hexane solution of Et3B (1.0 M, 1.0 equiv).  The reaction mixture 
was sealed and stirred at room temperature (23 ˚C) until the starting material was deemed 
consumed by TLC (typically less than 5 min). The solvent was removed under reduced pressure 
and the crude product was purified by flash column chromatography on silica gel eluting with 
hexanes/diethyl ether provided the respective oxindole. 
 
6.3. Compound Data for Chapter 3 
 
N
H
O
I  
6.3.1. N-(2-Iodo-4,6-dimethylphenyl)benzamide (not shown in text): 
This compound was prepared according to general procedure I.  A white, crystalline solid (mp 
175–176 ˚C) was obtained in quantitative yield: IR (thin film, CH2Cl2, NaCl, cm
–1
) 1679, 1500, 
1480, 1265, 1257; 
1
H NMR (300 MHz, CDCl3) ? 2.25 (s, 6 H), 7.06 (s, 1 H), 7.45–7.60 (m, 3 H), 
7.55 (s, 1 H), 7.65 (s, 1 H), 7.97 (d, J = 7.1 Hz, 2 H; 
13
C NMR (75 MHz, CDCl3) ? 19.6, 20.5, 
99.3, 127.4, 128.7, 131.8, 131.9, 134.2, 134.4, 137.2, 137.3, 139.1, 165.6; HRMS (EI) calcd for 
C15H14INO 351.0120, found 351.0107; LRMS (EI) m/z 351 (M
+
, 50), 259 (29), 246 (51), 224 
(49), 105 (100), 77 (50).  
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6.3.2. N-(2-Iodo-4,6-dimethylphenyl)-4-bromobenzamide (not shown in text): 
This compound was prepared according to general procedure I.  A white, crystalline solid (mp 
242–244 ˚C) was obtained in 82 % yield: IR (thin film, CH2Cl2, NaCl, cm
–1
) 1681, 1477, 1421, 
1271, 896; 
1
H NMR (300 MHz, CDCl3) ? 2.30 (s, 6 H), 7.09 (s, 1 H), 7.45 (bs, 1 H), 7.57 (s, 1 
H), 7.65 (d, J = 6.8 Hz, 2 H), 7.68 (d, J = 6.8 Hz, 2 H); 
13
C NMR (75 MHz, CDCl3) ? 19.6, 20.5, 
99.1, 126.8, 129.0, 132.0, 132.1, 133.0, 134.1, 137.1, 137.3, 139.4; HRMS (EI) calcd for 
C15H13NOBrI 428.9225, found 428.9225; LRMS (EI) m/z 429 (M
+
, 23), 302 (87), 183 (100).  
N
H
O
I  
6.3.3. N-(2-Iodo-4,6-dimethylphenyl)-2-phenylacetamide (not shown in text): 
This compound was prepared according to general procedure I.  A white, crystalline solid (mp 
161–162 ˚C) was obtained in 47 % yield: IR (thin film, CHCl3, NaCl, cm
–1
) 3388, 3015, 2923, 
1680, 1601, 1558, 1490, 1283, 1236, 852; 
1
H NMR (300 MHz, CDCl3) ? 2.18 (s, 3 H), 2.24 (s, 3 
H), 3.80 (s, 2 H), 6.70 (s, 1 H), 6.99 (s, 1 H), 7.45 (m, 5 H), 7.47 (s, 1 H); 
13
C NMR (75 MHz, 
CDCl3) ? 19.4, 20.4, 44.1, 99.0, 127.6, 129.2, 129.9, 131.7, 134.2, 134.6, 136.9, 137.0, 139.1, 
169.1; HRMS (EI) calcd for C16H16INO 365.0277, found 365.0289; LRMS (EI) m/z 365 (M
+
, 3), 
274 (3), 27 3 (4), 247 (66), 238 (100), 91 (71). 
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6.3.4. N-(2-Iodo-4,6-dimethylphenyl)-3-phenylpropionamide (not shown in text): 
This compound was prepared according to general procedure I.  A white, crystalline solid (mp 
156–157 ˚C) was obtained in 76 % yield: IR (thin film, CH2Cl2, NaCl, cm
–1
) 1689, 1482, 1421, 
1265; 
1
H NMR (300 MHz, CDCl3) ? 2.13 (s, 3 H), 2.25 (s, 3 H), 2.74 (t, J = 8.1 Hz, 2 H), 3.10 (t, 
J = 8.1 Hz, 2 H), 6.93 (s, 1 H), 6.98 (s, 1 H), 7.15–7.45 (m, 5 H), 7.49 (s, 1 H); 
13
C NMR (75 
MHz, CDCl3) ? 19.5, 20.4, 31.5, 38.3, 99.4, 126.3, 128.5, 128.6, 131.7, 134.4, 137.0, 137.1, 
139.0, 140.7, 170.5; HRMS (EI) calcd for C17H18INO 379.0433, found 379.0439; LRMS (EI) 
m/z 379 (M
+
, 37), 351 (88), 252 (68), 247 (53), 224 (99), 111 (80), 105 (100).  
N
I
O
 
6.3.5. rac-N-Allyl-N-(2-iodo-4,6-dimethylphenyl)benzamide (56a): 
This compound was prepared according to general procedure II.  A clear, colorless oil was 
obtained in 35 % yield: IR (thin film, CH2Cl2, NaCl, cm
–1
) 2927, 1641, 1380, 1258; 
1
H NMR 
(300 MHz, CDCl3) ? 2.10 (s, 3 H), 2.18 (s, 3 H), 4.04 (dd, J = 14.2, 7.9 Hz, 1 H), 4.80 (dd, J = 
14.2, 6.1 Hz, 1 H), 5.05–5.20 (m, 2 H), 6.08 (dddd, J = 14.0, 9.9, 7.8, 6.2 Hz, 1 H), 6.82 (s, 1 H), 
7.13 (t, J = 7.6 Hz, 2 H), 7.21 (d, J = 7.6 Hz, 1 H), 7.39 (d, J = 7.0 Hz, 2 H); 
13
C NMR (75 MHz, 
CDCl3) ? 19.8, 20.3, 53.1, 101.4, 119.0, 127.3, 127.9, 129.8, 132.0, 132.5, 135.8, 137.6, 138.3, 
139.3, 140.7; HRMS (EI) calcd for C18H18INO 391.0433, found 391.0432; LRMS (EI) m/z 391 
(M
+
, 27), 264 (70), 223 (31), 144 (32), 105 (100), 77 (58); The racemate was submitted to 
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preparative chiral HPLC separation (Regis Technologies (S,S)-Whelk-O 1; 25 cm x 10.0 mm 
I.D.; 10 mL/min Hexanes/iPrOH; first eluting enantiomer (P) ?D23  +140, 87 % ee (c 5.4 mg/mL, 
CHCl3); second eluting enantiomer (M) ?D23  -191, 97 % ee (c 2.4 mg/mL, CHCl3). 
N
I
O
Br
 
6.3.6. rac-N-(2-Iodo-4,6-dimethylphenyl)-N-(3-methylbut-2-enyl)-4-bromobenzamide (56b): 
This compound was prepared according to general procedure II.  A white, crystalline solid (mp 
101 ˚C) was obtained in 91 % yield:  IR (thin film, CH2Cl2, NaCl, cm
–1
) 2927, 1642, 1442, 1399, 
1264, 1012; 
1
H NMR (300 MHz, CDCl3) ? 1.44 (s, 3 H), 1.66 (s, 3 H), 2.08 (s, 3 H), 2.23 (s, 3 
H), 4.11 (dd, J = 14.5, 8.6 Hz, 1 H), 4.71 (dd, J = 14.5, 6.8 Hz, 1 H), 5.42 (app t, J = 7.0 Hz, 1 
H), 6.85 (s, 1 H), 7.20–7.35 (m, 4 H), 7.52 (s, 1 H); 
13
C NMR (75 MHz, CDCl3) ? 17.6, 19.6, 
20.3, 25.7, 47.5, 101.2, 118.4, 124.3, 129.7, 130.6, 132.1, 134.9, 136.9, 137.7, 138.5, 139.5, 
140.6, 168.8; HRMS (EI) calcd for C20H23IBrNO 496.9851, found 496.9859; LRMS (EI) m/z 
497 (M
+
, 37), 454 (13), 429 (28), 302 (32), 191 (100); The racemate was submitted to 
preparative chiral HPLC separation (Regis Technologies (S,S)-Whelk-O 1; 25 cm x 10.0 mm 
I.D.; 10 mL/min Hexanes/iPrOH; first eluting enantiomer (P) ?D23  +156, 99 % ee (c 1.4 mg/mL, 
CHCl3); second eluting enantiomer (M) ?D23  -146, 98 % ee (c 1.5 mg/mL, CHCl3). 
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6.3.7. rac-N-Allyl-N-(2-iodo-4,6-dimethylphenyl)-2-phenylacetamide (56c): 
This compound was prepared according to general procedure II.  A clear, colorless oil was 
obtained in 93 % yield:  IR (thin film, CHCl3, NaCl, cm
–1
) 3066, 3024, 3013, 2961, 2926, 2858, 
1652, 1466, 1456, 1389, 1261, 990; 
1
H NMR (300 MHz, CDCl3) ? 2.05 (s, 3 H), 2.33 (s, 3 H), 
3.22 (d, J = 15.0 Hz, 1 H), 3.40 (d, J = 15.0 Hz, 1 H), 4.00 (dd, J = 14.3, 7.5 Hz, 1 H), 4.45 (dd, J 
= 14.3, 6.3 Hz, 1 H), 5.05 (dd, J = 10.0, 1.4 Hz, 1 H), 5.09 (dd, J = 17.3, 1.4 Hz, 1 H), 5.96 
(dddd, J = 17.3, 10.0, 7.5, 6.3 Hz, 1 H), 7.04 (s, 1 H), 7.09 (d, J = 6.2 Hz, 2 H), 7.20–7.29 (m, 3 
H), 7.64 (s, 1 H); 
13
C NMR (75 MHz, CDCl3) ? 19.8, 20.8, 41.8, 52.3, 102.3, 119.1, 119.2, 
127.0, 128.5, 130.0, 132.5, 133.2, 134.9, 138.7, 140.4, 140.7, 171.0; HRMS (EI) calcd for 
C19H20INO 405.0590, found 405.0601; LRMS (EI) m/z 405 (M
+
, 43), 314 (19), 287 (26), 278 
(100), 187 (58), 158 (52), 91 (97); The racemate was submitted to preparative chiral HPLC 
separation (Regis Technologies (S,S)-Whelk-O 1; 25 cm x 10.0 mm I.D.; 10 mL/min 
Hexanes/iPrOH; first eluting enantiomer (P) ?D23  -55, 97 % ee  (c 3.5 mg/mL, CHCl3); second 
eluting enantiomer (M) ?D23  +59, 99 % ee (c 1.4 mg/mL, CHCl3). 
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6.3.8. rac-N-(2-Iodo-4,6-dimethylphenyl)-N-(3-phenylallyl)-2-phenylacetamide (56d): 
This compound was prepared according to general procedure II.  A clear, yellow oil was 
obtained in 100 % yield:  IR (thin film, CHCl3, NaCl, cm
–1
) 3008, 2925, 1652, 1495, 1465, 1455, 
1393, 1351, 1310, 1247, 968; 
1
H NMR (300 MHz, CDCl3) ? 2.05 (s, 3 H), 2.32 (s, 3 H), 3.23 (d, 
J = 15.0 Hz, 1 H), 3.43 (d, J = 15.0 Hz, 1 H), 4.10–4.21 (m, 1 H), 4.50–4.61 (m, 1 H), 6.37–6.40 
(m, 2 H), 7.02 (s, 1 H), 7.07–7.12 (m, 2 H), 7.18–7.30 (m, 8H), 7.64 (s, 1 H); 
13
C NMR (75 
MHz, CDCl3) ? 19.3, 20.4, 41.3, 51.3, 101.3, 124.1, 126.3, 126.6, 127.5, 128.1, 128.4, 129.5, 
132.2, 133.4, 134.4, 136.5, 138.1, 138.3, 140.0, 140.1, 170.6; HRMS (EI) calcd for C25H24INO 
481.0903, found 481.0927; LRMS (EI) m/z 481 (M
+
, 58), 390 (44), 363 (8), 236 (27), 158 (21), 
117 (100), 91 (84);  The racemate was submitted to preparative chiral HPLC separation (Regis 
Technologies (S,S)-Whelk-O 1; 25 cm x 10.0 mm I.D.; 10 mL/min hexanes/iPrOH; first eluting 
enantiomer (P) ?D23  -17, 94 % ee(c 6.3 mg/mL, CHCl3); second eluting enantiomer (M) ?D23  +11, 
98 % ee (c 9.9 mg/mL, CHCl3). 
N
I
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6.3.9. rac-N-But-2E-enyl-N-(2-iodo-4,6-dimethylphenyl)-2-phenylacetamide (56e): 
This compound was prepared according to general procedure II.  A clear, yellow oil was 
obtained in 41 % yield: IR (thin film, CHCl3, NaCl, cm
–1) 3012, 2921, 2856, 1650, 1496, 1465, 
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1455, 1393, 1313, 1262, 1247, 1165, 970; 1H NMR (300 MHz, CDCl3) ? 1.59 (d, J = 5.9 Hz, 3 
H), 2.04 (s, 3 H), 2.33 (s, 3 H), 3.20 (d, J = 15.0 Hz, 1 H), 3.39 (d, J = 15.0 Hz, 1 H), 3.94 (dd, J 
= 14.0, 7.1 Hz, 1 H), 4.38 (dd, J = 14.0, 6.3 Hz, 1 H), 5.50–5.79 (m, 2 H), 7.03 (s, 1 H), 7.05–
7.14 (m, 2 H), 7.20–7.34 (m, 3 H), 7.63 (s, 1 H); 13C NMR (75 MHz, CDCl3) ? 17.5, 19.2, 20.3, 
41.4, 50.9, 101.9, 125.5, 126.5, 128.0, 129.1, 129.5, 129.9, 132.0, 134.6, 138.2, 139.8, 140.3, 
170.4; HRMS (EI) calcd for C20H22INO 419.0746, found 419.0737; LRMS (EI) m/z 419 (M
+, 
55), 292 (44), 238 (37), 174 (30), 158 (33),  91 (98), 55(100); The racemate was submitted to 
preparative chiral HPLC separation (Regis Technologies (S,S)-Whelk-O 1; 25 cm x 10.0 mm 
I.D.; 10 mL/min Hexanes/iPrOH; first eluting enantiomer (P) ?D23 ? ??-46, 99 % ee ?( ?c? ?4.7 mg/mL?, ? 
?C?H?C?l3 ?); second eluting enantiomer ?(M) ?D23  ??+41, 99 % ee ? ( ?c? 11.4 mg/mL?, ? ?C?H?C?l3 ?). 
N
I
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6.3.10. rac-N-(2-Iodo-4,6-dimethylphenyl)-N-(3-methylbut-2-enyl)-2-phenylacetamide (56f): 
This compound was prepared according to general procedure II.  A clear, yellow oil was 
obtained in 79 % yield: IR (thin film, CHCl3, NaCl, cm
–1
) 3026, 3014, 2925, 2861, 1650, 1495, 
1455, 1383, 1236, 1186, 1162, 1032; 
1
H NMR (300 MHz, CDCl3) ? 1.43 (s, 3 H), 1.62 (s, 3 H), 
2.03 (s, 3 H), 2.43 (s, 3 H), 3.21 (d, J = 15.0 Hz, 1 H), 3.39 (d, J = 15.0 Hz, 1 H), 4.04 (dd, J = 
14.3, 8.0 Hz, 1 H), 4.45 (dd, J = 14.3, 7.1 Hz, 1 H), 5.03 (dd, J = 7.0, 7.0 Hz, 1 H), 7.03 (s, 1 H), 
7.05–7.13 (m, 2 H), 7.17–7.28 (m, 3 H), 7.62 (s, 1 H); 
13
C NMR (75 MHz, CDCl3) ? 17.4, 19.0, 
20.3, 25.5, 41.1, 45.9, 53.8, 101.7, 118.7, 126.4, 127.9, 129.4, 131.9, 134.5, 136.2, 138.1, 139.7, 
140.0, 170.4; HRMS (EI) calcd for C21H24INO 433.0903, found 433.0901; LRMS (EI) m/z 433 
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(M
+
, 100), 390 (9), 365 (27), 300 (21), 273 (14), 247 (17), 238 (41), 91 (93), 69 (66); The 
racemate was submitted to preparative chiral HPLC separation (Regis Technologies (S,S)-
Whelk-O 1; 25 cm x 10.0 mm I.D.; 10 mL/min Hexanes/iPrOH; first eluting enantiomer (P) ?D23  
-49, 99 % ee (c 2.2 mg/mL, CHCl3); second eluting enantiomer (M) ?D23  +43, 99 % ee (c 4.5 
mg/mL, CHCl3). 
N
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6.3.11. rac-N-Allyl-N-(2-iodo-4,6-dimethylphenyl)-3-phenylpropionamide (56g): 
This compound was prepared according to general procedure II.  A clear, yellow oil was 
obtained in 97 % yield: IR (thin film, CHCl3, NaCl, cm
–1
) 2926, 1649,1395; 
1
H NMR (300 MHz, 
CDCl3) ? 2.12 (s, 3 H), 2.28 (s, 3 H), 2.95–3.05 (m, 2 H), 3.96 (dd, J = 14.3, 7.6 Hz, 1 H), 4.54 
(dd, J = 14.3, 6.5 Hz, 1 H), 5.04-5.15 (m, 2 H), 5.97 (dddd, J = 6.5, 7.5, 9.8, 13.7 Hz, 1 H), 7.02 
(s, 1 H), 7.10–7.20 (m, 3 H), 7.23 (d, J = 6.7 Hz, 2 H), 7.58 (s, 1 H); 
13
C NMR (75 MHz, CDCl3) 
? 19.4, 20.4, 31.2, 36.3, 51.6, 101.4, 118.7, 125.9, 128.3, 128.5, 132.1, 132.9, 137.7, 138.3, 
139.9, 140.1, 141.4, 171.8; HRMS (EI) calcd for C20H22INO 419.0746, found 419.0743; LRMS 
(EI) m/z 419 (M
+
, 32), 292 (100), 160 (37), 158 (32), 155 (25), 131 (34), 105 (59); The racemate 
was submitted to preparative chiral HPLC separation (Regis Technologies (S,S)-Whelk-O 1; 25 
cm x 10.0 mm I.D.; 10 mL/min Hexanes/iPrOH; first eluting enantiomer (P) ?D23  -60, 99 % ee (c 
3.8 mg/mL, CHCl3); second eluting enantiomer (M) ?D23  +58, 99 % ee (c 4.3 mg/mL, CHCl3). 
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6.3.12. rac-N-Allyl-N-(2-iodo-4,6-dimethylphenyl)-trans-crotonamide (56h): 
This compound was prepared according to general procedure I.  A white, crystalline solid (mp 
56–58 °C) was obtained in 64 % yield: IR (thin film, CH2Cl2, NaCl, cm
–1
) 2984, 2854, 1666, 
1629, 1445, 1384, 1273; 
1
H NMR (300 MHz, CDCl3) ? 1.73 (dd, J = 6.9, 1.5 Hz, 3 H), 2.18 (s, 3 
H), 2.31 (s, 3 H), 3.94 (ddd, J = 14.3, 7.1, 0.6 Hz, 1 H), 4.58 (dd, J = 14.3, 6.4 Hz, 1 H), 5.02–
5.11 (m, 2 H), 5.48 (dd, J = 15.0, 1.7 Hz, 1 H), 5.97 (dddd, J = 17.0, 10.0, 7.7, 6.5 Hz, 1 H), 7.00 
(dq, J = 15.0, 6.9 Hz, 1 H), 7.04 (s, 1 H), 7.60 (s, 1 H); 
13
C NMR (75 MHz, CDCl3) ? 18.0, 19.7, 
20.5 51.6, 101.6, 118.7, 121.9, 125.4, 132.0, 133.1, 138.2, 138.8, 139.9, 140.0, 142.4, 165.8; 
HRMS (EI) calcd for C15H18INO 355.0433, found 355.0445; LRMS (EI) m/z 355 (M
+
, 25), 340 
(20), 313 (13), 287 (16), 228 (100), 18 (39), 158 (32), 69 (68).  
N
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6.3.13. Phenyl-(3,5,7-trimethyl-2,3-dihydroindol-1-yl)methanone (57a): 
This compound was prepared according to general procedure IV.  The atropisomer (P)-56a 
(99.5/0.5 er, first eluting enantiomer) yielded a white, crystalline solid in 95 % yield (93/7 er, +3, 
c 6.2 mg/mL, first eluting enantiomer).  The atropisomer (M)-56a (>99.5/0.5 er, second eluting 
enantiomer) yielded a white, crystalline solid in 92 % yield (93.5/6.5 er, -3, c 6.8 mg/mL, second 
eluting enantiomer): IR (thin film, CH2Cl2, NaCl, cm
–1
) 2966, 1649, 1371, 1264; 
1
H NMR (300 
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MHz, CDCl3) ? 1.24 (d, J = 7.0 Hz, 3 H), 2.20 (s, 3 H), 2.34 (s, 3 H), 3.33 (sex, J = 7.3 Hz, 1 H), 
3.65 (dd, J = 10.4, 7.6 Hz, 1 H), 4.22 (dd, J = 10.4, 7.7 Hz, 1 H), 6.88 (s, 1 H), 6.91 (s, 1 H), 
7.40–7.55 (m, 3 H), 7.74 (d, J = 6.7 Hz, 2 H); 
13
C NMR (75 MHz, CDCl3) ? 17.8, 19.9, 21.1, 
36.9, 61.6, 121.2, 128.4, 128.5, 128.6, 130.3, 131.1, 135.2, 136.2, 139.2, 139.5, 169.6; HRMS 
(EI) calcd for C18H19NO 265.1467, found 265.1462; LRMS (EI) m/z 265 (M
+
, 39), 105 (100), 77 
(35). 
N
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6.3.14. (4-Bromophenyl)-(3-isopropyl-5,7-dimethyl-2,3-dihydroinol-1-yl)methanone 
(57b): 
This compound was prepared according to general procedure IV. The atropisomer (P)-56b 
(99.5/0.5 er, first eluting enantiomer) yielded a white, crystalline solid in 72 % yield (74/26 er, 
+16, c 4.4 mg/mL, second eluting enantiomer). The atropisomer (M)-56b (99/1 er, second eluting 
enantiomer) yielded a white, crystalline solid in 95 % yield (73.5/26.5 er, -15, c 9.5 mg/mL, first 
eluting enantiomer):  IR (thin film, CH2Cl2, NaCl, cm
–1) 1649, 1421, 1267, 896; 1H NMR (300 
MHz, CDCl3) ? 0.79 (d, J = 6.8 Hz, 3 H), 0.88 (d, J = 7.2 Hz, 3 H), 1.92 (sex, J = 6.7 Hz, 1 H), 
2.16 (s, 3 H), 2.33 (s, 3 H), 2.99 (p, J = 4.1 Hz, 1 H), 3.86 (dd, J = 10.8, 3.3 Hz, 1 H), 4.08 (dd, J 
= 10.8, 8.1 Hz, 1 H), 6.89 (s, 1 H), 6.91 (s, 1 H), 7.60 (s, 4 H); 13C NMR (75 MHz, CDCl3) ? 
18.3, 20.0, 20.3, 21.1, 30.8, 48.2, 56.2, 122.8, 125.7, 128.4, 130.2, 130.6, 131.7, 135.1, 134.2, 
136.8, 139.6, 168.6; HRMS (EI) calcd for C20H22NOBr 371.0885, found 371.0870; LRMS (EI) 
m/z  371 (M+, 33), 183 (87), 91 (100). 
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6.3.15. 1-(3-5,7-Trimethyl-2,3-dihydroindol-1-yl)-2-phenylethanone (57c): 
This compound was prepared according to general procedure IV.  The atropisomer (P)-56c 
(>99.5/0.5 er, second eluting enantiomer) yielded a clear oil in 54 % yield (96.5/3.5 er, +27, c 2.5 
mg/mL, first eluting enantiomer).  The atropisomer (M)-56c (98.5/1.5 er, first eluting 
enantiomer) yielded a clear oil in 53 % yield (93.5/6.5 er, -32, c 3.7 mg/mL, second eluting 
enantiomer): IR (thin film, CHCl3, NaCl, cm
–1
) 2965, 2928, 1649, 1388; 
1
H NMR (300 MHz, 
CDCl3) ? 1.15 (d, J = 6.8 Hz, 3 H), 2.26 (s, 3 H), 2.30 (s, 3 H), 3.21 (sex, J = 6.9 Hz, 1 H), 3.52 
(dd, J = 10.3, 7.3 Hz, 1 H), 3.88 (s, 2 H), 4.17 (app t, J = 8.5 Hz, 1 H), 6.81 (s, 1 H), 6.87 (s, 1 
H), 7.23–7.36 (m, 5 H); 
13
C NMR (75 MHz, CDCl3) ? 19.4, 20.5, 20.9, 36.5, 43.4, 58.4, 121.0, 
126.8, 127.1, 128.6, 128.7, 129.6, 130.4, 135.0, 135.1, 136.0, no carbonyl signal observed; IR 
(thin film, CH2Cl2, NaCl, cm
–1
) 1679, 1500, 1480, 1265, 1257; HRMS (EI) calcd for C19H21NO 
279.1623, found 279.1627; LRMS (EI) m/z 279 (M
+
, 64), 188 (7), 161 (100), 146 (69), 91 (52). 
N
O
 
6.3.16. 1-(3-Benzyl-5,7-dimethyl-2,3-dihydroindol-1-yl)-2-phenylethanone (57d): 
This compound was prepared according to general procedure IV. The atropisomer (P)-56d 
(>99.5/0.5 er, second eluting enantiomer) yielded a clear oil in 95 % yield (87/13 er, +24, c 4.7 
mg/mL, first eluting enantiomer).  The atropisomer (M)-56d (99/1 er, first eluting enantiomer) 
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yielded a clear oil in 72 % yield (88/12 er, -29, c 4.3 mg/mL, second eluting enantiomer): IR 
(thin film, CH2Cl2, NaCl, cm
–1
) 2927, 1660, 1377, 1268; 
1
H NMR (300 MHz, CDCl3) ? 2.27 (s, 
3 H), 2.29 (s, 3 H), 2.53 (dd, J = 13.9. 9.9 Hz, 1 H), 2.96 (dd, J = 13.9, 5.3 Hz, 1 H), 3.23 – 3.42 
(m, 1 H), 3.76 (m, 1 H), 3.82 (d, J = 3.2 Hz, 2 H), 3.94 (dd, J = 10.6, 7.4 Hz, 1 H), 6.75 (s, 1 H), 
6.91 (s, 1 H), 7.30 (m, 10H); 
13
C NMR (75 MHz, CDCl3) ? 20.6, 21.0, 29.7, 39.6, 43.6, 55.9, 
121.8, 126.4, 126.9, 128.6 (2 C), 128.8 (6 C), 130.9, 135.0, 135.1, 127.7, 137.7, 139.2; HRMS 
(EI) calcd for C25H25NO 355.1936, found 355.1938; LRMS (EI) m/z 355 (M
+
, 37), 146 (100), 
131 (20), 105 (18), 91 (62). 
N
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6.3.17. 1-(3-Ethyl-5,7-dimethyl-2,3-dihydroindol-1-yl)-2-phenylethanone (57e): 
This compound was prepared according to general procedure IV.  The atropisomer (P)-56e 
(>99.5/0.5 er, second eluting enantiomer) yielded a clear oil in 77 % yield (89.5/10.5 er, +34, c 
6.7 mg/mL, first eluting enantiomer). The atropisomer (M)-56e (>99.5/0.5 er, first eluting 
enantiomer) yielded a clear oil in 71 % yield (91.5/8.5 er, -38, c 1.8 mg/mL, second eluting 
enantiomer): IR (thin film, CH2Cl2, NaCl, cm
–1
) 2927, 2876, 1656, 1598, 1379, 1268; 
1
H NMR 
(300 MHz, CDCl3) ? 0.84 (t, J = 7.4 Hz, 3 H), 1.25–1.35 (m, 1 H), 1.61–1.70 (m, 1 H), 2.26 (s, 3 
H), 2.30 (s, 3 H), 2.95 (m, 1 H), 3.69 (dd, J = 10.3, 5.4 Hz, 1 H), 3.88 (s, 2 H), 4.09 (app t, J = 
8.8 Hz, 1 H), 6.82 (s, 1 H), 6.87 (s, 1 H), 7.20–7.34 (m, 5 H); 
13
C NMR (75 MHz, CDCl3) ? 11.5, 
20.5, 20.9, 26.2, 56.2, 64.7, 121.7, 126.8, 128.7, 128.8, 130.0, 130.6, 134.9, 135.2, 138.4, 139.1; 
HRMS (EI) calcd for C20H23NO 293.1780, found 293.1779; LRMS (EI) m/z 293 (M
+
, 64), 175 
(86), 146 (100), 91 (56). 
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6.3.18. 1-(3-Isopropyl-5,7-dimethyl-2,3-dihydroindol-1-yl)-2-phenylethanone (57f): 
This compound was prepared according to general procedure IV. The atropisomer (P)-56f 
(>99.5/0.5 er, first eluting enantiomer) yielded a white, waxy solid in 79 % yield (80/20 er, +12, 
c 1.9 mg/mL, second eluting enantiomer). The atropisomer (M)-56f (>99.5/0.5 er, second eluting 
enantiomer) yielded a white, waxy solid in 81 % yield (79/21 er, -11, c 2.3 mg/mL, first eluting 
enantiomer): IR (thin film, CH2Cl2, NaCl, cm
–1
) 1656, 1602, 1378; 
1
H NMR (300 MHz, CDCl3) 
? 0.68 (d, J = 6.7 Hz, 3 H), 0.88 (d, J = 6.8 Hz, 3 H), 1.77 (o, J = 6.7 Hz, 1 H), 2.24 (s, 3 H), 2.29 
(s, 3 H), 2.83 (q, J = 5.9 Hz, 1 H), 3.83–3.90 (m, 2 H), 3.90–4.01 (m, 2 H), 6.81 (s, 1 H), 6.87 (s, 
1 H), 7.25–7.35 (m, 2 H), 7.38–7.56 (m, 3 H); 
13
C NMR (75 MHz, CDCl3) ? 18.5, 20.3, 20.7, 
21.0, 30.5, 43.7, 48.1, 54.5, 122.8, 126.9, 128.7, 128.9, 130.7, 134.6, 135.0, 136.9, 136.9, 139.4, 
168.9; LRMS (EI) m/z 307 (M
+
, 22), 189 (19), 146 (100), 91 (47), 69 (16); HRMS (EI) calcd for 
C19H20INO 307.1936, found 307.1931; LRMS (EI) m/z 307 (M
+
, 27), 189 (22), 146 (100), 91 
(37).  
N
O
 
6.3.19. 1-(3-Methyl-5,7-dimethyl-2,3-dihydroindol-1-yl)-3-phenylpropanone (57g): 
This compound was prepared according to general procedure IV. The atropisomer (P)-56g (98/2 
er, second eluting enantiomer) yielded a clear oil in 67 % yield (92.5/7.5 er, +24, c 5.2 mg/mL, 
 89 
first eluting enantiomer).  The atropisomer (M)-56g (>99.5/0.5 er, first eluting enantiomer) 
yielded a clear oil in 74 % yield (95/5 er, -25, c 4.1 mg/mL, second eluting enantiomer): IR (thin 
film, CH2Cl2, NaCl, cm
–1
) 1641, 1421, 1264; 
1
H NMR (300 MHz, CDCl3) ? 1.18 (d, J = 6.8 Hz, 
3 H), 2.20 (s, 3 H), 2.30 (s, 3 H), 2.8 (t, J = 7.5 Hz, 2 H), 3.09 (t, J = 7.5 Hz, 2 H), 3.08–3.20 (m, 
1 H), 3.46 (dd, J = 10.1, 7.7 Hz, 1 H), 4.04–4.24 (m, 1 H), 6.81 (s, 1 H), 6.86 (s, 1 H), 7.15–7.35 
(m, 5 H); 
13
C NMR (75 MHz, CDCl3) ? 17.8, 21.0, 29.7, 31.8, 35.9, 41.4, 58.4, 118.1, 121.1, 
126.0, 126.2, 127.6, 128.5, 129.0, 130.4, 132.0, 133.0, 134.9, 138.2, 138.9, 141.1, 172.1; HRMS 
(EI) calcd for C20H23NO 293.1780, found 279.1792; LRMS (EI) m/z 293 (M
+
, 34), 205 (9), 161 
(100), 146 (38), 105 (25), 91 (44). 
N
O
 
6.3.20. 1-(3-Methyl-5,7-dimethyl-2,3-dihydroindol-1-yl)but-2-enone (57h): 
This compound was prepared from 56h according to general procedure I.  A brown oil was 
obtained in 72 % yield: IR (thin film, CH2Cl2, NaCl, cm
–1) 1666, 1630, 1470, 1423; 1H NMR 
(300 MHz, CDCl3) ? 1.26 (d, J = 6.7 Hz, 3 H), 1.92 (dd, J = 6.9, 1.5 Hz, 3 H), 2.22 (s, 3 H), 2.31 
(s, 3 H), 3.32 (sex, J = 7.1 Hz, 1 H), 3.61 (dd, J = 10.2, 7.6 Hz, 1 H), 4.33 (app t, J = 8.2 Hz, 1 
H), 6.17 (d, J = 15.0 Hz, 1 H), 6.85 (s, 1 H), 6.87 (s, 1 H), 7.00 (dt, J = 15.0, 6.8 Hz, 1 H); 13C 
NMR (75 MHz, CDCl3) ? 18.1, 18.2, 20.2, 21.0, 21.1, 36.5, 58.9, 121.3, 124.6, 130.4, 134.9, 
138.9, 140.2, 141.7, 165.4; HRMS (EI) calcd for C11H15N 161.1204, found 161.1211; LRMS (EI) 
m/z 161 (M+, 67), 146 (100), 131 (67). 
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6.3.21. rac-N-Allyl-N-(2-iodophenyl)-trans-crotonamide (71b-I): 
This compound was prepared according to general procedure I from N-allyl-2-iodoaniline.  A 
clear, yellow oil was obtained in 59 % yield: IR (thin film, CH2Cl2, NaCl, cm
–1
) 1666, 1630, 
1470, 1422, 1386, 1271; 
1
H NMR (300 MHz, CDCl3) ? 1.67 (d, J = 7.0 Hz, 3 H), 3.62 (dd, J = 
14.6, 7.6 Hz, 1 H), 4.83 (dd, J = 14.6, 5.2 Hz, 1 H), 4.98–5.11  (m, 2 H), 5.44 (d, J = 15.0 Hz, 1 
H), 5.80–5.98 (m, 1 H), 6.94 (dq, J = 14.6, 7.0 Hz, 1 H), 7.06 (t, J = 7.6 Hz, 1 H), 7.13 (d, J = 7.6 
Hz, 1 H), 7.36 (t, J = 7.6 Hz, 1 H), 7.91 (d, J = 7.6 Hz, 1 H); 
13
C NMR (75 MHz, CDCl3) ? 17.9, 
51.1, 100.7, 118.4, 122.3, 129.1, 129.6, 130.9, 132.6, 139.6, 142.1, 143.8, 165.2; HRMS (EI) 
calcd for C13H14INO 327.0120, found 327.0123; LRMS (EI) m/z 327 (M
+
, 3), 259 (21), 200 (99), 
130 (33), 69 (100). 
HN
I
 
6.3.22. N-Allyl-2-iodo-4,6-dimethylaniline (75): 
A dry flask was charged with a stir bar and aniline 59 (1.0 g, 4.0 mmol) before capping with a  
septum and back filling with argon.  Anhydrous THF (15 mL) was introduced via syringe and 
the flask was cooled to 0 ˚C.  A solution of LDA (2.0 M, 1.8 mL, 3.7 mmol) was added via 
syringe and the reaction mixture was stirred for 5 min.  Finally, allyl iodide (343 mL, 3.7 mmol) 
was added and reaction mixture was allowed to warm to room temperature over an hour. After 
warming, water (50 mL) was added and the biphasic solution extracted with diethyl ether (3 x 15 
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mL).  The combined organic fractions were washed with brine, dried with MgSO4, filtered and 
concentrated in vacuo.  The resulting crude oil was purified by silica gel flash chromatography 
(hexanes/diethyl ether, 9/1) to give the title compound as a reddish oil in 83 % yield: 
1
H NMR 
(300 MHz, CDCl3) ? 1.77 (s, 3H), 1.84 (s, 3H), 2.27 (s, 3H), 2.42 (s, 3H), 3.29 (s, 1H), 3.58 (d, J 
= 6.9 Hz, 2 H), 5.51 (m, 1H), 6.97 (s, 1H), 7.50 (s, 1H); 
13
C NMR (75 MHz, CDCl3) ? 17.8, 
19.4, 19.6, 22.5, 25.6, 31.5, 46.3, 96.1, 122.1, 130.9, 132.2, 133.5, 134.8, 136.8, 145.6; HRMS 
(EI) calcd for C11H14IN 287.0171, found 287.0173; LRMS (EI) m/z 287 (M
+
, 100), 246 (80), 160 
(84) 145 (58), 119 (57), 91 (50), 77 (32), 65 (29). 
HN
 
6.3.23. 3,5,7-Trimethyl-2,3-dihydroindole (76): 
This compound was prepared according to general procedure III using 75.  A clear, orange oil 
was obtained in 72 % yield: IR (thin film, CHCl3, NaCl, cm
–1
) 2964, 2927, 2872, 2857, 1660, 
1605, 1486, 1463; 
1
H NMR (300 MHz, CDCl3) ? 1.42 (d, J = 6.8 Hz, 3 H), 2.22 (s, 3 H), 2.37 (s, 
3 H), 3.19 (t, J = 8.6 Hz, 1 H), 3.38–3.50 (m, 1 H), 3.78 (t, J = 8.6 Hz, 1 H), 6.82 (s, 1 H), 6.89 
(s, 1 H); 
13
C NMR (75 MHz, CDCl3) ? 16.5, 18.6, 20.7, 36.9, 55.4, 118.8, 121.4, 128.1, 128.7, 
133.9, 147.2; HRMS (EI) calcd for C11H15N 161.1204, found 161.1211; LRMS (EI) m/z 161 
(M
+
, 67), 146 (100), 131 (67).  
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6.4. Compound Data for Chapter 4 
HN
 
6.4.1. N-Cyclohexyl-p-toluidine (108): 
To a dry septum-capped tube was added K2CO3 (8.08 g, 58.5 mmol), L-proline (2.0 g, 17.5 
mmol), and cyclohexylamine (5.0 mL, 43.8 mmol). A solution of p-bromotoluene (5.0 g, 29.2 
mmol) in anhydrous DMSO (19.5 mL) was introduced by syringe.  Cu(I) iodide (1.67 g, 87.7 
mmol) was added and the tube was capped.  The reaction mixture was heated at 100 ˚C for 24 
hours.
49
 After cooling, the reaction mixture was diluted with CH2Cl2 (20 mL) and filtered twice 
through a pad of silica gel/celite (1/1) to remove insolubles.  The remaining solution was 
concentrated in vacuo.  Water (20 mL) was added to the crude and the mixture was extracted 
with diethyl ether (4 x 20 mL).  The organic fractions were dried over MgSO4, filtered, and 
concentrated in vacuo.  The crude oil was purified via silica gel flash chromatography 
(hexanes/Et2O, 95/5) to give the title compound as a tan, crystalline solid (mp 40–41 ˚C) in 55 % 
yield: 
1
H NMR (300 MHz, CDCl3) ? 1.09–1.50 (m, 5H), 1.64–1.74 (m, 1 H), 1.74–1.87 (m, 2 H), 
2.05–2.16 (m, 2 H), 2.26 (s, 3 H), 3.26 (tt, J = 10.1, 3.7 Hz, 1 H), 3.31 (bs, 1 H), 6.54 (d, J = 7.9 
Hz, 2 H), 7.01 (d, J = 7.9 Hz, 2 H); 
13
C NMR (75 MHz, CDCl3) ? 20.3, 25.0, 26.0, 33.5, 52.0, 
113.4, 126.0, 129.7, 145.1. 
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6.4.2. N-Cyclohexyl-2-iodo-4-methylaniline (not shown in text): 
To a solution of aniline 108 (500 mg, 2.64 mmol) in CH2Cl2 (6.6 mL) was added 
(pyridine)2I•BF4 (982 mg, 2.64 mmol).
77a
  After 15 min, water (5 mL) was added and the mixture 
was extracted with CH2Cl2 (3 x 10 mL).  The combined organic fractions were washed with sat. 
Na2S2O3 and dried over MgSO4.  The solids were removed by filtration and the volatiles were 
removed in vacuo.  Purification by silica gel flash chromatography (hexanes/diethyl ether, 95/5) 
gave the title compound as a clear, yellow oil in 68 % yield: IR (thin film, CH2Cl2, NaCl, cm
–1
) 
3020, 2931, 2856, 1604, 1510, 1313; 
1
H NMR (300 MHz, CDCl3) ? 1.25–1.55 (m, 5H), 1.65–
1.75 (m, 1 H), 1.78–1.90 (m, 2 H), 2.30–2.15 (m, 2 H), 2.55 (s, 3 H), 3.35 (bs, 1 H), 4.00 (m, 1 
H), 6.56 (d, J = 8.2 Hz, 1 H), 7.04 (d, J = 8.2 Hz, 1 H), 7.56 (s, 1 H); 
13
C NMR (75 MHz, CDCl3) 
? 19.7, 24.7, 25.9, 33.0, 52.0, 86.0, 111.2, 127.4, 129.9, 139.3, 144.2; HRMS (EI) calcd for C13 
H18IN 315.0484, found 315.0484; LRMS (EI) m/z 315 (M
+
, 100), 272 (82), 259 (23), 144 (36), 
106 (27). 
N
I
O
 
6.4.3. N-Cyclohexyl-N-(2-iodo-4-methyphenyl)-but-2E-enamide (rac-109): 
To a dry sealable tube was added DMAP (78 mg, 0.64 mmol), N-Cyclohexyl-2-iodo-4-
methylaniline (100 mg, 0.32 mmol), pyridine (77 ?L, 0.95 mmol) to CH2Cl2 (1 mL).  Trans-
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crotonyl chloride (91 ?L, 0.95 mmol) was introduced via syringe and the tube was sealed. The 
reaction mixture was heated at 35 ˚C for 4 h, cooled, and then quenched with sat. NaHCO3 (5 
mL).  The resulting heterogeneous mixture was extracted with CH2Cl2 (3 x 10 mL).  The organic 
fractions were washed with brine (5 mL), dried over MgSO4, filtered of solids and concentrated 
in vacuo.  The resulting crude oil was purified by silica gel flash chromatography 
(hexanes/diethyl ether, 7/3) to give the title compound as a white, crystalline solid (mp 134–135 
˚C) in 74 % yield: IR (thin film, CH2Cl2, NaCl, cm
–1
) 3024, 2935, 1664, 1616, 1483; 
1
H NMR 
(300 MHz, CDCl3) ? 0.79–1.08 (m, 2 H), 1.22–1.51 (m, 4 H), 1.58–1.85 (m, 2 H), 1.71 (d, J = 
7.0 Hz, 3 H), 1.92–2.02 (m, 1 H), 2.11–2.23 (m, 1 H), 2.37 (s, 3 H), 4.47 (tt, J = 11.8, 3.4 Hz, 1 
H), 5.42 (dd, J = 14.9, 1.4 Hz, 1 H), 6.93 (dq, J = 14.9, 7.0 Hz, 1 H), 7.08 (d, J = 8.0 Hz, 1 H), 
7.20 (d, J = 8.0 Hz, 1 H), 7.77 (s, 1 H); 
13
C NMR (75 MHz, CDCl3) ? 17.9, 20.5, 25.7, 25.8, 
25.9, 30.3, 32.4, 56.4, 103.9, 123.8, 129.8, 130.3, 139.8, 139.9, 140.6, 141.1, 165.4; HRMS (EI) 
calcd for C16H19INO 368.0511, found 368.0515; LRMS (EI) m/z 368 (M
+
, 8), 301 (48), 256 (88), 
174 (83), 149 (64), 57 (100). 
HN
I
 
6.4.4. (2-Iodophenyl)-isopropylamine (111): 
A round bottom flask was charged with a stir bar and of sodium triacetoxyborohydride (6.1 g, 
28.8 mmol) and capped with a septum.  Acetone (532 ?L, 7.2 mmol) was added via syringe to 
the flask followed by 2-iodoaniline (1.58 g, 7.2 mmol) dissolved in 1/1 THF/dichloromethane 
(18 mL).  Two drops of glacial acetic acid was introduced and the heterogeneous mixture was 
stirred for 7 d.
78
  The reaction was quenched with water (25 mL) and the resulting biphasic 
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solution was extracted with dichloromethane (3 x 20 mL).  The combined organic fractions were 
washed with brine, dried with MgSO4, filtered and concentrated in vacuo.  The crude oil was 
purified by silica gel flash chromatography (hexanes/diethyl ether, 98/2) to give 1.46 g of the 
title compound as a clear oil (78 % yield):  IR (thin film, CH2Cl2, NaCl, cm
–1
) 2965, 1586, 1500, 
1458, 1316, 1169; 
1
H NMR
79
 (300 MHz, CDCl3) ? 1.29 (d, J = 6.3 Hz, 6 H), 3.69 (sept, J = 6.2 
Hz, 1 H), 4.04 (bs, 1 H), 6.43 (td, J = 7.7, 1.4 Hz, 1 H), 6.60 (dd, J = 8.2, 1.1 Hz, 1 H), 7.21 (td, J 
= 7.3, 1.5 Hz, 1 H), 7.68 (dd, J = 7.8, 1.5 Hz, 1 H); 
13
C NMR (75 MHz, CDCl3) ? 22.9 (2 C), 
44.77, 85.8, 111.1, 118.1, 129.3, 139.2, 146.6; HRMS (EI) calcd for C9H12IN 261.0015, found 
261.0008; LRMS (EI) m/z 261 (M
+
, 44), 246 (100). 
N
I
O
 
6.4.5. N-(2-Iodophenyl)-N-isopropylacrylamide (rac-112): 
A dry flask was charged with a stir bar and aniline 111 (2.61 g, 10 mmol) before capping with a  
septum and back filling with argon.  Diisopropylethylamine (2.67 mL, 15 mmol) and anhydrous 
dichloromethane (33 mL) was introduced via syringe.  Acryloyl chloride (1.21 mL, 15 mmol) 
was added and the reaction mixture was heated at reflux for 4 h.  After cooling, water (50 mL) 
was added and the biphasic solution extracted with dichloromethane (3 x 25 mL).  The combined 
organic fractions were washed with sat. NaHCO3, dried with MgSO4, filtered and concentrated in 
vacuo.  The resulting crude oil was purified by silica gel flash chromatography (hexanes/diethyl 
ether, 8/2) to give the title compound as a white, crystalline solid (mp 77–79 ˚C) in 84 % yield: 
IR (thin film, CH2Cl2, NaCl, cm
–1
) 2976, 1655, 1616, 1463, 1410, 1331; 
1
H NMR (300 MHz, 
CDCl3) ? 1.05 (d, J = 6.9 Hz, 3 H), 1.35 (d, J = 6.6 Hz, 3 H), 4.83 (sept, J = 6.8 Hz, 1 H), 5.49 
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(dd, J = 10.3, 2.0 Hz, 1 H), 5.76 (dd, J = 16.7, 10.3 Hz, 1 H), 6.40 (dd, J = 16.7, 2.0 Hz, 1 H), 
7.11 (td, J = 7.7, 1.5 Hz, 1 H), 7.24 (dd, J = 7.8, 1.5 Hz, 1 H), 7.43 (td, J = 7.6, 1.2 Hz, 1 H), 7.97 
(dd, J = 7.8, 1.2 Hz, 1 H); 
13
C NMR (75 MHz, CDCl3) ? 19.6, 22.2, 48.7, 104.0, 127.8, 129.2, 
129.4, 129.8, 130.6, 140.3, 142.0; HRMS (EI) calcd for C12H14INO 315.0120, found 315.0124; 
LRMS (EI) m/z 315 (M
+
, <1), 246 (44), 188 (84), 146 (85), 55 (100). 
N
O
 
6.4.6. 3-Ethyl-1-cyclohexyl-5-methyl-1,3-dihydroindol-2-one (114): 
Enantioenriched samples of 109 were cyclized according to the general asymmetric radical 
cyclization procedure in benzene. The atropisomer (M)-109 (91/9 er, first eluting enantiomer) 
yielded a clear, colorless oil (R)-114 in 81 % yield (71/29 er, +3 (CHCl3, c 4.2 mg/mL), second 
eluting enantiomer). The atropisomer (P)-109 (86/14 er, second eluting enantiomer) yielded a 
clear, colorless oil (S)-114 in 85 % yield (75/25 er, -3 (CHCl3, c 4.3 mg/mL), first eluting 
enantiomer).  IR (thin film, CH2Cl2, NaCl, cm
–1
) 2932, 2857, 1706, 1622, 1597, 1490; 
1
H NMR 
(300 MHz, CDCl3) ? 0.83 (t, J = 7.4 Hz, 3 H), 1.27 (tt, J = 12.6, 2.9 Hz, 1 H), 1.34–1.52 (m, 2 
H), 1.62 (app s, 1 H), 1.65–1.83 (m, 2 H), 1.85–1.94 (m, 2 H), 1.96–2.07 (m, 2 H), 2.07–2.23 (m, 
2 H), 2.34 (s, 3 H), 3.35 (t, J = 5.5 Hz, 1 H), 4.19 (tt, J = 12.4, 3.9 Hz, 1 H), 6.94 (d, J = 8.0 Hz, 
1 H), 7.04 (d, J = 8.0 Hz, 1 H), 7.07 (s, 1 H); 
13
C NMR (75 MHz, CDCl3) ? 9.6, 21.0, 23.9, 25.5, 
26.0, 29.1, 29.3, 46.5, 51.9, 109.5, 124.8, 127.6, 129.5, 131.0, 141.2, 177.6; HRMS (EI) calcd for 
C17H23NO 257.1780, found 257.1786; LRMS (EI) m/z 257 (M+, 68), 175 (100), 147 (44). 
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6.4.7. 3-Methyl-1-isopropyl-1,3-dihydroindolin-2-one (115): 
Enantioenriched samples of 112 were cyclized according to the general asymmetric radical 
cyclization procedure in benzene. The atropisomer (M)-112 (83/17 er, second eluting 
enantiomer) yielded a clear, colorless oil (R)-115 in 85 % yield (76/24 er, +5 (CHCl3, c 10.0 
mg/mL), second eluting enantiomer). The atropisomer (P)-112 (86/14 er, first eluting 
enantiomer) yielded a clear, colorless oil (S)-115 in 78 % yield (75/25 er, -4 (CHCl3, c 10.4 
mg/mL), first eluting enantiomer).  IR (thin film, CH2Cl2, NaCl, cm
–1
) 2930, 2857, 1704, 1622, 
1596, 1490; 
1
H NMR (300 MHz, CDCl3) ? 1.46 (d, J = 7.6 Hz, 3 H), 1.48 (d, J = 7.0 Hz, 6 H), 
3.38 (q, J = 7.6 Hz, 1 H), 4.67 (sept, J = 7.0 Hz, 1 H), 6.98–7.08 (m, 2 H), 7.20–7.28 (m, 2 H); 
13
C NMR (75 MHz, CDCl3) ? 15.5, 19.3, 40.5, 43.4, 109.7, 121.7, 123.7, 127.5, 131.2, 142.5, 
178.3; HRMS (EI) calcd for C12H15NO 189.1154, found 189.1148; LRMS (EI) m/z 189 (M
+
, 93), 
174 (62), 146 (100) 119 (43).  
 
6.5. Compound Data for Chapter 5 
O
N
H
I  
6.5.1. N-(2-Iodo-4,6-dimethylphenyl)-2-methyl-2E-butenamide (153a): 
In a round bottom flask equipped with a stir bar aniline 59 (700 mg, 2.83 mmol) and pyridine 
(344 µL, 4.24 mmol) were dissolved in dichloromethane (5 mL).  The flask was capped and 
backfilled with argon.  The contents were cooled of the flask were cooled to 0 ˚C and tigloyl 
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chloride (508 µL, 4.24 mmol) was added via syringe.  The reaction mixture was allowed to warm 
to room temperature over 1 hr.  After quenching with water (5 mL), the biphasic mixture was 
extracted with dichloromethane (3 x 5 mL).  The combined organic fractions were washed with 
brine, dried over MgSO4, and concentrated in vacuo.  The resulting crude was purified by silica 
gel chromatography (hexanes/diethyl ether, 6/4) to give the title compound as a white, crystalline 
solid (mp 108–110 ˚C) n 81 % yield: IR (neat, KBr, cm
–1
) 2918, 2856, 1666, 1631, 1495, 1381, 
1286; 
1
H NMR (300 MHz, CDCl3) ? 1.83 (d, J = 6.8 Hz, 3 H), 1.98 (s, 3 H), 2.24 (s, 3 H), 2.27 
(s, 3 H), 6.67 (q, J = 6.8 Hz, 1 H), 7.02 (s, 1 H), 7.15 (bs, 1 H), 7.51 (s, 1 H); 
13
C NMR (75 MHz, 
CDCl3) ? 12.6, 14.0, 19.5, 20.4, 99.2, 131.7, 134.6, 136.9, 137.2, 38.7, 167.4; HRMS (EI) calcd 
for C13H16INO 329.0277, found 329.0278; LRMS (EI) m/z 329 (M
+
, 23), 247 (9), 202 (100), 83 
(92).  
N
O
I
 
 
6.5.2. N-(2-Iodo-4,6-dimethylphenyl)-N,2-dimethyl-2E-butenamide (154a): 
To a round bottom flask equipped with a stir bar a slurry of NaH (95 %, 55 mg, 2.19 mmol) and 
THF (1 mL) was created.  The flask was capped, backfilled with argon, and its contents cooled to 
0 ˚C.  Amide 153a (600 mg, 1.82 mmol) was dissolved in THF (5 mL) and added dropwise via 
syringe to the slurry.  After stirring for 15 min methyl iodide (127 µL, 2.19 mmol) was added via 
syringe.  After a further 15 min water was carefully added to quench remaining hydride.  The 
resulting biphasic mixture was extracted with diethyl ether (3 x 5 mL).  The combined organic 
fractions were washed with brine, dried over MgSO4, and concentrated in vacuo.  The resulting 
crude material was purified by silica gel chromatography (hexanes/diethyl ether, 7/3) to give a 
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white, crystalline solid (mp 80–82 ˚C) in 77 % yield: IR (thin film, CH2Cl2, NaCl, cm
–1
) 2921, 
1634, 1472, 1354; Note: Compound exists as a 3.2:1 mixture of E/Z amide rotamers in CDCl3.  
1
H NMR (300 MHz, CDCl3) ? 1.48 (d, J = 6.8 Hz, 3 H), 1.65 (s, 3 H), 2.22 (s, 3 H), 2.27 (s, 3 
H), 3.15 (s, 3 H), 5.79 (qd, J = 6.8, 1.1 Hz, 1 H), 7.00 (s, 1 H), 7.52 (s, 1 H); 
13
C NMR (75 MHz, 
CDCl3) ? 13.5, 13.8, 19.1, 20.3, 35.9, 100.5, 130.0, 132.0, 132.0, 136.9, 137.9, 138.2, 139.1, 
172.7; HRMS (EI) calcd for C14H18INO 344.0511, found 344.0503; LRMS (EI) m/z 344 (M+H
+
, 
52), 216 (100), 83 (78).  The racemate was submitted to preparative chiral HPLC separation 
(Regis Technologies (S,S)-Whelk-O 1; 25 cm x 10.0 mm I.D.; 10 mL/min Hexanes/iPrOH, 95/5; 
first eluting enantiomer (M) ?D23  –51, 93/7 er (c 4.4 mg/mL, CHCl3); second eluting enantiomer 
(P) ?D23  52, 96/4 er (c 6.9 mg/mL, CHCl3). 
N
O
Br
 
 
6.5.3. N-(2-Bromo-4,6-dimethylphenyl)-N,2-dimethyl-2E-butenamide (154b): 
To a round bottom flask equipped with a stir bar a slurry of NaH (95 %, 11 mg, 0.45 mmol) and 
THF (600 µL) was created.  The flask was capped, backfilled with argon, and its contents cooled 
to 0 ˚C.  Amide 153b (106 mg, 0.38 mmol) was dissolved in THF (600 µL) and added dropwise 
via syringe to the slurry.  After stirring for 15 min methyl iodide (28 µL, 0.45 mmol) was added 
via syringe.  After a further 15 min water was carefully added to quench remaining hydride.  The 
resulting biphasic mixture was extracted with diethyl ether (3 x 5 mL).  The combined organic 
fractions were washed with brine, dried over MgSO4, and concentrated in vacuo.  The resulting 
crude material was purified by silica gel chromatography (hexanes/diethyl ether, 1/1) to give a 
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white, crystalline solid (mp 50–52 °C) in 69 % yield: Note: Compound exists as a 4.2:1 mixture 
of E/Z amide rotamers in CDCl3; signals assigned to the major isomer are in bold and those of a 
mixture italicized.  
1
H NMR (300 MHz, CDCl3) ? 1.46 (dd, J = 6.8, 1.1 Hz, 3 H), 1.64 (s, 3 H), 
1.64 (t, J = 1.4 Hz, 3 H), 1.76 (dd, J = 6.8, 1.1 Hz, 3 H), 1.96 (t, J = 1.4 Hz, 3 H), 2.21 (s, 3 H), 
2.29 (s, 3 H), 3.14 (s, 3 H), 3.19 (s, 3 H), 5.34 (qq, J = 6.8, 1.4 Hz, 1 H), 5.89 (qq, J = 6.8, 1.4 
Hz, 1 H), 6.96 (s, 1 H), 7.03 (s, 1 H), 7.25 (s, 1 H), 7.27 (s, 1 H); 
13
C NMR (75 MHz, CDCl3) ? 
13.5, 18.6, 20.7, 35.6, 123.7, 129.3, 131.0, 131.6, 132.0, 137.4, 138.9, 139.6. 
N
O
I TMS
 
6.5.4. N-(2-Iodo-4-methyl-6-trimethylsilylphenyl)-N,2-dimethyl-2E-butenamide (rac-
156a): 
To a round bottom flask equipped with a stir bar was dissolved 2-iodo-N,4-bismethyl-N,6-bis-
(trimethylsilyl)aniline (657 mg, 1.68 mmol) in dichloromethane (6 mL).  Tigloyl chloride (219 
mg, 1.85 mmol) was added and the reaction mixture stirred for 24 hr.
9i
 The reaction was 
quenched with sat. NaHCO3 (10 mL) and the resulting biphasic mixture was extracted with 
dichloromethane (3 x 10 mL).  The combined organic fractions were washed with brine (10 mL), 
dried with MgSO4, filtered, and concentrated in vacuo.  The crude material was purified by silica 
gel flash chromatography (hexanes/diethyl ether, 8/4 ? 6/2) to give a clear, yellow oil in 97 % 
yield: Note: Compound exists as a 1.2:1 mixture of E/Z amide rotamers in CDCl3; signals 
assigned to the major isomer are in bold and those of a mixture italicized. 
1
H NMR (300 MHz, 
CDCl3) ? 0.27 (s, 9 H), 1.47 (dd, J = 6.9, 1.1 Hz, 3 H), 1.65 (s, 3 H), 1.76 (dd, J = 6.9, 1.1 Hz, 3 
H), 1.98 (s, 3 H), 2.29 (s, 3 H), 2.30 (s, 3 H), 3.16 (s, 3 H), 3.19 (s, 3 H), 5.69 (qq, J = 6.7, 1.1 
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Hz, 1 H), 5.98 (qq, J = 6.7, 1.1 Hz, 1 H), 7.28 (d, J = 0.6 Hz, 1 H), 7.32 (d, J = 0.6 Hz, 1 H), 7.68 
(d, J = 0.6 Hz, 1 H), 7.46 (d, J = 0.6 Hz, 1 H).    
Br
NH2
I I
 
6.5.5. 4-Bromo-2,6-diiodoaniline (not shown in text): 
In a round bottom flask equipped with a stir bar was dissolved 4-bromoaniline (1.70 g, 10.0 
mmol) in ethanol (30 mL). In succession, iodine (5.08 g, 20.0 mmol) and Ag2SO4 (6.22 g, 20.0 
mmol) were added to the reaction mixture.
80
  After stirring for 2.5 h the solids were removed by 
filtration and the resulting solution was concentrated in vacuo.  The crude material was 
redissolved in dichloromethane (30 mL) and washed with 5 % NaOH (25 mL) and water (25 
mL).  The organic fraction was dried over MgSO4 and concentrated in vacuo.  The resulting 
crude was purified by silica gel chromatography (hexanes/diethyl ether, 8/2) to give a white, 
crystalline solid (mp 132–133 ˚C) in 67 % yield: 
1
H NMR
77b
 (300 MHz, CDCl3) ? 4.63 (bs, 2 H), 
7.81 (s, 2 H). 
I
Br
I
N
TMS TMS
 
6.5.6. 4-Bromo-2,6-diiodo-N,N-bis(trimethylsilyl)aniline (158): 
In a round bottom flask equipped with a stir bar was dissolved 4-bromo-2,6-diiodoaniline (1.00 
g, 2.36 mmol) in THF (10 mL).  The flask was capped with a septum, backfilled with Ar, and 
cooled to -78 °C.  In succession a 2.0 M solution of LDA (2.83 mL, 5.66 mmol) and TMSCl 
(657 µL, 5.19 mmol) were added via syringe.  After 5 min, another round of reagents were added 
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and the entire reaction mixture allowed to stir for 30 min.
9i
 The reaction was quenched at -78 °C 
with water and allowed to warm to room temperature.  The resulting biphasic mixture was 
extracted with diethyl ether (3 x 10 mL), dried over MgSO4, filtered, and dried in vacuo.  The 
crude material was purified by silica gel flash chromatography (hexanes/diethyl ether, 99/1) to 
give an orange oil in 83 % yield: ; 
1
H NMR (300 MHz, CDCl3) ? 0.26 (s, 18 H), 8.00 (s, 2 H). 
I
Br
TMS
N
TMS
 
6.5.7. 4-Bromo-2-iodo-N-methyl-N,6-bis-(trimethylsilyl)aniline (not shown in text): 
In a round bottom flask equipped with a stir bar was dissolved aniline 158 (1.20 g, 2.11 mmol) in 
THF (6 mL). The flask was capped with a septum, backfilled with Ar, and cooled to -78 °C.  A 
1.4 M solution of sec-BuLi (3.02 mL, 4.22 mmol) was via syringe.  After 10 min, methyl iodide 
(144 µL, 2.32 mmol) was added via syringe and the reaction mixture was allowed to warm to 
room temperature over 30 min.
9i
 Water (5 mL) was added and the resulting biphasic mixture was 
extracted with diethyl ether (3 x 5 mL).  The combined organic fractions were washed with brine 
(5 mL), dried over MgSO4, filtered, and concentrated in vacuo.  The resulting crude material was 
purified by silica gel flash chromatography (hexanes/diethyl ether, 98/2) to give the title 
compound as a clear, yellow oil in 50 % yield: 
1
H NMR (300 MHz, CDCl3) ? 0.19 (s, 9 H), 0.31 
(s, 9 H), 2.71 (s, 3 H), 7.54 (d, J = 2.4 Hz, 1 H), 8.02 (s, J = 2.4 Hz, 1 H). 
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6.5.8. N-(4-Bromo-2-iodo-6-trimethylsilylphenyl)-N,2-dimethyl-2E-butenamide (rac-
156b): 
In a round bottom flask equipped with a stir bar was dissolved 4-bromo-2-iodo-N-methyl-N,6-
bis-(trimethylsilyl)aniline (45.6 mg, 0.100 mmol) in dichlormethane (400 µL). The flask was 
capped with a septum, backfilled with Ar.  Tigloyl chloride (13.0 µL, 0.110 mmol) was added 
via syringe and the reaction mixture was stired at room temperature for 24 h. The reaction was 
quenched with sat. NaHCO3 (10 mL) and the resulting biphasic mixture was extracted with 
dichloromethane (3 x 3 mL).  The combined organic fractions were washed with brine (1 mL), 
dried with MgSO4, filtered, and concentrated in vacuo.  The crude material was purified by silica 
gel flash chromatography (hexanes/diethyl ether, 8/4) to give a clear, yellow oil in 53 % yield: 
Note: Compound exists as a 1:1 mixture of E/Z amide rotamers in CDCl3; signals assigned as a 
mixture italicized. 
1
H NMR (300 MHz, CDCl3) ? 0.30 (s, 9 H), 1.50 (d, J = 6.7 Hz, 3 H), 1.69 (s, 
3 H), 1.78 (d, J = 6.7 Hz, 3 H), 1.98 (s, 3 H), 3.17 (s, 3 H), 3.21 (s, 3 H), 5.67 (qq, J = 6.1, 1.1 
Hz, 1 H), 5.99 (qq, J = 6.1, 1.1 Hz, 1 H), 7.61 (d, J = 0.7 Hz, 1 H), 7.64 (d, J = 0.7 Hz, 1 H), 8.00 
(d, J = 0.7 Hz, 1 H), 8.07 (d, J = 0.7 Hz, 1 H).  
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6.5.9. 1,3,5,7-Tetramethyl-1-vinyl-1,3-dihydroindol-2-one (rac-159): 
To a dry flask equipped with a stir bar was charged Pd2(dba)3 (18 mg, 20 µmol) and (tert-
Bu3PH•BF4 (23 mg, 80 µmol).  The flask was capped with a septum and backfilled with Ar.  A 
solution of enantioenriched anilide 154a (34 mg, 99 µmol) in degassed toluene (500 µL) was 
added by syringe, followed by triethyl amine (19 µL, 14 µmol).  The reaction mixture was stirred 
at room temperature for 48 h.  The reaction mixture was diluted with CH2Cl2 (5 mL) and filtered 
through a pad of celite.  The resulting solution was concentrated in vacuo to generate a dark 
brown crude solid.  The crude material was purified by silica gel flash chromatography 
(hexanes/ethyl ether, 6/4) to give 159 as a yellow oil.  The atropisomer (-)-(M)-154a (92/7 er, 
first eluting enantiomer) yielded a yellow oil (+)-159 in 85 % yield (79/21, +30, c 13.4 mg/mL, 
second eluting enantiomer). The atropisomer (+)-(P)-154a (96/4 er, second eluting enantiomer) 
yielded a yellow oil (–)-159 in 88 % yield (85/15 er, -34, c 11.2 mg/mL, first eluting 
enantiomer): IR (neat, KBr, cm
–1
) 2972, 2925, 1711, 1635, 1601, 1481, 1342, 1088; 
1
H NMR 
(300 MHz, CDCl3) ? 1.56 (s, 3 H), 2.23 (s, 3 H), 2.55 (s, 3 H), 3.48 (s, 3 H), 5.13 (d, J = 17.0 Hz, 
1 H), 5.15 (d, J = 10.6 Hz, 1 H), 5.91 (dd, J = 17.0, 10.6 Hz, 1 H), 6. 83 (s, 2 H); 
13
C NMR (75 
MHz, CDCl3) ? 18.9, 20.8, 22.7, 29.6, 50.6, 115.0, 119.5, 122.5, 131.9, 132.2, 133.6, 138.3, 
138.5, 179.3; HRMS (EI) calcd for C14H17NO 215.1310, found 215.1308; LRMS (EI) m/z 215 
(M
+
, 100), 200 (58), 173 (46). 
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6.5.10. Methyl 4-(tert-butyldiphenylsilyloxy)-2-methylbut-2E-enoate (not shown in text): 
A round bottom flask equipped a stir bar was charged with alcohol 168 (1.13 g, 8.7 mmol), 
imidazole (887 mg, 13.0 mmol), DMAP (53 mg, 0.43 mmol), and dichloromethane (9 mL).  The 
flask was capped and backfilled with argon.  To the reaction mixture was added tert-
butyldiphenylchlorosilane (2.5 mL, 9.6 mmol) via syringe.  Over time a white precipitate was 
observed.  After 3 h, water was added and the resulting biphasic mixture was extracted with 
dichloromethane (3 x 5 mL).  The combined organic fractions were washed with brine, dried 
over MgSO4, and concentrated in vacuo.  The resulting crude oil was purified with silica gel` 
chromatography (hexanes/diethyl ether, 8/2) to give a clear oil in 99 % yield: IR (neat, KBr, cm
–
1
) 3070, 3049, 2950, 2933, 2895, 2858, 1714, 1655, 1429, 1244; 
1
H NMR (300 MHz, CDCl3) ? 
1.06 (s, 9 H), 1.66 (s, 3 H), 3.76 (s, 3 H), 4.36 (dd, J = 5.8, 0.8 Hz, 2 H), 6.90 (qd, J = 5.8, 1.4 
Hz, 1 H), 7.37–7.48 (m, 6 H), 7.68 (dd, J = 7.7, 1.8 Hz, 4 H); 
13
C NMR (75 MHz, CDCl3) ? 12.6, 
19.1, 26.7, 51.8, 61.3, 127.2, 127.8, 129.8, 133.3, 135.5, 141.2, 167.2; HRMS (EI) calcd for 
C22H28O3Si 368.1808, found 368.1813; LRMS (EI) m/z 368 (M
+
, 2), 311 (34), 213 (100), 199 
(32), 183 (19), 84 (34).  
NH2
Cl
Br  
6.5.11. 4-Bromo-2-chloroaniline (166): 
A round bottom flask equipped with a stir bar was charged with 2-chloroaniline (2.54 g, 20.0 
mmol), NaBO3•(H2O)4 (3.40 g, 22.0 mmol), KBr (2.86 g, 24.0 mmol), (NH3)6Mo7O24•(H2O)4 
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(248 mg, 0.68 mmol).
81
  Acetic acid (24 mL) was added and the reaction mixture was stirred for 
2 hr at room temperature.  The reaction was quenched with ice and the resulting precipitate was 
filtered and washed with water.  The resulting crude solid was flushed through plug of silica 
(hexanes/diethyl ether, 7/3) to remove any residual inorganics.  After concentration in vacuo 
brownish crystals (mp 156–157 ˚C) were obtained in 76 % yield: 
1
H NMR (300 MHz, CDCl3) ? 
4.05 (s, 2 H), 6.65 (d, J = 8.5 Hz, 1 H), 7.17 (dd, J = 8.5, 2.2 Hz, 1 H), 7.39 (d, J = 2.2 Hz, 1 H); 
13
C NMR (75 MHz, CDCl3) ? 109.3, 116.8, 119.9, 130.5, 131.6, 142.1.  
NH2
Cl
Br
I
 
6.5.12. 4-Bromo-2-chloro-6-iodoaniline (167): 
To a round bottom flask equipped with a stir bar aniline 166 (900 mg, 4.36 mmol) was dissolved 
in ethanol (14.5 mL).  In succession, iodine (1.11 g, 4.36 mmol) and Ag2SO4 (1.35 g, 4.36 mmol) 
were added to the reaction mixture.
80
  After stirring for 2 h the solids were removed by filtration 
and the resulting solution was concentrated in vacuo.  The crude was redissolved in 
dichloromethane (30 mL) and washed with 5 % NaOH (25 mL) and water (25 mL).  The organic 
fraction was dried over MgSO4 and concentrated in vacuo.  The resulting crude was purified by 
silica gel chromatography (hexanes, 100 %) to give a white, crystalline solid (mp 92–94 ˚C) in 
79 % yield: 
1
H NMR
77b
 (300 MHz, CDCl3) ? 4.55 (bs, 2 H), 7.39 (d, J = 2.0 Hz, 1 H), 7.67 (d, J 
= 2.0 Hz, 1 H); 
13
C NMR (75 MHz, CDCl3) ? 83.1, 109.1, 118.0, 131.8, 139.1, 142.7.  
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6.5.13. N-(4-Bromo-2-chloro-6-iodophenyl)-4-(tert-butyldiphenylsilyloxy)-N,2-methylbut-
2E-enamide (169): 
A dry tube equipped with a stir bar, sealed, and backfilled with Ar.  Benzene (7 mL) was added 
and the flask cooled to 0 ˚C.  A 2.0 M solution of AlMe3 (4.9 mL, 9.8 mmol) was slowly 
added,
82
 followed by 4-bromo-6-chloro-2-iodoaniline (1.6 g, 4.9 mmol) dissolved in benzene (15 
mL).  The mixture was allowed to warm to room temperature over 1 hr before methyl 4-(tert-
butyldiphenylsilyloxy)-2-methylbut-2E-enoate (1.8 g, 4.9 mmol) was added as a solution in 
benzene (7 mL).  The tube was then sealed and then refluxed at 80 ˚C for 24 hr.  When the 
mixture had cooled to room temperature 1 M HCl (15 mL) was added, followed by stirring for 1 
hr.  The organic layer was separated and the remaining aqueous layer was extracted with ethyl 
acetate (2 x 15 mL).  The combined organic layers were washed with brine (15 mL), dried with 
MgSO4, filtered, and concentrated in vacuo.  The crude was purified by silica gel flash 
chromatography (hexanes/diethyl ether, 8/2) to give yellow, viscous oil in 75 % yield: IR (thin 
neat, KBr, cm
–1
) 326, 3070, 2952, 2931, 2856, 1670, 1641, 1560, 1493, 1371, 1265, 1113, 1061; 
1
H NMR (300 MHz, CDCl3) ? 1.09 (s, 9 H), 1.76 (d, J = 0.9 Hz, 3 H), 4.45 (d, J = 4.9 Hz, 2 H), 
6.58 (t, J = 4.9 Hz, 1 H), 7.01 (s, 1 H), 7.38–7.52 (m, 6 H), 7.61 (d, J = 2.0 Hz, 1 H), 7.68–7.80 
(m, 4 H), 7.93 (d, J = 2.0 Hz, 1 H); 
13
C NMR (75 MHz, CDCl3) ? 13.1, 19.1, 26.8 (3 C), 61.1, 
100.4, 121.6, 127.8 (4 C), 129.9 (2 C), 131.0, 132.7, 133.2, 133.3 (2 C), 135.6 (4 C), 135.7, 
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136.4, 139.9, 166.9; HRMS (EI) calcd for C27H28I
127
BrClSiNO2Na
23
 689.9704, found 689.9687; 
LRMS (EI) m/z 692 (M+Na
+
 (Br
81
), 100), 592 (37).  
N
O
TBDPSO
I
Br
Cl
 
6.5.14. N-(4-Bromo-2-chloro-6-iodophenyl)-4-(tert-butyldiphenylsilyloxy)-N,2-
dimethylbut-2E-enamide (164): 
In a dry flask equipped with a stir bar, a slurry of 95 % NaH (118 mg, 4.7 mmol) in anhydrous 
THF (12 mL) was prepared.  The flask was capped with a septa, backfilled with Ar, and cooled 
to 0 ˚C.  Amide 169 (2.4 g, 3.6 mmol) was dissolved in THF (24 mL) and added dropwise to the 
flask.  After stirring for 10 min, methyl iodide (2.2 mL, 36.0 mmol) was added dropwise.  The 
reaction mixture was allowed to warm to room temperature over 3 h.  The remaining base was 
carefully quenched with water.  The biphasic mixture was extracted with diethyl ether (3 x 25 
mL).  The combined organic fractions were washed with brine (25 mL), dried with MgSO4, 
filtered, and concentrated in vacuo.  The crude mixture was purified by silica gel flash 
chromatography (hexanes/diethyl ether, 8/2) to give anilide 164 as a colorless oil in 99 % yield: 
IR (neat, KBr, cm
–1
) 3066, 3051, 2952, 2856, 1668, 1645, 1558, 1441, 1348, 1111; Note: 
Compound exists as a 6.3/1 mixture of E/Z amide rotamers in CDCl3. 
1
H NMR (300 MHz, 
CDCl3) ? 0.99 (s, 9 H), 1.68 (s, 3 H), 3.19 (s, 3 H), 4.09 (d, J = 5.7 Hz, 2 H), 5.88 (td, J = 5.7, 
1.1 Hz, 1 H), 7.34–7.48 (m, 6 H), 7.51–7.60 (m, 4 H), 7.73 (dd, J = 7.1, 1.6 Hz, 1 H), 7.92 (d, J = 
2.1 Hz, 1 H); 
13
C NMR (75 MHz, CDCl3) ? 14.6, 19.2, 26.7 (3 C), 35.3, 60.5, 101.6, 122.2, 
127.8 (4 C), 129.8 (2 C), 130.6, 133.3, 133.4, 134.1, 134.2, 135.4 (4 C), 135.6, 140.8, 144.0, 
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172.0; HRMS (EI) calcd for C24H21NOSiClBrI 623.9258, found 623.9261; LRMS (EI) m/z 668 
(M+Na
+
, <1), 626 (100), 199 (84), 135 (41). 
 
Enantiomers of 164 were separated by injection (36, 40 mg ea) onto a preparative (S,S)-Whelk-O 
1 chiral column (25 cm x 10.0 mm I.D.) eluting with hexanes/iPrOH 98/2.  The first eluting 
enantiomer was recovered in 31 %; second eluting enantiomer, 19 %.  Second eluting enantiomer 
?D23  16, 98 % ee (c 3.2 mg/mL, CHCl3). 
N
Br
Cl
O
TBDPSO
 
6.5.15. (S)-5-Bromo-3-(2-(tert-butyldiphenylsilyloxy)vinyl)-7-chloro-1,3-dimethylindolin-
2-one (170): 
To a dry flask equipped with a stir bar was charged Pd2(dba)3 (59 mg, 64 µmol) and (tert-
Bu3PH•BF4 (37 mg, 0.13 mmol).  The flask was capped with a septum and backfilled with Ar.  A 
solution of anilide (+)-164 (220 mg, 0.32 mmol, 99/1 er) in degassed toluene (3.2 mL) was 
added by syringe, followed by triethyl amine (63 µL, 0.45 mmol).  The reaction mixture was 
stirred at room temperature for 48 h.  The reaction mixture was diluted with CH2Cl2 (5 mL) and 
filtered through a pad of celite.  The resulting solution was concentrated in vacuo to generate a 
dark brown crude solid.  The crude material was purified by silica gel flash chromatography 
(hexanes/ethyl ether, 9/1) to remove the majority of the dibenzylideneacetone.  The mixture of 
alkene isomers was determined to be 1.2/1 by 
1
H NMR, the first eluting isomer being the major 
component.  The er of each geometrical isomer was determined to be 83/17 by injection of a 
sample onto a (S,S)-Whelk O 1 chiral HPLC column.  For each geometrical isomer, the first 
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eluting enantiomer was the major component.   
1
H NMR (300 MHz, CDCl3, peaks assigned to 
the major isomer are in bold and those of a mixture italicized) ? 0.83 (s, 9 H), 1.03 (s, 9 H), 1.29 
(s, 3 H), 1.99 (s, 3 H), 3.47 (s, 3 H), 3.54 (s, 3 H), 4.64 (d, J = 5.6 Hz, 1 H), 5.11 (d, J = 12.1 Hz, 
1 H), 6.01 (d, J = 5.6 Hz, 1 H), 6.22 (d, J = 12.1 Hz, 1 H), 6.87 (d, J = 2.0 Hz, 1 H), 7.26 (d, J = 
2.1 Hz, 1 H), 7.30–7.57 (m, 14 H), 7.58–7.70 (m, 8 H).  
N
Br
Cl
O
O
 
6.5.16. (S)-5-Bromo-7-chloro-1,2-dihydro-3-(2-oxoethyl)-1,3-dimethyl-2-oxo-[3H]indole 
(163): 
In a glass vial equipped with a stir bar, silyl enol ethers (E/Z)-170 (150 mg, 27.0 mmol) was 
dissolved in pyridine (3.75 mL).  The flask was cooled to 0 ˚C and HF-pyridine (375 µL) was 
added dropwise.  The reaction mixture was warmed to room temperature over 90 min.  The 
reaction mixture was then diluted with diethyl ether (10 mL) and carefully quenched with sat. 
NaHCO3.  The organic layer was removed and the aqueous fraction was extracted further with 
diethyl ether (2 x 10 mL).  The combined organic fractions were dried with MgSO4, filtered, and 
concentrated in vacuo.  The crude mixture was purified by silica gel flash chromatography 
(hexanes/diethyl ether, 8/2 ? 1/1) to give 163 as a white, crystalline solid (mp 158–160 ˚C) in 
70 % yield over two steps from 164 (+18, c 2.0 mg/mL): IR (thin film, CH2Cl2, NaCl, cm
–1
) 
1708, 1454; 
1
H NMR (300 MHz, CDCl3) ? 1.37 (s, 3 H), 3.07 (qd, J = 18.2, 1.1 Hz, 2 H), 3.61 
(s, 3 H), 7.14 (d, J = 1.9 Hz, 1 H), 7.37 (d, J = 1.9 Hz, 1 H), 9.51 (d, J = 1.1 Hz, 1 H); 
13
C NMR 
(75 MHz, CDCl3) ? 24.4, 29.7, 44.5, 50.8, 114.8, 116.4, 123.9, 132.6, 137.3, 138.7, 179.3, 197.6; 
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HRMS (EI) calcd for C12H11NO2ClBr 314.9668, found 314.9661; LRMS (EI) m/z 317 (M
+
[Br
81
], 
4), 315 (4), 253 (30), 186 (28), 57 (100). 
N
N
Br
Cl
Me
H
 
6.5.17. (3aS-cis)-5-Bromo-7-chloro-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-
b]indole (S-cis-171): 
A dry flask equipped with a stir bar was charged with MgSO4 (26 mg), capped with a septum, 
and backfilled with Ar.
61a
  Enriched aldehyde (12 mg, 38 µmol) dissolved in THF (925 µL) and 
methylamine (23 µL, 2.0 M in THF) were added to the flask via syringe.  After triethylamine 
(5.3 µL, 38 µmol) was added the reaction mixture was stirred at room temperature for 20 h.  The 
flask was uncapped and lithium aluminum hydride (2 mg, 57 µmol) was added slowly.  A water-
cooled reflux condensor was attached to the flask and the reaction mixture was refluxed for 3 h.  
When the reaction mixture had cooled to room temperature a 1/1 mixture of ethyl acetate/sat. 
NaHCO3 was carefully added to quench remaining reagent.  The biphasic mixture was extracted 
with ethyl acetate (3 X, 5 mL).  The combined organic fractions were dried with MgSO4, filtered, 
and concentrated in vacuo.  The crude material was purified by silica gel flash chromatography 
(hexanes/ethyl acetate, 1/1 ? 1/4) to give 5.1 mg of a ~1/1 mixture (as determined by GC) of the 
title compound and debromo by-product.  The mixture was dissolved in acetonitrile (500 µL) and 
N-bromosuccinimide (1.9 mg, 10.8 µmol) was added.  After 1 h the solvents were removed in 
vacuo.  The reddish crude material was purified by semi-preparative HPLC (Nova-Pak silica, 7.8 
x 300 mm, hexanes/ethyl acetate 8/2) to give 171 as a white solid in 43 % yield (-16, c 5.0 
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mg/mL): 
 1
H NMR (300 MHz, CDCl3) ? 1.43 (s, 3 H), 1.92–1.97 (m, 3 H), 2.53 (s, 3 H), 2.54–
2.62 (m, 1 H), 2.65–2.74 (m, 1 H), 2.78 (s, 3 H), 3.19 (s, 3 H), 4.01 (s, 1 H), 6.97 (d, J = 1.9 Hz, 
1 H), 7.17 (d, J = 1.9 Hz, 1 H). 
N
Me
N H
OMe
Cl
 
6.5.18. (rac-cis)-7-Chloro-5-methoxy-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-
pyrrolo[2,3-b]indole (not shown in text): 
In a dry tube equipped with a stir bar was added absolute MeOH (150 µL).  Na metal (12 mg, 
0.53 mmol) was carefully added.  When the metal was consumed, rac-171 (16.7 mg, 52.9 µmol) 
that was dissolved in DMF (600 µL) was added to the methoxide solution.  Cu(I)I (40.2 mg, 0.21 
mmol) was introduced, the flask was sealed and heated to 120 °C for 3 h.  After cooling to room 
temperature, the reaction mixture was passed through a celite plug to remove insoluble salts. 
Brine (1 mL) was added to the filtrate and the resulting solution was extracted with diethyl ether 
(3 x 3 mL).  The combined organic fractions were concentrated in vacuo.  The resulting crude oil 
was purified by silica gel flash chromatography (hexanes/ethyl acetate, 2/8) to give a yellow oil 
in 65 % yield: ):
 1
H NMR (300 MHz, CDCl3) ? 1.44 (s, 3 H), 1.88–1.96 (m, 2 H), 2.52 (s, 3 H), 
2.50–2.68 (m, 2 H), 3.11 (s, 3 H), 3.74 (s, 3 H), 3.99 (s, 1 H), 6.54 (d, J = 2.4 Hz, 1 H), 6.68 (d, J 
= 2.4 Hz, 1 H). 
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N
Me
N H
OMe  
6.5.19. rac-esermethole (rac-162): 
A flask equipped with a stir bar was charged with sodium formate (22.8 mg, 0.34 mmol), 10 % 
Pd/C (60 mg), and (rac-cis)-7-chloro-5-methoxy-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydro-
pyrrolo[2,3-b]indole (4.5 mg, 17 µmol).  Water (1.5 mL) was added and the reaction stirred for 
24 h.  After filtration through a plug of cotton, the filtrate was extracted with diethyl ether (3 x 3 
mL).  The combined organic fractions were concentrated in vacuo to give a yellow crude solid: 
1
H NMR (300 MHz, CDCl3) ? 1.44 (s, 3 H), 1.94 (dd, J = 7.1, 5.5 Hz, 2 H), 2.54 (s, 3 H), 2.61–
2.75 (m, 2 H), 2.96 (s, 3 H), 3.76 (s, 3 H), 4.06 (s, 1 H), 6.36 (d, J = 8.0 Hz, 1 H),  6.62–6.69 (m, 
2 H). 
 
6.6. Resolution of Compunds by Chiral HPLC 
 
Listed below are typical sets of conditions for analytical and semi-preparative methods. 
 
6.6.1. Analytical method 
Column: Regis Technologies, Inc. (S,S)-Whelk-O 1; 25 cm x 4.6 mm I.D. 
Solvent: 10 % isopropanol in hexanes 
Flow: 1 ml/min (uncyclized substrates), 2 mL/min (cyclized products) 
Sample concentration: 3–5 mg/mL 
Injection volume: 10 µL 
 114 
 
6.6.2. Semi-preparative method 
Column: Regis Technologies, Inc. (S,S)-Whelk-O 1; 25 cm x 10.0 mm I.D. 
Solvent: 10–40 % isopropanol in hexanes 
Flow: 8–10 mL/min 
Sample concentration: 40–80 mg/mL 
Injection volume: 1 µL 
 
6.7. Measurement of N-Aryl Bond Rotation Barriers 
 
6.7.1. General Procedure for N-Aryl Bond Rotation Barrier Measurement 
Enantiomerically enriched anilide is dissolved in a 10 % solution of iPrOH in hexanes (10 
mg/mL) in a sealable tube.  The tube is sealed and equilibrated to the given temperature.  At 
given interval of time an aliquot of 100 µL is removed via syringe and injected into the HPLC to 
measure the ee.  The ratio of enantiomers is plotted against time and the barrier to rotation is 
calculated according to the method described in Eliel.
83
  As an example, a full treatment of data 
is shown for anilide 56b. 
N
I
O
Br
N
I
O
Br
(M)-56b(P)-56b
114 •C
 
Figure 6.1 – Thermal Equilibration of 56b 
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56b T = 387 K 
Time (mins)  % ee 
0 96 
7 96 
36 92 
68 70 
104 61 
131 55 
161 49 
196 41 
267 32 
Table 6-1 – Thermal Equilibration Data for 56b 
 
 
Figure 6.2 – Thermal Equillibration Plot for 56b 
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(M)-56b(P)-56b
114 •C
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(M)-56b T = 387 K 
Time (min) % ee 
0 96 
36 92 
68 70 
104 61 
131 55 
161 49 
196 41 
267 32 
Table 6-2 – Thermal Equilibration Data for (M)-56b 
 
 
ln
1 + [P-56b]/[M-56b]
1 - [P-56b]/[M-56b]
= 2kt + c ln
1 + [P-56b]/[M-56b]
1 - [P-56b]/[M-56b]
Plot
vs Time (seconds)
where slope = krac or 2krot
krot =  slope/2 = (7.29x10
-5 s-1)/2 = 3.65x10-5 s-1
Krot = krach / kT  =
(3.65x10-5 s-1) (6.626x10-34 Js)
(1.381x10-23 J/K) (387 K)
Krot    = 4.52x10
-18
?Grot    = 128.314 kJ/mol or 30.7 kcal/mol
Equation
2krac = 7.29x10
-5 s-1
substitute into ?G   = -RTlnK
 
 
Equation 6-1 - Calculation of N-Aryl Bond Rotation Barrier of (M)-56b 
 
 
(M)-56a T = 387 K 
Time (min) % ee 
0 99 
17 86 
37 66 
68 48 
120 26 
Table 6-3 – Thermal Equilibration Data for (M)-56a 
?Grot = 124.3 kJ/mol or 29.7 kcal/mol 
 117 
 
(M)-56c T = 413 K 
Time (min) % ee 
0 100 
15 98 
30 93 
46 87 
113 59 
200 32 
Table 6-4 – Thermal Equilibration Data for (M)-56c 
?Grot = 136.0 kJ/mol or 32.5 kcal/mol 
 
(M)-56g T = 413 K 
Time (min) % ee 
0 93 
19 84 
34 80 
57 70 
128 47 
Table 6-5 – Thermal Equilbration Data for (M)-56g 
?Grot = 136.9 kJ/mol or 32.7 kcal/mol 
 
(M)-109 T = 296 K 
Time (sec) % ee 
0 91.7 
5820 47.9 
8400 36.7 
11280 26.6 
14100 20.3 
Table 6-6 – Thermal Equilibration Data for (M)-109 
?Grot = 96.7 kJ/mol or 23.1 kcal/mol 
 
 
 
 
 118 
(P)-112 T = 296 K 
Time (sec) % ee 
0 83.0 
1740 59.7 
3540 46.6 
4680 38.0 
6240 27.8 
 
Table 6-7 – Thermal Equilibration Data for (P)-112 
?Grot = 95.5 kJ/mol or 22.8 kcal/mol 
 
(P)-154a T = 363 K 
Time (sec) % ee 
0 85.0 
900 49.0 
1380 43.0 
2340 34.0 
3600 18.0 
Table 6-8 – Thermal Equilibration Data for (P)-154a 
?Grot = 115.1 kJ/mol or 27.5 kcal/mol 
 
FEE-164 T = 353 K 
Time (sec) % ee 
0 92.0 
1020 54.0 
2040 32.0 
3060 26.0 
6360 24.0 
Table 6-9 – Thermal Equilibration Data for FEE-164 
?Grot = 111.8 kJ/mol or 26.7 kcal/mol 
 
6.8. Rate Constant Studies 
The rate constant of radical cyclization was measured by cyclization of the respective substrates 
at variable Bu3SnH concentrations and analyzing aliquots of the finished reaction by analytical 
 119 
GC, using an internal standard (dibutyl phthalate) to quantify the ratio of cyclized to reduced 
product.  Calculations were performed accordin g to the indirect competition method.
40
 
  
Figure 6.3 - Rate Constant Plot for 81 
  (X-axis)   (Y-axis) 
[Tin] corr 1/[Tin]corr Area Integration (GC)  
(mol / L) ( L / mol) Cyclized Reduced C / R 
0.100 10.00 28.95 1.00 28.9 
0.364 2.74 6.62 1.00 6.6 
0.655 1.53 2.74 1.00 2.7 
0.990 1.01 2.04 0.95 2.2 
3.565 0.28 0.78 1.00 0.8 
Table 6-10 - Rate Constant Data for 81 
N
O
N
O
81 82
kc
3.0 x 109 s-1
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Figure 6.4 - Rate Constant Plot for 85 
 
 (X-axis)   (Y-axis) 
[Tin] corr 1/[Tin]corr Area Integration (GC)   
(mol / L) ( L / mol) Cyclized Reduced C / R 
0.016 64.52 3.00 0.58 5.2 
0.025 40.00 3.00 0.86 3.5 
0.045 22.22 3.00 1.35 2.2 
0.054 18.52 3.00 2.32 1.3 
0.095 10.53 3.00 2.75 1.1 
Table 6-11 - Rate Constant Data for 85 
 
N
O
Et N
O Et
85 86
kc
7.8 x 107 s-1
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7. SUPPLEMENTARY DATA 
7.1. Select 
1
H and 
13
C NMR 
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7.2. X-ray Crystallography Data 
 
 
 
 
Figure 7.1 - ORTEP of (M)-56b 
The corresponding CIF file for (M)-56b is found below, between the lines of '+' symbols. 
  
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
 
data_al0331  
 
_audit_creation_method            SHELXL-97  
_chemical_name_systematic  
;  
 ?  
;  
_chemical_name_common             ?  
_chemical_melting_point           ?  
_chemical_formula_moiety          ?  
_chemical_formula_sum  
 'C20 H21 Br I N O'  
_chemical_formula_weight          498.19  
 
loop_  
 _atom_type_symbol  
 _atom_type_description  
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 _atom_type_scat_dispersion_real  
 _atom_type_scat_dispersion_imag  
 _atom_type_scat_source  
 'C'  'C'   0.0033   0.0016  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'H'  'H'   0.0000   0.0000  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'N'  'N'   0.0061   0.0033  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'O'  'O'   0.0106   0.0060  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'Br'  'Br'  -0.2901   2.4595  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'I'  'I'  -0.4742   1.8119  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 
_symmetry_cell_setting            ?  
_symmetry_space_group_name_H-M    ?  
 
loop_  
 _symmetry_equiv_pos_as_xyz  
 'x, y, z'  
 '-y, x-y, z+1/3'  
 '-x+y, -x, z+2/3'  
 
_cell_length_a                    14.0919(6)  
_cell_length_b                    14.0919(6)  
_cell_length_c                    8.7408(5)  
_cell_angle_alpha                 90.00  
_cell_angle_beta                  90.00  
_cell_angle_gamma                 120.00  
_cell_volume                      1503.21(12)  
_cell_formula_units_Z             3  
_cell_measurement_temperature     150(2)  
_cell_measurement_reflns_used     ?  
_cell_measurement_theta_min       ?  
_cell_measurement_theta_max       ?  
 
_exptl_crystal_description        ?  
_exptl_crystal_colour             ?  
_exptl_crystal_size_max           0.14  
_exptl_crystal_size_mid           0.14  
_exptl_crystal_size_min           0.08  
_exptl_crystal_density_meas       ?  
_exptl_crystal_density_diffrn     1.651  
_exptl_crystal_density_method     'not measured'  
_exptl_crystal_F_000              732  
_exptl_absorpt_coefficient_mu     3.597  
_exptl_absorpt_correction_type    ?  
_exptl_absorpt_correction_T_min   0.6328  
_exptl_absorpt_correction_T_max   0.7618  
_exptl_absorpt_process_details    ?  
 
_exptl_special_details  
;  
 ?  
;  
 
 212 
_diffrn_ambient_temperature       150(2)  
_diffrn_radiation_wavelength      0.71073  
_diffrn_radiation_type            MoK\a  
_diffrn_radiation_source          'fine-focus sealed tube'  
_diffrn_radiation_monochromator   graphite  
_diffrn_measurement_device_type   ?  
_diffrn_measurement_method        ?  
_diffrn_detector_area_resol_mean  ?  
_diffrn_standards_number          ?  
_diffrn_standards_interval_count  ?  
_diffrn_standards_interval_time   ?  
_diffrn_standards_decay_%         ?  
_diffrn_reflns_number             19491  
_diffrn_reflns_av_R_equivalents   0.0304  
_diffrn_reflns_av_sigmaI/netI     0.0426  
_diffrn_reflns_limit_h_min        -20  
_diffrn_reflns_limit_h_max        20  
_diffrn_reflns_limit_k_min        -20  
_diffrn_reflns_limit_k_max        20  
_diffrn_reflns_limit_l_min        -13  
_diffrn_reflns_limit_l_max        13  
_diffrn_reflns_theta_min          1.67  
_diffrn_reflns_theta_max          32.46  
_reflns_number_total              6981  
_reflns_number_gt                 6216  
_reflns_threshold_expression      >2sigma(I)  
 
_computing_data_collection        ?  
_computing_cell_refinement        ?  
_computing_data_reduction         ?  
_computing_structure_solution     'SHELXS-97 (Sheldrick, 1990)'  
_computing_structure_refinement   'SHELXL-97 (Sheldrick, 1997)'  
_computing_molecular_graphics     ?  
_computing_publication_material   ?  
 
_refine_special_details  
;  
 Refinement of F^2^ against ALL reflections.  The weighted R-factor wR and  
 goodness of fit S are based on F^2^, conventional R-factors R are based  
 on F, with F set to zero for negative F^2^. The threshold expression of  
 F^2^ > 2sigma(F^2^) is used only for calculating R-factors(gt) etc. and is  
 not relevant to the choice of reflections for refinement.  R-factors based  
 on F^2^ are statistically about twice as large as those based on F, and R-  
 factors based on ALL data will be even larger.  
;  
 
_refine_ls_structure_factor_coef  Fsqd   
_refine_ls_matrix_type            full  
_refine_ls_weighting_scheme       calc   
_refine_ls_weighting_details  
 'calc w=1/[\s^2^(Fo^2^)+(0.0172P)^2^+0.0000P] where P=(Fo^2^+2Fc^2^)/3'  
_atom_sites_solution_primary      direct  
_atom_sites_solution_secondary    difmap  
_atom_sites_solution_hydrogens    geom  
_refine_ls_hydrogen_treatment     mixed  
_refine_ls_extinction_method      none  
_refine_ls_extinction_coef        ?  
_refine_ls_abs_structure_details  
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 'Flack H D (1983), Acta Cryst. A39, 876-881'  
_refine_ls_abs_structure_Flack    0.005(6)  
_refine_ls_number_reflns          6981  
_refine_ls_number_parameters      302  
_refine_ls_number_restraints      1  
_refine_ls_R_factor_all           0.0314  
_refine_ls_R_factor_gt            0.0269  
_refine_ls_wR_factor_ref          0.0514  
_refine_ls_wR_factor_gt           0.0505  
_refine_ls_goodness_of_fit_ref    0.922  
_refine_ls_restrained_S_all       0.922  
_refine_ls_shift/su_max           0.033  
_refine_ls_shift/su_mean          0.002  
 
loop_  
 _atom_site_label  
 _atom_site_type_symbol  
 _atom_site_fract_x  
 _atom_site_fract_y  
 _atom_site_fract_z  
 _atom_site_U_iso_or_equiv  
 _atom_site_adp_type  
 _atom_site_occupancy  
 _atom_site_symmetry_multiplicity  
 _atom_site_calc_flag  
 _atom_site_refinement_flags  
 _atom_site_disorder_assembly  
 _atom_site_disorder_group  
N N 0.84912(16) 0.14757(15) -0.5811(2) 0.0247(4) Uani 1 1 d . . .  
O O 0.89348(14) 0.08208(14) -0.78871(19) 0.0328(4) Uani 1 1 d . . .  
I I 0.664422(13) 0.221534(12) -0.558141(17) 0.03436(4) Uani 1 1 d . . .  
Br Br 0.48424(2) -0.41967(2) -0.58354(4) 0.04741(8) Uani 1 1 d . . .  
C1 C 0.72829(17) 0.16129(17) -0.3912(3) 0.0252(4) Uani 1 1 d . . .  
C2 C 0.68774(19) 0.14885(19) -0.2439(3) 0.0270(4) Uani 1 1 d . . .  
H2 H 0.638(3) 0.170(3) -0.230(4) 0.051(9) Uiso 1 1 d . . .  
C3 C 0.72476(19) 0.10790(19) -0.1294(3) 0.0288(5) Uani 1 1 d . . .  
C4 C 0.80318(19) 0.07989(19) -0.1662(3) 0.0266(4) Uani 1 1 d . . .  
H4 H 0.828(2) 0.054(2) -0.095(3) 0.026(6) Uiso 1 1 d . . .  
C5 C 0.84524(17) 0.09059(17) -0.3135(2) 0.0236(4) Uani 1 1 d . . .  
C6 C 0.80653(17) 0.13207(17) -0.4286(2) 0.0225(4) Uani 1 1 d . . .  
C7 C 0.83634(17) 0.06437(18) -0.6751(2) 0.0240(4) Uani 1 1 d . . .  
C8 C 0.74811(17) -0.05080(18) -0.6406(2) 0.0231(4) Uani 1 1 d . . .  
C9 C 0.77183(19) -0.13309(19) -0.6765(3) 0.0272(4) Uani 1 1 d . . .  
H9 H 0.847(2) -0.110(2) -0.722(3) 0.032(7) Uiso 1 1 d . . .  
C10 C 0.6933(2) -0.2426(2) -0.6608(3) 0.0308(5) Uani 1 1 d . . .  
H10 H 0.707(2) -0.299(2) -0.685(3) 0.033(7) Uiso 1 1 d . . .  
C11 C 0.59060(19) -0.26961(18) -0.6078(3) 0.0289(5) Uani 1 1 d . . .  
C12 C 0.56442(19) -0.1895(2) -0.5725(3) 0.0321(5) Uani 1 1 d . . .  
H12 H 0.490(3) -0.210(3) -0.534(4) 0.046(8) Uiso 1 1 d . . .  
C13 C 0.64347(18) -0.08030(19) -0.5889(3) 0.0278(4) Uani 1 1 d . . .  
H13 H 0.625(3) -0.029(3) -0.562(3) 0.043(8) Uiso 1 1 d . . .  
C14 C 0.9305(2) 0.26142(19) -0.6267(3) 0.0324(5) Uani 1 1 d . . .  
H14A H 0.901(2) 0.310(2) -0.596(3) 0.036(7) Uiso 1 1 d . . .  
H14B H 0.926(2) 0.260(2) -0.742(4) 0.041(8) Uiso 1 1 d . . .  
C15 C 1.0426(2) 0.30104(19) -0.5622(3) 0.0323(5) Uani 1 1 d . . .  
H15 H 1.078(2) 0.267(2) -0.605(3) 0.038(8) Uiso 1 1 d . . .  
C16 C 1.0924(2) 0.3785(2) -0.4578(3) 0.0323(5) Uani 1 1 d . . .  
C17 C 1.2058(3) 0.4123(3) -0.4028(5) 0.0524(8) Uani 1 1 d . . .  
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H17C H 1.233(3) 0.367(3) -0.451(4) 0.052(9) Uiso 1 1 d . . .  
H17A H 1.259(4) 0.494(4) -0.414(6) 0.096(14) Uiso 1 1 d . . .  
H17B H 1.214(4) 0.395(4) -0.298(5) 0.084(14) Uiso 1 1 d . . .  
C18 C 1.0439(3) 0.4402(3) -0.3840(5) 0.0551(9) Uani 1 1 d . . .  
H18A H 0.978(4) 0.418(3) -0.411(5) 0.071(13) Uiso 1 1 d . . .  
H18B H 1.099(4) 0.527(4) -0.410(5) 0.082(13) Uiso 1 1 d . . .  
H18C H 1.054(3) 0.447(3) -0.287(5) 0.053(10) Uiso 1 1 d . . .  
C19 C 0.6809(3) 0.0953(3) 0.0307(3) 0.0443(7) Uani 1 1 d . . .  
H19B H 0.637(3) 0.112(3) 0.041(5) 0.063(12) Uiso 1 1 d . . .  
H19C H 0.672(4) 0.025(4) 0.074(5) 0.090(14) Uiso 1 1 d . . .  
H19A H 0.740(4) 0.155(4) 0.090(6) 0.084(13) Uiso 1 1 d . . .  
C20 C 0.9303(2) 0.0584(2) -0.3479(3) 0.0274(5) Uani 1 1 d . . .  
H20B H 0.948(2) 0.046(2) -0.263(3) 0.031(7) Uiso 1 1 d . . .  
H20B H 0.903(2) 0.001(2) -0.407(3) 0.028(7) Uiso 1 1 d . . .  
H20A H 0.989(3) 0.105(3) -0.409(4) 0.054(10) Uiso 1 1 d . . .  
 
loop_  
 _atom_site_aniso_label  
 _atom_site_aniso_U_11  
 _atom_site_aniso_U_22  
 _atom_site_aniso_U_33  
 _atom_site_aniso_U_23  
 _atom_site_aniso_U_13  
 _atom_site_aniso_U_12  
N 0.0242(9) 0.0209(9) 0.0256(9) 0.0021(7) 0.0010(7) 0.0088(8)  
O 0.0317(9) 0.0324(9) 0.0283(8) 0.0008(7) 0.0058(7) 0.0115(7)  
I 0.04048(9) 0.03306(8) 0.03904(7) -0.00609(7) -0.01360(7) 0.02551(8)  
Br 0.04288(16) 0.02426(12) 0.05994(17) 0.00140(12) 0.00297(13) 0.00542(12)  
C1 0.0231(10) 0.0193(10) 0.0322(11) -0.0049(8) -0.0070(8) 0.0100(8)  
C2 0.0231(10) 0.0233(10) 0.0350(12) -0.0056(8) -0.0008(9) 0.0119(9)  
C3 0.0271(11) 0.0258(11) 0.0278(11) -0.0029(9) -0.0003(9) 0.0088(9)  
C4 0.0266(11) 0.0273(11) 0.0237(10) 0.0002(8) -0.0037(8) 0.0118(9)  
C5 0.0205(9) 0.0204(9) 0.0276(10) -0.0040(8) -0.0041(8) 0.0085(8)  
C6 0.0221(10) 0.0192(9) 0.0244(10) -0.0015(8) -0.0013(8) 0.0089(8)  
C7 0.0211(10) 0.0253(10) 0.0240(10) 0.0021(8) -0.0010(8) 0.0104(8)  
C8 0.0234(10) 0.0250(10) 0.0212(10) -0.0017(8) -0.0020(8) 0.0123(8)  
C9 0.0274(11) 0.0314(12) 0.0273(11) -0.0012(8) -0.0005(8) 0.0180(10)  
C10 0.0355(12) 0.0275(11) 0.0344(12) -0.0029(9) -0.0013(10) 0.0194(10)  
C11 0.0273(11) 0.0222(10) 0.0316(11) 0.0003(8) -0.0021(9) 0.0083(9)  
C12 0.0217(11) 0.0298(12) 0.0398(13) -0.0043(10) 0.0029(9) 0.0091(10)  
C13 0.0237(10) 0.0248(11) 0.0360(12) -0.0051(9) -0.0015(9) 0.0131(9)  
C14 0.0334(12) 0.0223(11) 0.0338(13) 0.0053(9) 0.0028(10) 0.0080(10)  
C15 0.0265(11) 0.0222(11) 0.0446(14) 0.0029(10) 0.0095(10) 0.0096(9)  
C16 0.0275(11) 0.0287(12) 0.0397(13) 0.0029(10) 0.0040(9) 0.0134(10)  
C17 0.0273(14) 0.0458(18) 0.078(2) -0.0067(17) -0.0031(14) 0.0136(13)  
C18 0.054(2) 0.065(2) 0.060(2) -0.0281(18) -0.0161(17) 0.0399(19)  
C19 0.0496(18) 0.060(2) 0.0337(14) 0.0000(13) 0.0072(13) 0.0351(17)  
C20 0.0266(11) 0.0293(12) 0.0286(12) 0.0011(10) -0.0017(9) 0.0157(10)  
 
_geom_special_details  
;  
 All esds (except the esd in the dihedral angle between two l.s. planes)  
 are estimated using the full covariance matrix.  The cell esds are taken  
 into account individually in the estimation of esds in distances, angles  
 and torsion angles; correlations between esds in cell parameters are only  
 used when they are defined by crystal symmetry.  An approximate (isotropic)  
 treatment of cell esds is used for estimating esds involving l.s. planes.  
;  
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loop_  
 _geom_bond_atom_site_label_1  
 _geom_bond_atom_site_label_2  
 _geom_bond_distance  
 _geom_bond_site_symmetry_2  
 _geom_bond_publ_flag  
N C7 1.368(3) . ?  
N C6 1.433(3) . ?  
N C14 1.486(3) . ?  
O C7 1.223(3) . ?  
I C1 2.103(2) . ?  
Br C11 1.896(2) . ?  
C1 C2 1.384(3) . ?  
C1 C6 1.395(3) . ?  
C2 C3 1.382(3) . ?  
C3 C4 1.385(3) . ?  
C3 C19 1.503(4) . ?  
C4 C5 1.393(3) . ?  
C5 C6 1.404(3) . ?  
C5 C20 1.508(3) . ?  
C7 C8 1.501(3) . ?  
C8 C13 1.392(3) . ?  
C8 C9 1.394(3) . ?  
C9 C10 1.384(3) . ?  
C10 C11 1.380(3) . ?  
C11 C12 1.386(3) . ?  
C12 C13 1.384(3) . ?  
C14 C15 1.498(4) . ?  
C15 C16 1.323(4) . ?  
C16 C18 1.495(4) . ?  
C16 C17 1.500(4) . ?  
 
loop_  
 _geom_angle_atom_site_label_1  
 _geom_angle_atom_site_label_2  
 _geom_angle_atom_site_label_3  
 _geom_angle  
 _geom_angle_site_symmetry_1  
 _geom_angle_site_symmetry_3  
 _geom_angle_publ_flag  
C7 N C6 124.22(18) . . ?  
C7 N C14 117.66(19) . . ?  
C6 N C14 116.89(18) . . ?  
C2 C1 C6 121.2(2) . . ?  
C2 C1 I 117.62(16) . . ?  
C6 C1 I 121.17(16) . . ?  
C3 C2 C1 120.6(2) . . ?  
C2 C3 C4 118.2(2) . . ?  
C2 C3 C19 120.3(2) . . ?  
C4 C3 C19 121.5(2) . . ?  
C3 C4 C5 122.8(2) . . ?  
C4 C5 C6 118.3(2) . . ?  
C4 C5 C20 120.7(2) . . ?  
C6 C5 C20 120.99(19) . . ?  
C1 C6 C5 118.96(19) . . ?  
C1 C6 N 120.36(19) . . ?  
C5 C6 N 120.65(19) . . ?  
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O C7 N 121.4(2) . . ?  
O C7 C8 119.3(2) . . ?  
N C7 C8 119.28(18) . . ?  
C13 C8 C9 118.9(2) . . ?  
C13 C8 C7 124.7(2) . . ?  
C9 C8 C7 116.14(19) . . ?  
C10 C9 C8 121.0(2) . . ?  
C11 C10 C9 119.0(2) . . ?  
C10 C11 C12 121.3(2) . . ?  
C10 C11 Br 118.73(18) . . ?  
C12 C11 Br 119.96(18) . . ?  
C13 C12 C11 119.2(2) . . ?  
C12 C13 C8 120.6(2) . . ?  
N C14 C15 113.7(2) . . ?  
C16 C15 C14 126.4(2) . . ?  
C15 C16 C18 124.7(3) . . ?  
C15 C16 C17 121.7(3) . . ?  
C18 C16 C17 113.6(3) . . ?  
 
_diffrn_measured_fraction_theta_max    0.984  
_diffrn_reflns_theta_full              32.46  
_diffrn_measured_fraction_theta_full   0.984  
_refine_diff_density_max    1.456  
_refine_diff_density_min   -0.459  
_refine_diff_density_rms    0.081  
 
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
 
 
 
Figure 7.2 - ORTEP of (R)-57b 
The corresponding CIF file for (R)-57b is found below, between the lines of '+' symbols. 
 
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
 
data_cur602s  
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_audit_creation_method            SHELXL-97  
_chemical_name_systematic  
;  
 ?  
;  
_chemical_name_common             ?  
_chemical_melting_point           ?  
_chemical_formula_moiety          ?  
_chemical_formula_sum  
 'C20 H22 Br N O'  
_chemical_formula_weight          372.30  
 
loop_  
 _atom_type_symbol  
 _atom_type_description  
 _atom_type_scat_dispersion_real  
 _atom_type_scat_dispersion_imag  
 _atom_type_scat_source  
 'C'  'C'   0.0033   0.0016  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'H'  'H'   0.0000   0.0000  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'N'  'N'   0.0061   0.0033  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'O'  'O'   0.0106   0.0060  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'Br'  'Br'  -0.2901   2.4595  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 
_symmetry_cell_setting            Orthorhombic  
_symmetry_space_group_name_H-M    P2(1)2(1)2(1)  
 
loop_  
 _symmetry_equiv_pos_as_xyz  
 'x, y, z'  
 '-x+1/2, -y, z+1/2'  
 '-x, y+1/2, -z+1/2'  
 'x+1/2, -y+1/2, -z'  
 
_cell_length_a                    9.0591(7)  
_cell_length_b                    9.9088(8)  
_cell_length_c                    19.8827(16)  
_cell_angle_alpha                 90.00  
_cell_angle_beta                  90.00  
_cell_angle_gamma                 90.00  
_cell_volume                      1784.8(2)  
_cell_formula_units_Z             4  
_cell_measurement_temperature     200(2)  
_cell_measurement_reflns_used     3545  
_cell_measurement_theta_min       2.30  
_cell_measurement_theta_max       20.94  
 
_exptl_crystal_description        ?  
_exptl_crystal_colour             ?  
_exptl_crystal_size_max           0.34  
_exptl_crystal_size_mid           0.20  
_exptl_crystal_size_min           0.20  
_exptl_crystal_density_meas       0  
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_exptl_crystal_density_diffrn     1.386  
_exptl_crystal_density_method     'not measured'  
_exptl_crystal_F_000              768  
_exptl_absorpt_coefficient_mu     2.307  
_exptl_absorpt_correction_type    none  
_exptl_absorpt_correction_T_min   0.5076  
_exptl_absorpt_correction_T_max   0.6554  
_exptl_absorpt_process_details    ?  
 
_exptl_special_details  
;  
 ?  
;  
 
_diffrn_ambient_temperature       200(2)  
_diffrn_radiation_wavelength      0.71073  
_diffrn_radiation_type            MoK\a  
_diffrn_radiation_source          'fine-focus sealed tube'  
_diffrn_radiation_monochromator   graphite  
_diffrn_measurement_device_type   'CCD area detector'  
_diffrn_measurement_method        'phi and omega scans'  
_diffrn_detector_area_resol_mean  ?  
_diffrn_standards_number          ?  
_diffrn_standards_interval_count  ?  
_diffrn_standards_interval_time   ?  
_diffrn_standards_decay_%         ?  
_diffrn_reflns_number             14269  
_diffrn_reflns_av_R_equivalents   0.0477  
_diffrn_reflns_av_sigmaI/netI     0.0576  
_diffrn_reflns_limit_h_min        -10  
_diffrn_reflns_limit_h_max        10  
_diffrn_reflns_limit_k_min        -11  
_diffrn_reflns_limit_k_max        11  
_diffrn_reflns_limit_l_min        -23  
_diffrn_reflns_limit_l_max        23  
_diffrn_reflns_theta_min          2.05  
_diffrn_reflns_theta_max          25.00  
_reflns_number_total              3132  
_reflns_number_gt                 1993  
_reflns_threshold_expression      >2sigma(I)  
 
_computing_data_collection        'Bruker SMART'  
_computing_cell_refinement        'Bruker SMART'  
_computing_data_reduction         'Bruker SAINT'  
_computing_structure_solution     'SHELXS-97 (Sheldrick, 1990)'  
_computing_structure_refinement   'SHELXL-97 (Sheldrick, 1997)'  
_computing_molecular_graphics     'Bruker SHELXTL'  
_computing_publication_material   'Bruker SHELXTL'  
 
_refine_special_details  
;  
 Refinement of F^2^ against ALL reflections.  The weighted R-factor wR and  
 goodness of fit S are based on F^2^, conventional R-factors R are based  
 on F, with F set to zero for negative F^2^. The threshold expression of  
 F^2^ > 2sigma(F^2^) is used only for calculating R-factors(gt) etc. and is  
 not relevant to the choice of reflections for refinement.  R-factors based  
 on F^2^ are statistically about twice as large as those based on F, and R-  
 factors based on ALL data will be even larger.  
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;  
 
_refine_ls_structure_factor_coef  Fsqd  
_refine_ls_matrix_type            full  
_refine_ls_weighting_scheme       calc  
_refine_ls_weighting_details  
 'calc w=1/[\s^2^(Fo^2^)+(0.0553P)^2^+0.0000P] where P=(Fo^2^+2Fc^2^)/3'  
_atom_sites_solution_primary      direct  
_atom_sites_solution_secondary    difmap  
_atom_sites_solution_hydrogens    geom  
_refine_ls_hydrogen_treatment     mixed  
_refine_ls_extinction_method      none  
_refine_ls_extinction_coef        ?  
_refine_ls_abs_structure_details  
 'Flack H D (1983), Acta Cryst. A39, 876-881'  
_refine_ls_abs_structure_Flack    0.013(15)  
_refine_ls_number_reflns          3132  
_refine_ls_number_parameters      218  
_refine_ls_number_restraints      0  
_refine_ls_R_factor_all           0.0802  
_refine_ls_R_factor_gt            0.0440  
_refine_ls_wR_factor_ref          0.1177  
_refine_ls_wR_factor_gt           0.1067  
_refine_ls_goodness_of_fit_ref    0.998  
_refine_ls_restrained_S_all       0.998  
_refine_ls_shift/su_max           0.049  
_refine_ls_shift/su_mean          0.004  
 
loop_  
 _atom_site_label  
 _atom_site_type_symbol  
 _atom_site_fract_x  
 _atom_site_fract_y  
 _atom_site_fract_z  
 _atom_site_U_iso_or_equiv  
 _atom_site_adp_type  
 _atom_site_occupancy  
 _atom_site_symmetry_multiplicity  
 _atom_site_calc_flag  
 _atom_site_refinement_flags  
 _atom_site_disorder_assembly  
 _atom_site_disorder_group  
Br Br -0.90041(7) -0.18939(6) 0.50262(3) 0.1134(3) Uani 1 1 d . A 1  
O O -0.5675(4) -0.0370(4) 0.20368(14) 0.0868(9) Uani 1 1 d . A 1  
N N -0.3825(4) -0.1669(4) 0.24743(14) 0.0764(10) Uani 1 1 d . A 1  
C1 C -0.6203(5) -0.2559(5) 0.3423(2) 0.0802(13) Uani 1 1 d . A 1  
H1A H -0.5662 -0.3304 0.3251 0.096 Uiso 1 1 calc R A 1  
C2 C -0.7092(6) -0.2731(5) 0.3984(2) 0.0832(14) Uani 1 1 d . A 1  
H2A H -0.7190 -0.3597 0.4184 0.100 Uiso 1 1 calc R A 1  
C3 C -0.7831(5) -0.1640(6) 0.4250(2) 0.0826(13) Uani 1 1 d . A 1  
C4 C -0.7728(5) -0.0391(5) 0.3947(2) 0.0809(13) Uani 1 1 d . A 1  
H4A H -0.8235 0.0360 0.4133 0.097 Uiso 1 1 calc R A 1  
C5 C -0.6894(6) -0.0234(5) 0.3380(2) 0.0763(12) Uani 1 1 d . A 1  
H5A H -0.6855 0.0619 0.3162 0.092 Uiso 1 1 calc R A 1  
C6 C -0.6094(5) -0.1327(5) 0.31158(19) 0.0720(11) Uani 1 1 d . A 1  
C7 C -0.5185(6) -0.1073(5) 0.2496(2) 0.0759(12) Uani 1 1 d . A 1  
C8 C -0.2946(5) -0.1925(5) 0.30970(18) 0.0812(13) Uani 1 1 d . A 1  
H8A H -0.2652 -0.2885 0.3129 0.097 Uiso 1 1 calc R A 1  
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H8B H -0.3511 -0.1675 0.3505 0.097 Uiso 1 1 calc R A 1  
C9 C -0.1592(6) -0.1009(5) 0.30061(18) 0.0768(14) Uani 1 1 d . A 1  
H9A H -0.0701 -0.1437 0.3213 0.092 Uiso 1 1 calc R A 1  
C10 C -0.1441(6) -0.0985(5) 0.22394(19) 0.0772(13) Uani 1 1 d . A 1  
C11 C -0.0238(6) -0.0668(5) 0.1855(2) 0.0855(14) Uani 1 1 d . A 1  
H11A H 0.0667 -0.0408 0.2059 0.103 Uiso 1 1 calc R A 1  
C12 C -0.0371(7) -0.0734(5) 0.1160(2) 0.0919(15) Uani 1 1 d . A 1  
C13 C -0.1692(7) -0.1169(5) 0.08830(19) 0.0877(15) Uani 1 1 d . A 1  
H13A H -0.1749 -0.1251 0.0408 0.105 Uiso 1 1 calc R A 1  
C14 C -0.2945(6) -0.1495(5) 0.1260(2) 0.0856(13) Uani 1 1 d . A 1  
C15 C -0.2783(6) -0.1365(5) 0.1961(2) 0.0764(13) Uani 1 1 d . A 1  
C16 C -0.1825(13) 0.0375(7) 0.3292(3) 0.151(3) Uani 1 1 d . A 1  
H16A H -0.0793 0.0726 0.3255 0.181 Uiso 1 1 calc R A 1  
C17 C -0.1959(11) 0.0330(6) 0.4074(2) 0.152(3) Uani 1 1 d . A 1  
H17A H -0.2002 0.1252 0.4250 0.227 Uiso 1 1 calc R A 1  
H17B H -0.1099 -0.0135 0.4262 0.227 Uiso 1 1 calc R A 1  
H17C H -0.2860 -0.0156 0.4199 0.227 Uiso 1 1 calc R A 1  
C18 C -0.2475(11) 0.1320(12) 0.3051(5) 0.073(3) Uani 0.50 1 d P A 1  
H18A H -0.2318 0.1332 0.2563 0.110 Uiso 0.50 1 calc PR A 1  
H18B H -0.2102 0.2161 0.3247 0.110 Uiso 0.50 1 calc PR A 1  
H18C H -0.3532 0.1235 0.3146 0.110 Uiso 0.50 1 calc PR A 1  
C18' C -0.1176(16) 0.1514(11) 0.3018(5) 0.095(3) Uani 0.50 1 d P B 2  
C19 C 0.0942(6) -0.0398(7) 0.0712(2) 0.1101(18) Uani 1 1 d . A 1  
H19A H 0.0659 -0.0504 0.0239 0.165 Uiso 1 1 calc R A 1  
H19B H 0.1761 -0.1008 0.0816 0.165 Uiso 1 1 calc R A 1  
H19C H 0.1250 0.0537 0.0793 0.165 Uiso 1 1 calc R A 1  
C20 C -0.4336(6) -0.1951(6) 0.0936(2) 0.0966(16) Uani 1 1 d . A 1  
H20A H -0.4209 -0.1959 0.0447 0.145 Uiso 1 1 calc R A 1  
H20B H -0.5138 -0.1331 0.1056 0.145 Uiso 1 1 calc R A 1  
H20C H -0.4579 -0.2862 0.1092 0.145 Uiso 1 1 calc R A 1  
 
loop_  
 _atom_site_aniso_label  
 _atom_site_aniso_U_11  
 _atom_site_aniso_U_22  
 _atom_site_aniso_U_33  
 _atom_site_aniso_U_23  
 _atom_site_aniso_U_13  
 _atom_site_aniso_U_12  
Br 0.1200(4) 0.1490(5) 0.0713(3) 0.0176(4) 0.0239(3) -0.0174(4)  
O 0.101(2) 0.105(2) 0.0542(16) 0.0219(17) -0.0054(17) -0.0026(19)  
N 0.088(3) 0.104(3) 0.0369(16) 0.0152(18) -0.0008(17) 0.003(2)  
C1 0.100(3) 0.090(3) 0.051(2) 0.011(2) -0.003(2) 0.002(3)  
C2 0.100(3) 0.089(3) 0.061(3) 0.014(2) -0.012(3) -0.018(3)  
C3 0.087(3) 0.101(4) 0.059(2) 0.015(3) -0.004(2) -0.012(3)  
C4 0.082(3) 0.098(4) 0.063(3) 0.005(3) -0.005(2) 0.000(3)  
C5 0.088(3) 0.093(3) 0.048(2) 0.012(2) -0.009(2) -0.007(3)  
C6 0.085(3) 0.083(3) 0.048(2) 0.013(2) -0.009(2) -0.007(3)  
C7 0.095(3) 0.094(3) 0.039(2) 0.013(2) -0.010(2) -0.006(3)  
C8 0.100(3) 0.105(3) 0.039(2) 0.009(2) -0.001(2) 0.011(3)  
C9 0.099(4) 0.092(3) 0.039(2) 0.004(2) 0.008(2) -0.004(3)  
C10 0.096(4) 0.092(3) 0.043(2) -0.002(2) 0.004(2) 0.000(3)  
C11 0.089(3) 0.116(4) 0.051(2) -0.007(2) 0.011(2) -0.006(3)  
C12 0.119(4) 0.109(4) 0.048(2) -0.002(3) 0.023(3) 0.014(3)  
C13 0.136(4) 0.094(3) 0.034(2) 0.002(2) 0.005(3) 0.015(3)  
C14 0.113(4) 0.105(3) 0.040(2) 0.005(2) -0.006(3) 0.005(3)  
C15 0.098(4) 0.091(3) 0.040(2) 0.012(2) 0.003(2) 0.003(3)  
C16 0.301(10) 0.097(4) 0.056(3) -0.006(3) 0.063(5) -0.016(7)  
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C17 0.283(10) 0.122(5) 0.050(3) -0.014(3) 0.046(4) -0.020(6)  
C18 0.062(6) 0.095(8) 0.063(5) -0.019(6) -0.006(4) 0.011(5)  
C18' 0.109(9) 0.092(8) 0.083(7) -0.020(6) 0.000(7) -0.024(7)  
C19 0.123(4) 0.140(5) 0.067(3) 0.007(3) 0.029(3) 0.004(4)  
C20 0.126(4) 0.121(4) 0.042(2) 0.010(3) -0.009(2) 0.000(4)  
 
_geom_special_details  
;  
 All esds (except the esd in the dihedral angle between two l.s. planes)  
 are estimated using the full covariance matrix.  The cell esds are taken  
 into account individually in the estimation of esds in distances, angles  
 and torsion angles; correlations between esds in cell parameters are only  
 used when they are defined by crystal symmetry.  An approximate (isotropic)  
 treatment of cell esds is used for estimating esds involving l.s. planes.  
;  
 
loop_  
 _geom_bond_atom_site_label_1  
 _geom_bond_atom_site_label_2  
 _geom_bond_distance  
 _geom_bond_site_symmetry_2  
 _geom_bond_publ_flag  
Br C3 1.891(4) . ?  
O C7 1.232(5) . ?  
N C7 1.366(6) . ?  
N C15 1.423(5) . ?  
N C8 1.494(5) . ?  
C1 C6 1.369(6) . ?  
C1 C2 1.386(7) . ?  
C2 C3 1.377(7) . ?  
C3 C4 1.379(7) . ?  
C4 C5 1.367(6) . ?  
C5 C6 1.404(7) . ?  
C6 C7 1.503(6) . ?  
C8 C9 1.537(7) . ?  
C9 C16 1.500(8) . ?  
C9 C10 1.531(5) . ?  
C10 C11 1.368(6) . ?  
C10 C15 1.388(6) . ?  
C11 C12 1.388(6) . ?  
C12 C13 1.386(7) . ?  
C12 C19 1.523(7) . ?  
C13 C14 1.398(7) . ?  
C14 C15 1.408(6) . ?  
C14 C20 1.485(7) . ?  
C16 C18 1.206(11) . ?  
C16 C17 1.559(7) . ?  
 
loop_  
 _geom_angle_atom_site_label_1  
 _geom_angle_atom_site_label_2  
 _geom_angle_atom_site_label_3  
 _geom_angle  
 _geom_angle_site_symmetry_1  
 _geom_angle_site_symmetry_3  
 _geom_angle_publ_flag  
C7 N C15 122.0(3) . . ?  
C7 N C8 121.8(3) . . ?  
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C15 N C8 106.0(3) . . ?  
C6 C1 C2 120.7(5) . . ?  
C3 C2 C1 119.6(4) . . ?  
C2 C3 C4 120.3(4) . . ?  
C2 C3 Br 118.8(4) . . ?  
C4 C3 Br 120.9(4) . . ?  
C5 C4 C3 120.0(5) . . ?  
C4 C5 C6 120.4(4) . . ?  
C1 C6 C5 118.9(4) . . ?  
C1 C6 C7 123.7(5) . . ?  
C5 C6 C7 117.4(4) . . ?  
O C7 N 123.1(4) . . ?  
O C7 C6 120.3(5) . . ?  
N C7 C6 116.6(4) . . ?  
N C8 C9 103.2(3) . . ?  
C16 C9 C10 112.1(4) . . ?  
C16 C9 C8 112.5(5) . . ?  
C10 C9 C8 101.4(4) . . ?  
C11 C10 C15 122.5(4) . . ?  
C11 C10 C9 129.1(5) . . ?  
C15 C10 C9 108.3(4) . . ?  
C10 C11 C12 118.4(5) . . ?  
C13 C12 C11 119.0(5) . . ?  
C13 C12 C19 120.6(4) . . ?  
C11 C12 C19 120.2(6) . . ?  
C12 C13 C14 124.0(4) . . ?  
C13 C14 C15 115.1(5) . . ?  
C13 C14 C20 121.8(4) . . ?  
C15 C14 C20 123.1(5) . . ?  
C10 C15 C14 120.7(5) . . ?  
C10 C15 N 110.7(3) . . ?  
C14 C15 N 128.4(5) . . ?  
C18 C16 C9 128.9(8) . . ?  
C18 C16 C17 112.4(8) . . ?  
C9 C16 C17 111.3(5) . . ?  
 
_diffrn_measured_fraction_theta_max    0.999  
_diffrn_reflns_theta_full              25.00  
_diffrn_measured_fraction_theta_full   0.999  
_refine_diff_density_max    0.301  
_refine_diff_density_min   -0.171  
_refine_diff_density_rms    0.046  
 
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
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Figure 7.3 - ORTEP of (M)-109 
The corresponding CIF file for (M)-109 is found below, between the lines of '+' symbols. 
 
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
 
data_al714s  
 
   
_audit_creation_method            SHELXL-97  
_chemical_name_systematic  
 
;  
 ?  
;  
 
_chemical_name_common             ?  
_chemical_melting_point           ?  
_chemical_formula_moiety          ?  
_chemical_formula_sum  
 'C17 H22 I N O'  
_chemical_formula_weight          383.26  
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loop_  
 _atom_type_symbol  
 _atom_type_description  
 _atom_type_scat_dispersion_real  
 _atom_type_scat_dispersion_imag  
 _atom_type_scat_source  
 'C'  'C'   0.0033   0.0016  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'H'  'H'   0.0000   0.0000  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'N'  'N'   0.0061   0.0033  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'O'  'O'   0.0106   0.0060  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'I'  'I'  -0.4742   1.8119  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 
 
_symmetry_cell_setting            Orthorhombic  
_symmetry_space_group_name_H-M    P2(1)2(1)2(1)  
 
 
loop_  
 _symmetry_equiv_pos_as_xyz  
 'x, y, z'  
 '-x+1/2, -y, z+1/2'  
 '-x, y+1/2, -z+1/2'  
 'x+1/2, -y+1/2, -z'  
 
 
_cell_length_a                    9.166(2)  
_cell_length_b                    10.794(3)  
_cell_length_c                    17.987(4)  
_cell_angle_alpha                 90.00  
_cell_angle_beta                  90.00  
_cell_angle_gamma                 90.00  
_cell_volume                      1779.6(7)  
_cell_formula_units_Z             4  
_cell_measurement_temperature     295(2)  
_cell_measurement_reflns_used     5854  
_cell_measurement_theta_min       2.49  
_cell_measurement_theta_max       29.83  
 
   
_exptl_crystal_description        ?  
_exptl_crystal_colour             ?  
_exptl_crystal_size_max           0.15  
_exptl_crystal_size_mid           0.12  
_exptl_crystal_size_min           0.10  
_exptl_crystal_density_meas       0  
_exptl_crystal_density_diffrn     1.430  
_exptl_crystal_density_method     'not measured'  
_exptl_crystal_F_000              768  
_exptl_absorpt_coefficient_mu     1.796  
_exptl_absorpt_correction_type    none  
_exptl_absorpt_correction_T_min   0.7744  
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_exptl_absorpt_correction_T_max   0.8408  
_exptl_absorpt_process_details    ?  
 
   
 
_exptl_special_details  
 
;  
 ?  
;  
 
   
_diffrn_ambient_temperature       295(2)  
_diffrn_radiation_wavelength      0.71073  
_diffrn_radiation_type            MoK\a  
_diffrn_radiation_source          'fine-focus sealed tube'  
_diffrn_radiation_monochromator   graphite  
_diffrn_measurement_device_type   'CCD area detector'  
_diffrn_measurement_method        'phi and omega scans'  
_diffrn_detector_area_resol_mean  ?  
_diffrn_standards_number          ?  
_diffrn_standards_interval_count  ?  
_diffrn_standards_interval_time   ?  
_diffrn_standards_decay_%         ?  
_diffrn_reflns_number             14104  
_diffrn_reflns_av_R_equivalents   0.0799  
_diffrn_reflns_av_sigmaI/netI     0.0620  
_diffrn_reflns_limit_h_min        -11  
_diffrn_reflns_limit_h_max        11  
_diffrn_reflns_limit_k_min        -14  
_diffrn_reflns_limit_k_max        14  
_diffrn_reflns_limit_l_min        -22  
_diffrn_reflns_limit_l_max        23  
_diffrn_reflns_theta_min          2.20  
_diffrn_reflns_theta_max          27.50  
_reflns_number_total              3953  
_reflns_number_gt                 2737  
_reflns_threshold_expression      >2sigma(I)  
 
   
_computing_data_collection        'Bruker SMART'  
_computing_cell_refinement        'Bruker SMART'  
_computing_data_reduction         'Bruker SAINT'  
_computing_structure_solution     'SHELXS-97 (Sheldrick, 1990)'  
_computing_structure_refinement   'SHELXL-97 (Sheldrick, 1997)'  
_computing_molecular_graphics     'Bruker SHELXTL'  
_computing_publication_material   'Bruker SHELXTL'  
  
_refine_special_details  
 
;  
 
 Refinement of F^2^ against ALL reflections.  The weighted R-factor wR and  
 goodness of fit S are based on F^2^, conventional R-factors R are based  
 on F, with F set to zero for negative F^2^. The threshold expression of  
 F^2^ > 2sigma(F^2^) is used only for calculating R-factors(gt) etc. and is  
 not relevant to the choice of reflections for refinement.  R-factors based  
 on F^2^ are statistically about twice as large as those based on F, and R-  
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 factors based on ALL data will be even larger.  
 
;  
 
   
 
_refine_ls_structure_factor_coef  Fsqd  
_refine_ls_matrix_type            full  
_refine_ls_weighting_scheme       calc  
_refine_ls_weighting_details  
 'calc w=1/[\s^2^(Fo^2^)+(0.0851P)^2^+0.0000P] where P=(Fo^2^+2Fc^2^)/3'  
_atom_sites_solution_primary      direct  
_atom_sites_solution_secondary    difmap  
_atom_sites_solution_hydrogens    geom  
_refine_ls_hydrogen_treatment     mixed  
_refine_ls_extinction_method      SHELXL  
_refine_ls_extinction_coef        0.030(2)  
_refine_ls_extinction_expression  
 'Fc^*^=kFc[1+0.001xFc^2^\l^3^/sin(2\q)]^-1/4^'  
_refine_ls_abs_structure_details  
 'Flack H D (1983), Acta Cryst. A39, 876-881'  
_refine_ls_abs_structure_Flack    0.05(6)  
_refine_ls_number_reflns          3953  
_refine_ls_number_parameters      185  
_refine_ls_number_restraints      0  
_refine_ls_R_factor_all           0.0829  
_refine_ls_R_factor_gt            0.0532  
_refine_ls_wR_factor_ref          0.1511  
_refine_ls_wR_factor_gt           0.1306  
_refine_ls_goodness_of_fit_ref    1.032  
_refine_ls_restrained_S_all       1.032  
_refine_ls_shift/su_max           0.065  
_refine_ls_shift/su_mean          0.002  
 
 
loop_  
 _atom_site_label  
 _atom_site_type_symbol  
 _atom_site_fract_x  
 _atom_site_fract_y  
 _atom_site_fract_z  
 _atom_site_U_iso_or_equiv  
 _atom_site_adp_type  
 _atom_site_occupancy  
 _atom_site_symmetry_multiplicity  
 _atom_site_calc_flag  
 _atom_site_refinement_flags  
 _atom_site_disorder_assembly  
 _atom_site_disorder_group  
I1 I 0.84204(6) 1.12850(5) 0.17685(3) 0.0622(2) Uani 1 1 d . . .  
O1 O 1.1184(6) 0.7858(6) 0.1860(4) 0.0695(16) Uani 1 1 d . . .  
N1 N 0.9155(7) 0.8426(6) 0.1200(3) 0.0509(15) Uani 1 1 d . . .  
C1 C 0.7333(9) 1.0586(9) -0.0562(5) 0.063(2) Uani 1 1 d . . .  
C2 C 0.7678(11) 0.9307(10) -0.0667(5) 0.071(2) Uani 1 1 d . . .  
H2 H 0.7506 0.8932 -0.1124 0.085 Uiso 1 1 calc R . .  
C3 C 0.8274(9) 0.8622(8) -0.0084(4) 0.0580(17) Uani 1 1 d . . .  
H3 H 0.8515 0.7795 -0.0161 0.070 Uiso 1 1 calc R . .  
C4 C 0.8516(8) 0.9154(6) 0.0616(4) 0.0496(15) Uani 1 1 d . . .  
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C5 C 0.8132(8) 1.0403(7) 0.0704(4) 0.0492(17) Uani 1 1 d . . .  
C6 C 0.7553(8) 1.1101(8) 0.0129(5) 0.060(2) Uani 1 1 d . . .  
H6 H 0.7309 1.1926 0.0210 0.073 Uiso 1 1 calc R . .  
C8 C 1.0630(8) 0.8492(7) 0.1370(4) 0.0519(18) Uani 1 1 d . . .  
C9 C 1.1530(10) 0.9386(8) 0.0922(4) 0.0585(18) Uani 1 1 d . . .  
H9 H 1.1101 0.9827 0.0536 0.070 Uiso 1 1 calc R . .  
C10 C 1.2934(9) 0.9550(10) 0.1077(5) 0.068(2) Uani 1 1 d . . .  
H10 H 1.3317 0.9098 0.1471 0.082 Uiso 1 1 calc R . .  
C11 C 1.3969(12) 1.0407(12) 0.0666(7) 0.088(3) Uani 1 1 d . . .  
H11A H 1.4825 0.9956 0.0521 0.133 Uiso 1 1 calc R . .  
H11B H 1.4242 1.1080 0.0986 0.133 Uiso 1 1 calc R . .  
H11C H 1.3494 1.0729 0.0231 0.133 Uiso 1 1 calc R . .  
C12 C 0.6708(15) 1.1366(13) -0.1190(7) 0.103(4) Uani 1 1 d . . .  
H12A H 0.6891 1.2226 -0.1092 0.155 Uiso 1 1 calc R . .  
H12B H 0.5675 1.1229 -0.1223 0.155 Uiso 1 1 calc R . .  
H12C H 0.7162 1.1135 -0.1650 0.155 Uiso 1 1 calc R . .  
C13 C 0.8261(9) 0.7500(7) 0.1617(4) 0.0569(18) Uani 1 1 d . . .  
H13 H 0.8632 0.7484 0.2128 0.068 Uiso 1 1 calc R . .  
C15 C 0.6635(10) 0.7833(10) 0.1661(6) 0.072(2) Uani 1 1 d . . .  
H15A H 0.6528 0.8650 0.1879 0.087 Uiso 1 1 calc R . .  
H15B H 0.6228 0.7857 0.1163 0.087 Uiso 1 1 calc R . .  
C16 C 0.5807(13) 0.6905(12) 0.2121(7) 0.089(3) Uani 1 1 d . . .  
H16A H 0.4777 0.7111 0.2110 0.107 Uiso 1 1 calc R . .  
H16B H 0.6133 0.6960 0.2633 0.107 Uiso 1 1 calc R . .  
C17 C 0.6012(13) 0.5552(12) 0.1843(8) 0.096(4) Uani 1 1 d . . .  
H17A H 0.5560 0.4984 0.2192 0.115 Uiso 1 1 calc R . .  
H17B H 0.5536 0.5453 0.1365 0.115 Uiso 1 1 calc R . .  
C18 C 0.7588(13) 0.5254(10) 0.1771(8) 0.093(3) Uani 1 1 d . . .  
H18A H 0.7689 0.4441 0.1546 0.112 Uiso 1 1 calc R . .  
H18B H 0.8020 0.5218 0.2262 0.112 Uiso 1 1 calc R . .  
C19 C 0.8412(11) 0.6183(8) 0.1309(6) 0.072(2) Uani 1 1 d . . .  
H19A H 0.8047 0.6162 0.0803 0.087 Uiso 1 1 calc R . .  
H19B H 0.9436 0.5956 0.1297 0.087 Uiso 1 1 calc R . .  
   
 
loop_  
 _atom_site_aniso_label  
 _atom_site_aniso_U_11  
 _atom_site_aniso_U_22  
 _atom_site_aniso_U_33  
 _atom_site_aniso_U_23  
 _atom_site_aniso_U_13  
 _atom_site_aniso_U_12  
I1 0.0706(3) 0.0498(3) 0.0662(3) -0.0077(2) 0.0029(3) -0.0030(3)  
O1 0.065(3) 0.072(4) 0.072(4) 0.020(3) -0.011(3) 0.002(3)  
N1 0.050(3) 0.045(4) 0.057(3) 0.004(3) -0.002(3) -0.005(3)  
C1 0.050(4) 0.073(6) 0.064(5) 0.022(4) -0.006(4) -0.010(4)  
C2 0.075(6) 0.085(7) 0.053(4) 0.008(4) -0.008(4) -0.009(5)  
C3 0.066(4) 0.049(4) 0.059(4) 0.001(3) -0.001(4) -0.004(5)  
C4 0.049(4) 0.042(3) 0.058(4) 0.003(3) -0.003(3) 0.001(3)  
C5 0.054(4) 0.052(4) 0.042(3) -0.011(3) 0.000(3) -0.005(3)  
C6 0.058(4) 0.050(5) 0.074(5) 0.013(4) -0.010(4) -0.002(4)  
C8 0.046(4) 0.050(5) 0.060(4) -0.004(3) 0.000(3) 0.003(3)  
C9 0.049(4) 0.059(4) 0.068(5) 0.010(3) -0.004(4) -0.002(4)  
C10 0.056(5) 0.072(6) 0.077(5) -0.010(5) -0.002(4) 0.000(4)  
C11 0.067(6) 0.096(8) 0.102(8) -0.009(7) 0.021(6) -0.020(6)  
C12 0.104(8) 0.105(9) 0.100(7) 0.046(7) -0.028(7) 0.007(10)  
C13 0.062(5) 0.042(4) 0.066(5) 0.006(3) -0.002(4) -0.004(4)  
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C15 0.058(4) 0.076(6) 0.083(6) 0.011(5) 0.012(5) -0.002(5)  
C16 0.076(6) 0.095(8) 0.096(8) 0.021(6) 0.015(6) -0.015(6)  
C17 0.089(7) 0.093(8) 0.106(8) 0.043(8) -0.014(7) -0.033(6)  
C18 0.096(7) 0.060(6) 0.124(9) 0.021(7) -0.015(8) -0.013(5)  
C19 0.073(5) 0.047(4) 0.098(6) 0.007(5) -0.010(5) -0.002(5)  
 
   
_geom_special_details  
 
;  
 All esds (except the esd in the dihedral angle between two l.s. planes)  
 are estimated using the full covariance matrix.  The cell esds are taken  
 into account individually in the estimation of esds in distances, angles  
 and torsion angles; correlations between esds in cell parameters are only  
 used when they are defined by crystal symmetry.  An approximate (isotropic)  
 treatment of cell esds is used for estimating esds involving l.s. planes.  
;  
 
   
 
loop_  
 _geom_bond_atom_site_label_1  
 _geom_bond_atom_site_label_2  
 _geom_bond_distance  
 _geom_bond_site_symmetry_2  
 _geom_bond_publ_flag  
I1 C5 2.154(6) . ?  
O1 C8 1.226(9) . ?  
N1 C8 1.388(10) . ?  
N1 C4 1.436(9) . ?  
N1 C13 1.495(9) . ?  
C1 C6 1.375(12) . ?  
C1 C2 1.429(14) . ?  
C1 C12 1.521(12) . ?  
C2 C3 1.395(12) . ?  
C3 C4 1.401(10) . ?  
C4 C5 1.403(10) . ?  
C5 C6 1.386(11) . ?  
C8 C9 1.504(12) . ?  
C9 C10 1.329(13) . ?  
C10 C11 1.517(14) . ?  
C13 C19 1.532(12) . ?  
C13 C15 1.536(12) . ?  
C15 C16 1.505(14) . ?  
C16 C17 1.554(18) . ?  
C17 C18 1.486(19) . ?  
C18 C19 1.505(14) . ?  
 
 
loop_  
 _geom_angle_atom_site_label_1  
 _geom_angle_atom_site_label_2  
 _geom_angle_atom_site_label_3  
 _geom_angle  
 _geom_angle_site_symmetry_1  
 _geom_angle_site_symmetry_3  
 _geom_angle_publ_flag  
C8 N1 C4 122.1(7) . . ?  
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C8 N1 C13 117.2(7) . . ?  
C4 N1 C13 120.6(6) . . ?  
C6 C1 C2 118.5(8) . . ?  
C6 C1 C12 120.1(10) . . ?  
C2 C1 C12 121.3(10) . . ?  
C3 C2 C1 119.9(9) . . ?  
C2 C3 C4 121.4(8) . . ?  
C3 C4 C5 117.1(7) . . ?  
C3 C4 N1 119.8(6) . . ?  
C5 C4 N1 123.1(6) . . ?  
C6 C5 C4 122.3(7) . . ?  
C6 C5 I1 118.1(6) . . ?  
C4 C5 I1 119.6(5) . . ?  
C1 C6 C5 120.8(8) . . ?  
O1 C8 N1 122.3(8) . . ?  
O1 C8 C9 121.1(7) . . ?  
N1 C8 C9 116.6(7) . . ?  
C10 C9 C8 120.3(8) . . ?  
C9 C10 C11 125.8(10) . . ?  
N1 C13 C19 113.0(7) . . ?  
N1 C13 C15 113.7(7) . . ?  
C19 C13 C15 108.9(8) . . ?  
C16 C15 C13 111.2(8) . . ?  
C15 C16 C17 112.8(10) . . ?  
C18 C17 C16 110.5(10) . . ?  
C17 C18 C19 113.1(10) . . ?  
C18 C19 C13 111.9(9) . . ?  
   
 
_diffrn_measured_fraction_theta_max    0.968  
_diffrn_reflns_theta_full              27.50  
_diffrn_measured_fraction_theta_full   0.968  
_refine_diff_density_max    0.674  
_refine_diff_density_min   -1.170  
_refine_diff_density_rms    0.120  
 
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
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Figure 7.4 - ORTEP of (M)-112 
The corresponding CIF file for (M)-112 is found below, between the lines of '+' symbols. 
 
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
 
data_al428  
   
_audit_creation_method            SHELXL-97  
_chemical_name_systematic  
;  
 ?  
;  
_chemical_name_common             ?  
_chemical_melting_point           ?  
_chemical_formula_moiety          ?  
_chemical_formula_sum  
 'C12 H14 I N O'  
_chemical_formula_weight          315.14  
   
loop_  
 _atom_type_symbol  
 231 
 _atom_type_description  
 _atom_type_scat_dispersion_real  
 _atom_type_scat_dispersion_imag  
 _atom_type_scat_source  
 'C'  'C'   0.0033   0.0016  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'H'  'H'   0.0000   0.0000  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'N'  'N'   0.0061   0.0033  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'O'  'O'   0.0106   0.0060  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'I'  'I'  -0.4742   1.8119  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
   
_symmetry_cell_setting            Monoclinic  
_symmetry_space_group_name_H-M    P2(1)  
   
loop_  
 _symmetry_equiv_pos_as_xyz  
 'x, y, z'  
 '-x, y+1/2, -z'  
   
_cell_length_a                    7.0983(7)  
_cell_length_b                    11.0402(12)  
_cell_length_c                    8.6438(9)  
_cell_angle_alpha                 90.00  
_cell_angle_beta                  112.212(2)  
_cell_angle_gamma                 90.00  
_cell_volume                      627.12(11)  
_cell_formula_units_Z             2  
_cell_measurement_temperature     100(2)  
_cell_measurement_reflns_used     7181  
_cell_measurement_theta_min       0.00  
_cell_measurement_theta_max       0.00  
   
_exptl_crystal_description        ?  
_exptl_crystal_colour             ?  
_exptl_crystal_size_max           0.32  
_exptl_crystal_size_mid           0.24  
_exptl_crystal_size_min           0.22  
_exptl_crystal_density_meas       0  
_exptl_crystal_density_diffrn     1.669  
_exptl_crystal_density_method     'not measured'  
_exptl_crystal_F_000              308  
_exptl_absorpt_coefficient_mu     2.529  
_exptl_absorpt_correction_type    none  
_exptl_absorpt_correction_T_min   0.4983  
_exptl_absorpt_correction_T_max   0.6062  
_exptl_absorpt_process_details    ?  
   
_exptl_special_details  
;  
 ?  
;  
   
_diffrn_ambient_temperature       100(2)  
_diffrn_radiation_wavelength      0.71073  
 232 
_diffrn_radiation_type            MoK\a  
_diffrn_radiation_source          'fine-focus sealed tube'  
_diffrn_radiation_monochromator   graphite  
_diffrn_measurement_device_type   'CCD area detector'  
_diffrn_measurement_method        'phi and omega scans'  
_diffrn_detector_area_resol_mean  ?  
_diffrn_standards_number          ?  
_diffrn_standards_interval_count  ?  
_diffrn_standards_interval_time   ?  
_diffrn_standards_decay_%         ?  
_diffrn_reflns_number             7969  
_diffrn_reflns_av_R_equivalents   0.0195  
_diffrn_reflns_av_sigmaI/netI     0.0283  
_diffrn_reflns_limit_h_min        -10  
_diffrn_reflns_limit_h_max        10  
_diffrn_reflns_limit_k_min        -16  
_diffrn_reflns_limit_k_max        16  
_diffrn_reflns_limit_l_min        -13  
_diffrn_reflns_limit_l_max        12  
_diffrn_reflns_theta_min          2.55  
_diffrn_reflns_theta_max          32.49  
_reflns_number_total              4296  
_reflns_number_gt                 4169  
_reflns_threshold_expression      >2sigma(I)  
   
_computing_data_collection        'Bruker SMART'  
_computing_cell_refinement        'Bruker SMART'  
_computing_data_reduction         'Bruker SAINT'  
_computing_structure_solution     'SHELXS-97 (Sheldrick, 1990)'  
_computing_structure_refinement   'SHELXL-97 (Sheldrick, 1997)'  
_computing_molecular_graphics     'Bruker SHELXTL'  
_computing_publication_material   'Bruker SHELXTL'  
   
_refine_special_details  
;  
 Refinement of F^2^ against ALL reflections.  The weighted R-factor wR and  
 goodness of fit S are based on F^2^, conventional R-factors R are based  
 on F, with F set to zero for negative F^2^. The threshold expression of  
 F^2^ > 2sigma(F^2^) is used only for calculating R-factors(gt) etc. and is  
 not relevant to the choice of reflections for refinement.  R-factors based  
 on F^2^ are statistically about twice as large as those based on F, and R-  
 factors based on ALL data will be even larger.  
;  
   
_refine_ls_structure_factor_coef  Fsqd  
_refine_ls_matrix_type            full  
_refine_ls_weighting_scheme       calc  
_refine_ls_weighting_details  
 'calc w=1/[\s^2^(Fo^2^)+(0.0414P)^2^+0.0000P] where P=(Fo^2^+2Fc^2^)/3'  
_atom_sites_solution_primary      direct  
_atom_sites_solution_secondary    difmap  
_atom_sites_solution_hydrogens    geom  
_refine_ls_hydrogen_treatment     mixed  
_refine_ls_extinction_method      none  
_refine_ls_extinction_coef        ?  
_refine_ls_abs_structure_details  
 'Flack H D (1983), Acta Cryst. A39, 876-881'  
_refine_ls_abs_structure_Flack    0.00(2)  
 233 
_refine_ls_number_reflns          4296  
_refine_ls_number_parameters      139  
_refine_ls_number_restraints      1  
_refine_ls_R_factor_all           0.0311  
_refine_ls_R_factor_gt            0.0301  
_refine_ls_wR_factor_ref          0.0772  
_refine_ls_wR_factor_gt           0.0765  
_refine_ls_goodness_of_fit_ref    1.254  
_refine_ls_restrained_S_all       1.254  
_refine_ls_shift/su_max           1.493  
_refine_ls_shift/su_mean          0.011  
   
loop_  
 _atom_site_label  
 _atom_site_type_symbol  
 _atom_site_fract_x  
 _atom_site_fract_y  
 _atom_site_fract_z  
 _atom_site_U_iso_or_equiv  
 _atom_site_adp_type  
 _atom_site_occupancy  
 _atom_site_symmetry_multiplicity  
 _atom_site_calc_flag  
 _atom_site_refinement_flags  
 _atom_site_disorder_assembly  
 _atom_site_disorder_group  
I I 0.43910(2) 0.56286(2) 0.215825(17) 0.02705(6) Uani 1 1 d . . .  
O O 0.7947(3) 0.7568(2) 0.6996(2) 0.0293(4) Uani 1 1 d . . .  
N N 0.6465(3) 0.8069(2) 0.4256(3) 0.0201(4) Uani 1 1 d . . .  
C1 C 0.3587(4) 0.7465(3) 0.1687(3) 0.0198(5) Uani 1 1 d . . .  
C2 C 0.4675(4) 0.8356(2) 0.2817(3) 0.0187(4) Uani 1 1 d . . .  
C3 C 0.4017(4) 0.9554(3) 0.2530(3) 0.0235(5) Uani 1 1 d . . .  
H3 H 0.4715 1.0164 0.3313 0.028 Uiso 1 1 calc R . .  
C4 C 0.2349(5) 0.9864(3) 0.1109(4) 0.0278(6) Uani 1 1 d . . .  
H4 H 0.1917 1.0684 0.0916 0.033 Uiso 1 1 calc R . .  
C5 C 0.1317(4) 0.8976(3) -0.0029(3) 0.0260(5) Uani 1 1 d . . .  
H5 H 0.0198 0.9191 -0.1016 0.031 Uiso 1 1 calc R . .  
C6 C 0.1914(4) 0.7774(3) 0.0269(3) 0.0222(5) Uani 1 1 d . . .  
H6 H 0.1180 0.7163 -0.0495 0.027 Uiso 1 1 calc R . .  
C7 C 0.6388(4) 0.7755(3) 0.5755(3) 0.0214(5) Uani 1 1 d . . .  
C8 C 0.8494(4) 0.8272(3) 0.4171(4) 0.0252(5) Uani 1 1 d . . .  
H8 H 0.9470 0.7700 0.4978 0.030 Uiso 1 1 calc R . .  
C9 C 0.8486(5) 0.7987(4) 0.2445(4) 0.0394(8) Uani 1 1 d . . .  
H9A H 0.8052 0.7147 0.2151 0.059 Uiso 1 1 calc R . .  
H9B H 0.9860 0.8097 0.2451 0.059 Uiso 1 1 calc R . .  
H9C H 0.7542 0.8534 0.1620 0.059 Uiso 1 1 calc R . .  
C10 C 0.9250(5) 0.9554(3) 0.4723(5) 0.0373(8) Uani 1 1 d . . .  
H10A H 0.8360 1.0138 0.3925 0.056 Uiso 1 1 calc R . .  
H10B H 1.0642 0.9641 0.4763 0.056 Uiso 1 1 calc R . .  
H10C H 0.9235 0.9707 0.5834 0.056 Uiso 1 1 calc R . .  
C11 C 0.4335(4) 0.7676(3) 0.5844(3) 0.0229(5) Uani 1 1 d . . .  
H11 H 0.3159 0.7706 0.4841 0.028 Uiso 1 1 calc R . .  
C12 C 0.4117(5) 0.7566(3) 0.7292(4) 0.0299(6) Uani 1 1 d . . .  
H12A H 0.5283 0.7535 0.8302 0.036 Uiso 1 1 calc R . .  
H12B H 0.2794 0.7517 0.7320 0.036 Uiso 1 1 calc R . .  
   
loop_  
 _atom_site_aniso_label  
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 _atom_site_aniso_U_11  
 _atom_site_aniso_U_22  
 _atom_site_aniso_U_33  
 _atom_site_aniso_U_23  
 _atom_site_aniso_U_13  
 _atom_site_aniso_U_12  
I 0.02712(8) 0.02363(8) 0.02876(8) -0.00226(10) 0.00872(6) 0.00017(11)  
O 0.0245(10) 0.0381(12) 0.0170(8) 0.0040(8) -0.0015(7) -0.0004(8)  
N 0.0138(9) 0.0273(11) 0.0173(9) 0.0017(8) 0.0036(7) 0.0001(8)  
C1 0.0131(10) 0.0296(13) 0.0157(10) -0.0018(9) 0.0043(8) 0.0001(8)  
C2 0.0138(9) 0.0262(12) 0.0152(10) -0.0003(9) 0.0046(8) 0.0010(8)  
C3 0.0212(11) 0.0255(12) 0.0227(11) -0.0017(9) 0.0069(10) -0.0009(9)  
C4 0.0236(12) 0.0311(14) 0.0265(13) 0.0050(11) 0.0070(10) 0.0053(10)  
C5 0.0184(11) 0.0380(16) 0.0188(11) 0.0047(10) 0.0040(9) 0.0052(10)  
C6 0.0172(10) 0.0324(13) 0.0169(10) -0.0014(9) 0.0061(9) -0.0004(9)  
C7 0.0204(11) 0.0233(12) 0.0179(10) -0.0001(9) 0.0042(9) -0.0002(9)  
C8 0.0101(9) 0.0373(15) 0.0262(12) 0.0019(11) 0.0044(9) -0.0007(9)  
C9 0.0235(13) 0.065(3) 0.0351(16) -0.0028(16) 0.0170(13) -0.0051(14)  
C10 0.0236(13) 0.0370(18) 0.048(2) -0.0010(15) 0.0102(13) -0.0091(12)  
C11 0.0211(11) 0.0271(13) 0.0198(11) 0.0000(10) 0.0068(9) -0.0016(10)  
C12 0.0368(16) 0.0318(16) 0.0248(13) -0.0009(10) 0.0158(12) -0.0010(12)  
   
_geom_special_details  
;  
 All esds (except the esd in the dihedral angle between two l.s. planes)  
 are estimated using the full covariance matrix.  The cell esds are taken  
 into account individually in the estimation of esds in distances, angles  
 and torsion angles; correlations between esds in cell parameters are only  
 used when they are defined by crystal symmetry.  An approximate (isotropic)  
 treatment of cell esds is used for estimating esds involving l.s. planes.  
;  
   
loop_  
 _geom_bond_atom_site_label_1  
 _geom_bond_atom_site_label_2  
 _geom_bond_distance  
 _geom_bond_site_symmetry_2  
 _geom_bond_publ_flag  
I C1 2.103(3) . ?  
O C7 1.233(3) . ?  
N C7 1.362(3) . ?  
N C2 1.438(3) . ?  
N C8 1.487(3) . ?  
C1 C6 1.389(4) . ?  
C1 C2 1.396(4) . ?  
C2 C3 1.394(4) . ?  
C3 C4 1.389(4) . ?  
C3 H3 0.9500 . ?  
C4 C5 1.386(5) . ?  
C4 H4 0.9500 . ?  
C5 C6 1.387(4) . ?  
C5 H5 0.9500 . ?  
C6 H6 0.9500 . ?  
C7 C11 1.491(4) . ?  
C8 C9 1.523(5) . ?  
C8 C10 1.525(5) . ?  
C8 H8 1.0000 . ?  
C9 H9A 0.9800 . ?  
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C9 H9B 0.9800 . ?  
C9 H9C 0.9800 . ?  
C10 H10A 0.9800 . ?  
C10 H10B 0.9800 . ?  
C10 H10C 0.9800 . ?  
C11 C12 1.323(4) . ?  
C11 H11 0.9500 . ?  
C12 H12A 0.9500 . ?  
C12 H12B 0.9500 . ?  
   
loop_  
 _geom_angle_atom_site_label_1  
 _geom_angle_atom_site_label_2  
 _geom_angle_atom_site_label_3  
 _geom_angle  
 _geom_angle_site_symmetry_1  
 _geom_angle_site_symmetry_3  
 _geom_angle_publ_flag  
C7 N C2 122.6(2) . . ?  
C7 N C8 118.3(2) . . ?  
C2 N C8 118.7(2) . . ?  
C6 C1 C2 120.4(3) . . ?  
C6 C1 I 119.1(2) . . ?  
C2 C1 I 120.39(18) . . ?  
C3 C2 C1 119.0(2) . . ?  
C3 C2 N 119.3(2) . . ?  
C1 C2 N 121.7(2) . . ?  
C4 C3 C2 120.5(3) . . ?  
C4 C3 H3 119.7 . . ?  
C2 C3 H3 119.7 . . ?  
C5 C4 C3 119.9(3) . . ?  
C5 C4 H4 120.1 . . ?  
C3 C4 H4 120.1 . . ?  
C4 C5 C6 120.2(3) . . ?  
C4 C5 H5 119.9 . . ?  
C6 C5 H5 119.9 . . ?  
C5 C6 C1 119.9(3) . . ?  
C5 C6 H6 120.0 . . ?  
C1 C6 H6 120.0 . . ?  
O C7 N 121.6(3) . . ?  
O C7 C11 121.3(3) . . ?  
N C7 C11 117.1(2) . . ?  
N C8 C9 111.9(2) . . ?  
N C8 C10 110.9(3) . . ?  
C9 C8 C10 111.6(3) . . ?  
N C8 H8 107.4 . . ?  
C9 C8 H8 107.4 . . ?  
C10 C8 H8 107.4 . . ?  
C8 C9 H9A 109.5 . . ?  
C8 C9 H9B 109.5 . . ?  
H9A C9 H9B 109.5 . . ?  
C8 C9 H9C 109.5 . . ?  
H9A C9 H9C 109.5 . . ?  
H9B C9 H9C 109.5 . . ?  
C8 C10 H10A 109.5 . . ?  
C8 C10 H10B 109.5 . . ?  
H10A C10 H10B 109.5 . . ?  
C8 C10 H10C 109.5 . . ?  
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H10A C10 H10C 109.5 . . ?  
H10B C10 H10C 109.5 . . ?  
C12 C11 C7 121.3(3) . . ?  
C12 C11 H11 119.3 . . ?  
C7 C11 H11 119.3 . . ?  
C11 C12 H12A 120.0 . . ?  
C11 C12 H12B 120.0 . . ?  
H12A C12 H12B 120.0 . . ?  
   
_diffrn_measured_fraction_theta_max    0.967  
_diffrn_reflns_theta_full              32.49  
_diffrn_measured_fraction_theta_full   0.967  
_refine_diff_density_max    1.911  
_refine_diff_density_min   -0.702  
_refine_diff_density_rms    0.115 
 
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
 
 
Figure 7.5 - ORTEP of rac-164 
The corresponding CIF file for rac-164 is found below, between the lines of '+' symbols. 
 
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
 
data_andre1  
 
_audit_creation_method            SHELXL-97  
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_chemical_name_systematic  
;  
 ?  
;  
_chemical_name_common             ?  
_chemical_melting_point           ?  
_chemical_formula_moiety          ?  
_chemical_formula_sum  
 'C28 H30 Br Cl I N O2 Si'  
_chemical_formula_weight          682.88  
 
loop_  
 _atom_type_symbol  
 _atom_type_description  
 _atom_type_scat_dispersion_real  
 _atom_type_scat_dispersion_imag  
 _atom_type_scat_source  
 'C'  'C'   0.0033   0.0016  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'H'  'H'   0.0000   0.0000  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'Br'  'Br'  -0.2901   2.4595  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'Cl'  'Cl'   0.1484   0.1585  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'I'  'I'  -0.4742   1.8119  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'N'  'N'   0.0061   0.0033  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'O'  'O'   0.0106   0.0060  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'Si'  'Si'   0.0817   0.0704  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 
_symmetry_cell_setting            Monoclinic  
_symmetry_space_group_name_H-M    P2(1)  
 
loop_  
 _symmetry_equiv_pos_as_xyz  
 'x, y, z'  
 '-x, y+1/2, -z+1/2'  
 '-x, -y, -z'  
 'x, -y-1/2, z-1/2'  
 
_cell_length_a                    14.9577(13)  
_cell_length_b                    8.6493(8)  
_cell_length_c                    24.7343(18)  
_cell_angle_alpha                 90.00  
_cell_angle_beta                  108.827(4)  
_cell_angle_gamma                 90.00  
_cell_volume                      3028.8(4)  
_cell_formula_units_Z             4  
_cell_measurement_temperature     295(2)  
_cell_measurement_reflns_used     3527  
_cell_measurement_theta_min       2.51  
_cell_measurement_theta_max       21.05  
 
_exptl_crystal_description        ?  
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_exptl_crystal_colour             ?  
_exptl_crystal_size_max           0.25  
_exptl_crystal_size_mid           0.08  
_exptl_crystal_size_min           0.08  
_exptl_crystal_density_meas       0  
_exptl_crystal_density_diffrn     1.498  
_exptl_crystal_density_method     'not measured'  
_exptl_crystal_F_000              1360  
_exptl_absorpt_coefficient_mu     2.528  
_exptl_absorpt_correction_type    none  
_exptl_absorpt_correction_T_min   0.5706  
_exptl_absorpt_correction_T_max   0.8233  
_exptl_absorpt_process_details    ?  
 
_exptl_special_details  
;  
 ?  
;  
 
_diffrn_ambient_temperature       295(2)  
_diffrn_radiation_wavelength      0.71073  
_diffrn_radiation_type            MoK\a  
_diffrn_radiation_source          'fine-focus sealed tube'  
_diffrn_radiation_monochromator   graphite  
_diffrn_measurement_device_type   'CCD area detector'  
_diffrn_measurement_method        'phi and omega scans'  
_diffrn_detector_area_resol_mean  ?  
_diffrn_standards_number          ?  
_diffrn_standards_interval_count  ?  
_diffrn_standards_interval_time   ?  
_diffrn_standards_decay_%         ?  
_diffrn_reflns_number             23683  
_diffrn_reflns_av_R_equivalents   0.1084  
_diffrn_reflns_av_sigmaI/netI     0.0932  
_diffrn_reflns_limit_h_min        -17  
_diffrn_reflns_limit_h_max        17  
_diffrn_reflns_limit_k_min        -10  
_diffrn_reflns_limit_k_max        10  
_diffrn_reflns_limit_l_min        -29  
_diffrn_reflns_limit_l_max        29  
_diffrn_reflns_theta_min          1.44  
_diffrn_reflns_theta_max          25.00  
_reflns_number_total              5342  
_reflns_number_gt                 2978  
_reflns_threshold_expression      >2sigma(I)  
 
_computing_data_collection        'Bruker SMART'  
_computing_cell_refinement        'Bruker SMART'  
_computing_data_reduction         'Bruker SAINT'  
_computing_structure_solution     'SHELXS-97 (Sheldrick, 1990)'  
_computing_structure_refinement   'SHELXL-97 (Sheldrick, 1997)'  
_computing_molecular_graphics     'Bruker SHELXTL'  
_computing_publication_material   'Bruker SHELXTL'  
 
_refine_special_details  
;  
 Refinement of F^2^ against ALL reflections.  The weighted R-factor wR and  
 goodness of fit S are based on F^2^, conventional R-factors R are based  
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 on F, with F set to zero for negative F^2^. The threshold expression of  
 F^2^ > 2sigma(F^2^) is used only for calculating R-factors(gt) etc. and is  
 not relevant to the choice of reflections for refinement.  R-factors based  
 on F^2^ are statistically about twice as large as those based on F, and R-  
 factors based on ALL data will be even larger.  
;  
 
_refine_ls_structure_factor_coef  Fsqd  
_refine_ls_matrix_type            full  
_refine_ls_weighting_scheme       calc  
_refine_ls_weighting_details  
 'calc w=1/[\s^2^(Fo^2^)+(0.0780P)^2^+0.0000P] where P=(Fo^2^+2Fc^2^)/3'  
_atom_sites_solution_primary      direct  
_atom_sites_solution_secondary    difmap  
_atom_sites_solution_hydrogens    geom  
_refine_ls_hydrogen_treatment     mixed  
_refine_ls_extinction_method      none  
_refine_ls_extinction_coef        ?  
_refine_ls_number_reflns          5342  
_refine_ls_number_parameters      316  
_refine_ls_number_restraints      0  
_refine_ls_R_factor_all           0.2076  
_refine_ls_R_factor_gt            0.1444  
_refine_ls_wR_factor_ref          0.3800  
_refine_ls_wR_factor_gt           0.3673  
_refine_ls_goodness_of_fit_ref    2.315  
_refine_ls_restrained_S_all       2.315  
_refine_ls_shift/su_max           0.061  
_refine_ls_shift/su_mean          0.006  
 
loop_  
 _atom_site_label  
 _atom_site_type_symbol  
 _atom_site_fract_x  
 _atom_site_fract_y  
 _atom_site_fract_z  
 _atom_site_U_iso_or_equiv  
 _atom_site_adp_type  
 _atom_site_occupancy  
 _atom_site_symmetry_multiplicity  
 _atom_site_calc_flag  
 _atom_site_refinement_flags  
 _atom_site_disorder_assembly  
 _atom_site_disorder_group  
I I 0.45188(11) 0.22816(18) 0.01639(8) 0.0907(7) Uani 1 1 d . . .  
Br Br 0.14257(16) -0.1818(2) 0.01288(13) 0.0926(9) Uani 1 1 d . . .  
Cl Cl 0.0542(2) 0.4273(4) -0.06221(18) 0.0436(10) Uani 1 1 d . . .  
Si Si 0.2199(3) 0.2505(6) 0.2070(2) 0.0518(13) Uani 1 1 d . . .  
N N 0.2731(9) 0.4549(16) -0.0329(6) 0.049(4) Uani 1 1 d . . .  
O1 O 0.2104(9) 0.3591(15) 0.1518(5) 0.065(3) Uani 1 1 d . . .  
C1 C 0.3112(11) 0.1873(18) 0.0020(7) 0.043(4) Uani 1 1 d . . .  
C2 C 0.2798(12) 0.041(2) 0.0093(7) 0.052(5) Uani 1 1 d . . .  
H2A H 0.3230 -0.0395 0.0216 0.063 Uiso 1 1 calc R . .  
O2 O 0.3562(9) 0.6759(13) -0.0093(5) 0.063(3) Uani 1 1 d . . .  
C3 C 0.1825(16) 0.013(2) -0.0018(8) 0.063(5) Uani 1 1 d . . .  
C4 C 0.1181(12) 0.127(2) -0.0224(8) 0.054(5) Uani 1 1 d . . .  
H4A H 0.0537 0.1083 -0.0317 0.065 Uiso 1 1 calc R . .  
C5 C 0.1519(12) 0.2715(17) -0.0289(7) 0.050(4) Uani 1 1 d . . .  
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C6 C 0.2465(11) 0.3064(16) -0.0208(7) 0.044(4) Uani 1 1 d . . .  
C7 C 0.3235(11) 0.563(2) 0.0069(8) 0.049(4) Uani 1 1 d . . .  
C8 C 0.3389(12) 0.5401(17) 0.0679(8) 0.051(5) Uani 1 1 d . . .  
C9 C 0.2763(14) 0.4937(19) 0.0870(8) 0.059(5) Uani 1 1 d . . .  
H9A H 0.2201 0.4680 0.0588 0.070 Uiso 1 1 calc R . .  
C10 C 0.2735(16) 0.470(2) 0.1492(8) 0.069(6) Uani 1 1 d . . .  
H10A H 0.3359 0.4413 0.1739 0.083 Uiso 1 1 calc R . .  
H10B H 0.2566 0.5671 0.1631 0.083 Uiso 1 1 calc R . .  
C11 C 0.0950(15) 0.153(3) 0.1888(10) 0.083(7) Uani 1 1 d . . .  
C12 C 0.083(2) 0.053(4) 0.1387(14) 0.157(14) Uani 1 1 d . . .  
H12A H 0.0220 0.0034 0.1286 0.235 Uiso 1 1 calc R . .  
H12B H 0.1314 -0.0235 0.1474 0.235 Uiso 1 1 calc R . .  
H12C H 0.0859 0.1151 0.1071 0.235 Uiso 1 1 calc R . .  
C13 C 0.0821(19) 0.085(4) 0.2430(12) 0.129(11) Uani 1 1 d . . .  
H13A H 0.0212 0.0372 0.2336 0.194 Uiso 1 1 calc R . .  
H13B H 0.0865 0.1668 0.2701 0.194 Uiso 1 1 calc R . .  
H13C H 0.1304 0.0101 0.2592 0.194 Uiso 1 1 calc R . .  
C14 C 0.029(2) 0.275(6) 0.1693(17) 0.27(3) Uani 1 1 d . . .  
H14A H -0.0338 0.2343 0.1592 0.409 Uiso 1 1 calc R . .  
H14B H 0.0385 0.3221 0.1364 0.409 Uiso 1 1 calc R . .  
H14C H 0.0385 0.3503 0.1990 0.409 Uiso 1 1 calc R . .  
C15 C 0.3362(14) -0.003(2) 0.2568(10) 0.080(6) Uani 1 1 d . . .  
H15A H 0.3049 0.0023 0.2837 0.096 Uiso 1 1 calc R . .  
C16 C 0.405(2) -0.126(3) 0.2633(15) 0.161(18) Uani 1 1 d . . .  
H16A H 0.4201 -0.2049 0.2905 0.193 Uiso 1 1 calc R . .  
C17 C 0.450(2) -0.096(6) 0.211(2) 0.20(3) Uani 1 1 d . . .  
H17A H 0.5049 -0.1483 0.2129 0.236 Uiso 1 1 calc R . .  
C18 C 0.420(3) -0.019(5) 0.1753(14) 0.16(2) Uani 1 1 d . . .  
H18A H 0.4366 -0.0289 0.1424 0.189 Uiso 1 1 calc R . .  
C19 C 0.3591(18) 0.088(3) 0.1787(11) 0.093(7) Uani 1 1 d . . .  
H19A H 0.3460 0.1632 0.1504 0.112 Uiso 1 1 calc R . .  
C20 C 0.3143(12) 0.104(2) 0.2160(9) 0.057(5) Uani 1 1 d . . .  
C21 C 0.3246(18) 0.358(3) 0.3193(9) 0.082(7) Uani 1 1 d . . .  
H21A H 0.3667 0.2785 0.3197 0.099 Uiso 1 1 calc R . .  
C22 C 0.341(2) 0.451(4) 0.3647(10) 0.112(10) Uani 1 1 d . . .  
H22A H 0.3920 0.4274 0.3966 0.135 Uiso 1 1 calc R . .  
C23 C 0.290(2) 0.573(3) 0.3681(14) 0.100(9) Uani 1 1 d . . .  
H23A H 0.2988 0.6307 0.4012 0.120 Uiso 1 1 calc R . .  
C24 C 0.232(3) 0.601(3) 0.322(2) 0.136(13) Uani 1 1 d . . .  
H24A H 0.2012 0.6956 0.3211 0.164 Uiso 1 1 calc R . .  
C25 C 0.1993(16) 0.513(3) 0.2687(12) 0.105(10) Uani 1 1 d . . .  
H25A H 0.1519 0.5451 0.2359 0.127 Uiso 1 1 calc R . .  
C26 C 0.2483(13) 0.378(2) 0.2733(8) 0.057(5) Uani 1 1 d . . .  
C27 C 0.2559(14) 0.492(2) -0.0931(8) 0.066(5) Uani 1 1 d . . .  
H27A H 0.2214 0.4089 -0.1164 0.100 Uiso 1 1 calc R . .  
H27B H 0.3151 0.5054 -0.0998 0.100 Uiso 1 1 calc R . .  
H27C H 0.2197 0.5855 -0.1025 0.100 Uiso 1 1 calc R . .  
C28 C 0.4379(14) 0.587(3) 0.1069(10) 0.086(7) Uani 1 1 d . . .  
H28A H 0.4426 0.5685 0.1460 0.129 Uiso 1 1 calc R . .  
H28B H 0.4483 0.6942 0.1016 0.129 Uiso 1 1 calc R . .  
H28C H 0.4846 0.5260 0.0975 0.129 Uiso 1 1 calc R . .  
 
loop_  
 _atom_site_aniso_label  
 _atom_site_aniso_U_11  
 _atom_site_aniso_U_22  
 _atom_site_aniso_U_33  
 _atom_site_aniso_U_23  
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 _atom_site_aniso_U_13  
 _atom_site_aniso_U_12  
I 0.0728(11) 0.0825(12) 0.1171(15) -0.0095(9) 0.0308(9) 0.0003(8)  
Br 0.0731(16) 0.0433(12) 0.168(3) 0.0157(13) 0.0472(16) -0.0016(9)  
Cl 0.032(2) 0.0166(17) 0.072(3) 0.0099(17) 0.0037(18) 0.0018(14)  
Si 0.047(3) 0.067(3) 0.042(3) 0.004(2) 0.017(2) 0.002(2)  
N 0.038(8) 0.063(9) 0.049(10) 0.004(7) 0.016(7) -0.010(7)  
O1 0.058(8) 0.072(9) 0.068(9) 0.021(7) 0.024(7) -0.003(6)  
C1 0.039(9) 0.042(9) 0.042(10) -0.011(7) 0.002(8) -0.010(7)  
C2 0.041(11) 0.055(11) 0.057(12) -0.003(8) 0.011(9) 0.024(8)  
O2 0.074(9) 0.053(8) 0.068(9) 0.023(6) 0.034(7) -0.003(6)  
C3 0.095(17) 0.044(11) 0.048(12) -0.008(9) 0.020(11) -0.001(10)  
C4 0.043(10) 0.053(11) 0.064(12) 0.005(9) 0.015(9) 0.011(8)  
C5 0.047(11) 0.029(9) 0.064(12) 0.005(8) 0.003(9) 0.012(7)  
C6 0.042(10) 0.023(8) 0.052(10) -0.002(7) -0.003(8) -0.002(7)  
C7 0.043(10) 0.056(11) 0.049(12) 0.009(9) 0.017(8) -0.015(8)  
C8 0.046(11) 0.033(9) 0.073(14) 0.000(8) 0.020(10) -0.015(7)  
C9 0.060(13) 0.048(11) 0.057(13) -0.029(9) 0.003(10) -0.001(9)  
C10 0.097(16) 0.066(13) 0.040(12) 0.001(9) 0.016(11) -0.025(11)  
C11 0.071(15) 0.086(16) 0.079(17) 0.009(13) 0.007(12) -0.020(12)  
C12 0.12(3) 0.24(4) 0.12(3) -0.08(3) 0.04(2) -0.04(2)  
C13 0.11(2) 0.16(3) 0.11(2) 0.040(19) 0.027(18) -0.051(19)  
C14 0.07(2) 0.54(9) 0.18(4) 0.07(5) 0.02(2) 0.18(4)  
C15 0.054(13) 0.080(15) 0.080(16) -0.009(13) -0.014(11) 0.008(11)  
C16 0.10(2) 0.087(18) 0.17(3) -0.024(18) -0.12(2) 0.040(15)  
C17 0.059(19) 0.34(7) 0.19(4) -0.22(5) 0.04(3) -0.02(3)  
C18 0.21(5) 0.15(3) 0.07(2) 0.02(2) -0.01(2) 0.09(3)  
C19 0.094(18) 0.098(19) 0.092(19) -0.020(14) 0.037(16) 0.013(14)  
C20 0.048(11) 0.069(13) 0.053(12) -0.007(10) 0.015(10) 0.009(9)  
C21 0.12(2) 0.078(15) 0.051(14) -0.012(12) 0.030(14) 0.022(13)  
C22 0.14(3) 0.13(3) 0.046(15) -0.001(16) -0.003(15) -0.06(2)  
C23 0.11(2) 0.071(19) 0.11(2) 0.004(16) 0.016(19) -0.003(16)  
C24 0.12(3) 0.08(2) 0.25(5) -0.02(3) 0.12(3) 0.002(19)  
C25 0.064(15) 0.103(19) 0.14(2) -0.074(18) 0.020(14) 0.018(12)  
C26 0.051(12) 0.072(12) 0.046(12) -0.004(9) 0.015(10) -0.004(9)  
C27 0.076(14) 0.076(13) 0.047(13) 0.001(10) 0.019(10) -0.026(10)  
C28 0.067(14) 0.084(16) 0.087(16) -0.028(12) -0.002(12) -0.024(11)  
 
_geom_special_details  
;  
 All esds (except the esd in the dihedral angle between two l.s. planes)  
 are estimated using the full covariance matrix.  The cell esds are taken  
 into account individually in the estimation of esds in distances, angles  
 and torsion angles; correlations between esds in cell parameters are only  
 used when they are defined by crystal symmetry.  An approximate (isotropic)  
 treatment of cell esds is used for estimating esds involving l.s. planes.  
;  
 
loop_  
 _geom_bond_atom_site_label_1  
 _geom_bond_atom_site_label_2  
 _geom_bond_distance  
 _geom_bond_site_symmetry_2  
 _geom_bond_publ_flag  
I C1 2.049(16) . ?  
Br C3 1.861(18) . ?  
Cl C5 1.963(15) . ?  
Si O1 1.626(13) . ?  
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Si C20 1.856(18) . ?  
Si C26 1.908(19) . ?  
Si C11 1.97(2) . ?  
N C7 1.39(2) . ?  
N C6 1.406(18) . ?  
N C27 1.46(2) . ?  
O1 C10 1.36(2) . ?  
C1 C2 1.38(2) . ?  
C1 C6 1.40(2) . ?  
C2 C3 1.41(2) . ?  
C2 H2A 0.9300 . ?  
O2 C7 1.217(17) . ?  
C3 C4 1.36(2) . ?  
C4 C5 1.38(2) . ?  
C4 H4A 0.9300 . ?  
C5 C6 1.40(2) . ?  
C7 C8 1.46(2) . ?  
C8 C9 1.24(2) . ?  
C8 C28 1.54(2) . ?  
C9 C10 1.56(3) . ?  
C9 H9A 0.9300 . ?  
C10 H10A 0.9700 . ?  
C10 H10B 0.9700 . ?  
C11 C14 1.42(4) . ?  
C11 C12 1.47(3) . ?  
C11 C13 1.53(3) . ?  
C12 H12A 0.9600 . ?  
C12 H12B 0.9600 . ?  
C12 H12C 0.9600 . ?  
C13 H13A 0.9600 . ?  
C13 H13B 0.9600 . ?  
C13 H13C 0.9600 . ?  
C14 H14A 0.9600 . ?  
C14 H14B 0.9600 . ?  
C14 H14C 0.9600 . ?  
C15 C20 1.33(3) . ?  
C15 C16 1.46(3) . ?  
C15 H15A 0.9300 . ?  
C16 C17 1.66(6) . ?  
C16 H16A 0.9300 . ?  
C17 C18 1.08(7) . ?  
C17 H17A 0.9300 . ?  
C18 C19 1.32(4) . ?  
C18 H18A 0.9300 . ?  
C19 C20 1.31(3) . ?  
C19 H19A 0.9300 . ?  
C21 C22 1.34(3) . ?  
C21 C26 1.34(3) . ?  
C21 H21A 0.9300 . ?  
C22 C23 1.32(4) . ?  
C22 H22A 0.9300 . ?  
C23 C24 1.21(4) . ?  
C23 H23A 0.9300 . ?  
C24 C25 1.47(5) . ?  
C24 H24A 0.9300 . ?  
C25 C26 1.36(3) . ?  
C25 H25A 0.9300 . ?  
C27 H27A 0.9600 . ?  
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C27 H27B 0.9600 . ?  
C27 H27C 0.9600 . ?  
C28 H28A 0.9600 . ?  
C28 H28B 0.9600 . ?  
C28 H28C 0.9600 . ?  
 
loop_  
 _geom_angle_atom_site_label_1  
 _geom_angle_atom_site_label_2  
 _geom_angle_atom_site_label_3  
 _geom_angle  
 _geom_angle_site_symmetry_1  
 _geom_angle_site_symmetry_3  
 _geom_angle_publ_flag  
O1 Si C20 110.6(8) . . ?  
O1 Si C26 108.8(8) . . ?  
C20 Si C26 110.0(8) . . ?  
O1 Si C11 103.7(8) . . ?  
C20 Si C11 111.4(10) . . ?  
C26 Si C11 112.2(9) . . ?  
C7 N C6 126.1(14) . . ?  
C7 N C27 116.9(13) . . ?  
C6 N C27 116.6(14) . . ?  
C10 O1 Si 125.0(12) . . ?  
C2 C1 C6 120.5(14) . . ?  
C2 C1 I 120.5(12) . . ?  
C6 C1 I 118.7(11) . . ?  
C1 C2 C3 120.2(14) . . ?  
C1 C2 H2A 119.9 . . ?  
C3 C2 H2A 119.9 . . ?  
C4 C3 C2 120.6(17) . . ?  
C4 C3 Br 119.9(16) . . ?  
C2 C3 Br 119.5(14) . . ?  
C3 C4 C5 117.5(17) . . ?  
C3 C4 H4A 121.3 . . ?  
C5 C4 H4A 121.3 . . ?  
C4 C5 C6 125.0(14) . . ?  
C4 C5 Cl 114.8(12) . . ?  
C6 C5 Cl 119.6(11) . . ?  
C5 C6 N 120.7(13) . . ?  
C5 C6 C1 115.8(14) . . ?  
N C6 C1 123.4(14) . . ?  
O2 C7 N 119.2(16) . . ?  
O2 C7 C8 120.2(16) . . ?  
N C7 C8 120.5(14) . . ?  
C9 C8 C7 123.2(17) . . ?  
C9 C8 C28 122(2) . . ?  
C7 C8 C28 114.3(16) . . ?  
C8 C9 C10 132.7(18) . . ?  
C8 C9 H9A 113.7 . . ?  
C10 C9 H9A 113.7 . . ?  
O1 C10 C9 112.1(15) . . ?  
O1 C10 H10A 109.2 . . ?  
C9 C10 H10A 109.2 . . ?  
O1 C10 H10B 109.2 . . ?  
C9 C10 H10B 109.2 . . ?  
H10A C10 H10B 107.9 . . ?  
C14 C11 C12 105(3) . . ?  
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C14 C11 C13 108(3) . . ?  
C12 C11 C13 120(2) . . ?  
C14 C11 Si 105(2) . . ?  
C12 C11 Si 107.3(18) . . ?  
C13 C11 Si 110.0(15) . . ?  
C11 C12 H12A 109.5 . . ?  
C11 C12 H12B 109.5 . . ?  
H12A C12 H12B 109.5 . . ?  
C11 C12 H12C 109.5 . . ?  
H12A C12 H12C 109.5 . . ?  
H12B C12 H12C 109.5 . . ?  
C11 C13 H13A 109.5 . . ?  
C11 C13 H13B 109.5 . . ?  
H13A C13 H13B 109.5 . . ?  
C11 C13 H13C 109.5 . . ?  
H13A C13 H13C 109.5 . . ?  
H13B C13 H13C 109.5 . . ?  
C11 C14 H14A 109.4 . . ?  
C11 C14 H14B 109.5 . . ?  
H14A C14 H14B 109.5 . . ?  
C11 C14 H14C 109.5 . . ?  
H14A C14 H14C 109.5 . . ?  
H14B C14 H14C 109.5 . . ?  
C20 C15 C16 126(3) . . ?  
C20 C15 H15A 117.0 . . ?  
C16 C15 H15A 117.0 . . ?  
C15 C16 C17 104(3) . . ?  
C15 C16 H16A 127.9 . . ?  
C17 C16 H16A 128.0 . . ?  
C18 C17 C16 125(4) . . ?  
C18 C17 H17A 117.6 . . ?  
C16 C17 H17A 117.4 . . ?  
C17 C18 C19 119(5) . . ?  
C17 C18 H18A 120.4 . . ?  
C19 C18 H18A 120.4 . . ?  
C20 C19 C18 130(3) . . ?  
C20 C19 H19A 115.1 . . ?  
C18 C19 H19A 115.1 . . ?  
C19 C20 C15 114(2) . . ?  
C19 C20 Si 122.0(18) . . ?  
C15 C20 Si 123.9(17) . . ?  
C22 C21 C26 120(2) . . ?  
C22 C21 H21A 119.8 . . ?  
C26 C21 H21A 119.8 . . ?  
C23 C22 C21 126(3) . . ?  
C23 C22 H22A 117.1 . . ?  
C21 C22 H22A 117.1 . . ?  
C24 C23 C22 111(3) . . ?  
C24 C23 H23A 124.5 . . ?  
C22 C23 H23A 124.5 . . ?  
C23 C24 C25 132(3) . . ?  
C23 C24 H24A 114.1 . . ?  
C25 C24 H24A 114.1 . . ?  
C26 C25 C24 111(3) . . ?  
C26 C25 H25A 124.6 . . ?  
C24 C25 H25A 124.5 . . ?  
C21 C26 C25 118.2(19) . . ?  
C21 C26 Si 123.2(15) . . ?  
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C25 C26 Si 117.3(16) . . ?  
N C27 H27A 109.5 . . ?  
N C27 H27B 109.5 . . ?  
H27A C27 H27B 109.5 . . ?  
N C27 H27C 109.5 . . ?  
H27A C27 H27C 109.5 . . ?  
H27B C27 H27C 109.5 . . ?  
C8 C28 H28A 109.5 . . ?  
C8 C28 H28B 109.5 . . ?  
H28A C28 H28B 109.5 . . ?  
C8 C28 H28C 109.5 . . ?  
H28A C28 H28C 109.5 . . ?  
H28B C28 H28C 109.5 . . ?  
 
_diffrn_measured_fraction_theta_max    1.000  
_diffrn_reflns_theta_full              25.00  
_diffrn_measured_fraction_theta_full   1.000  
_refine_diff_density_max    2.577  
_refine_diff_density_min   -1.750  
_refine_diff_density_rms    0.248 
 
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
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28 kcal/mol
117 kJ/mol
?1/2  = 260 days
30 kcal/mol
126 kJ/mol
?1/2  = 212 years
32 kcal/mol
134 kJ/mol
?1/2  = 627 years
34 kcal/mol
142 kJ/mol
?1/2  = 18,569 years
I
N
O
8, 30.89c
N
O
PhO
Br
175, 32.410a
N
O
Ph
I
56g, 32.79g
N
O
I
56b, 30.79g
Br
N
O
I
56a, 29.79g
164, 26.79j
N
Cl
Br
I
O
TBDPSO
N
I
O
154a, 27.59i
N
O
183, 26.417b
N
O
180, 29.117b
N
O
178, 29.617b
N
O
181, 28.817b
N
O
Ph OTIPS
184, 26.117a
179, 29.617a
N
O
OTMS
iPr
iPr
Ph
26 kcal/mol
109 kJ/mol
?1/2  = 88 days
N-Aryl Rotation Barriers 
(? 1/2 at 23 °C)
ITMS
N
O
176, 30.89h
BrTMS
N
O
182, 28.89h
BrI
N
O
177, 30.49h
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18 kcal/mol
75 kJ/mol
?1/2  = 986 milliseconds
20 kcal/mol
84 kJ/mol
?1/2  = 29 seconds
22 kcal/mol
92 kJ/mol
?1/2  = 14 minutes
24 kcal/mol
100 kJ/mol
?1/2  = 7 hours
N Ph
O
195, 19.310b
N
O
Ph
Cl
193, 20.310c
N
O
Ph
Cl
190, 21.710c
N
O
Ph
O
194, 20.110c
N
O
Ph
Cl
191, 21.310c
N
O
Ph
Cl
189, 22.310c
N Ph
O
Ph
197, 18.110b
N
O
Ph
Cl
Ph
192, 20.510c
N
OO
MeO2C CO2Me
16, 23.09c
N
I
O
N
I
O
109, 23.19i
112, 22.89i
,
O
196, 19.250
N
O
O
I
26 kcal/mol
109 kJ/mol
?1/2  = 88 days N
O
Ph
Cl
186, 25.310c
N
O
I
O
187, 25.150
N
O
OTMS
185, 25.417b
Ph
N
O
SO3Na
188, 23.48
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